Depression and Physical Illness


Depression and physical illness are intimately related. Depressed mood is thought to contribute to the development and progression of some illnesses, while physical illness can in turn increase the risk of depression. This book provides a critical overview of the evidence linking depression with several major health conditions, including coronary heart disease, diabetes, cancer, chronic pain, disability, chronic fatigue and obesity. It also explores the biological and behavioral processes underlying the association, discussing the role of neuroendocrine, immunological and inflammatory pathways, and the relationship between depression and health behaviours such as smoking, physical activity and adherence to medical advice. It combines a thorough analysis of the clinical, biological and epidemiological data with guidance to health professionals and patients on how to manage depression in people suffering from physical illness, pointing the way to an integrated approach to health care.


 Reviews:

'I recommend this book highly to all mental healthcare professionals … I would recommend this book to other medical specialists - on checking the contents of the latest editions of several prominent textbooks of medicine, I could find no reference to the role of depression despite the overwhelming evidence presented in Depression and Physical Illness.' British Journal of Psychiatry

'…a useful resource for those interested in depression.' Journal of Psychosomatic Research

'… this book is well worth considering. It gives helpful guidance to health professionals of all kinds on improving the health care of patients suffering from a wide range of disorders.' Journal of Mental Health

Reference Title: REFERENCE

Reference Type: reference-list

C. J. Murray, A. D. Lopez, Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 349 (1997), 1498–504.

Reference Title: REFERENCES

Reference Type: reference-list

C. J. Meakin, Screening for depression in the medically ill: the future of paper and pencil tests. Br. J. Psychiatry 160 (1992), 212–16.
G. Rodin, K. Voshart, Depression in the medically ill: an overview. Am. J. Psychiatry 143 (1986), 696–705.
R. Mayou, K. Hawton, Psychiatric disorder in the general hospital. Br. J. Psychiatry 149 (1986), 172–90.
J. S. McDaniel, D. L. Musselman, M. R. Porter, D. A. Reed, C. B. Nemeroff, Depression in patients with cancer: diagnosis, biology, and treatment. Arch. Gen. Psychiatry 52 (1995), 89–99.
F. H. Creed, Assessing depression in the context of physical illness. In M. M. Robinson, C. L. E. Katon, Depression and Physical Illness, ed. (Chichester: John Wiley & Sons, 1997), pp. 3–19.
F. Creed, Psychological disorders in rheumatoid arthritis: a growing consensus? Ann. Rheum. Dis. 49 (1990), 808–12.
M. Martucci, M. Balestrieri, G. Bisoffi, et al., Evaluating psychiatric morbidity in a general hospital: a two-phase epidemiological survey. Psychol. Med. 29 (1999), 823–32.
G. Gainotti, A. Azzoni, C. Marra, Frequency, phenomenology and anatomical-clinical correlates of major post-stroke depression. Br. J. Psychiatry 175 (1999), 163–7.
F. Creed, R. Morgan, M. Fiddler, et al., Depression and anxiety impair health-related quality of life and are associated with increased costs in general medical inpatients. Psychosomatics 43 (2002), 302–9.
K. W. Bridges, D. P. Goldberg, The validation of the GHQ-28 and the use of the MMSE in neurological in-patients. Br. J. Psychiatry 148 (1986), 548–53.
A. House, P. Knapp, J. Bamford, A. Vail, Mortality at 12 and 24 months after stroke may be associated with depressive symptoms at 1 month. Stroke 32 (2001), 696–701.
A. House, Mood disorders in the physically ill: problems of definition and measurement. J. Psychosom. Res 32 (1988), 345–53.
G. Dunn, A. Pickles, M. Tansella, J. L. Vazquez-Barquero, Two-phase epidemiological surveys in psychiatric research. Br. J. Psychiatry 174 (1999), 95–100.
A. Solomon, D. A. Haaga, B. A. Arnow, Is clinical depression distinct from subthreshold depressive symptoms? A review of the continuity issue in depression research. J. Nerv. Ment. Dis. 189 (2001), 498–506.
P. Rucci, S. Gherardi, M. Tansella, et al., Subthreshold psychiatric disorders in primary care: prevalence and associated characteristics. J. Affect. Dis. 76 (2003), 171–81.
K. B. Wells, J. M. Golding, M. A. Burnam, Psychiatric disorder in a sample of the general population with and without chronic medical conditions. Am. J. Psychiatry 145 (1988), 976–81.
T. Pincus, L. F. Callahan, L. A. Bradley, W. K. Vaughn, F. Wolfe, Elevated MMPI scores for hypochondriasis, depression, and hysteria in patients with rheumatoid arthritis reflect disease rather than psychological status. Arth. Rheum. 29 (1986), 1456–66.
J. Endicott, Measurement of depression in patients with cancer. Cancer 53 (1984), 2243–9.
A. L. Wesley, R. J. Gatchel, J. P. Garofalo, P. B. Polatin, Toward more accurate use of the Beck Depression Inventory with chronic back pain patients. Clin. J. Pain 15 (1999), 117–21.
J. E. Holm, D. B. Penzien, K. A. Holroyd, T. A. Brown, Headache and depression: confounding effects of transdiagnostic symptoms. Headache 34 (1994), 418–23.
P. J. Lustman, R. E. Clouse, L. S. Griffith, R. M. Carney, K. E. Freedland, Screening for depression in diabetes using the Beck Depression Inventory. Psychosom. Med. 59 (1997), 24–31.
J. E. Aikens, M. A. Reinecke, N. H. Pliskin, et al., Assessing depressive symptoms in multiple sclerosis: is it necessary to omit items from the original Beck Depression Inventory? J. Behav. Med. 22 (1999), 127–42.
A. S. Zigmond, R. P. Snaith, The hospital anxiety and depression scale. Acta Psychiatr. Scand. 67 (1983), 361–70.
J. S. Lyons, J. J. Strain, J. S. Hammer, A. D. Ackerman, G. Fulop, Reliability, validity, and temporal stability of the geriatric depression scale in hospitalized elderly. Int. J. Psychiatr. Med. 19 (1989), 203–9.
R. A. Incalzi, M. Cesari, C. Pedone, P. U. Carbonin, Construct validity of the 15-item geriatric depression scale in older medical inpatients. J. Geriatr. Psychiatr. Neurol. 16 (2003), 23–8.
C. Herrmann, International experiences with the Hospital Anxiety and Depression Scale: a review of validation data and clinical results. J. Psychosom. Res. 42 (1997), 17–41.
I. Bjelland, A. A. Dahl, T. T. Haug, D. Neckelmann, The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J. Psychosom. Res. 52 (2002), 69–77.
M. Johnston, B. Pollard, P. Hennessey, Construct validation of the hospital anxiety and depression scale with clinical populations. J. Psychosom. Res. 48 (2000), 579–84.
World Health Organization. Schedules for Clinical Assessment in Neuropsychiatry. Washington, DC: American Psychiatric Press, 1994.
V. Arolt, A. Fein, M. Driessen, L. Dorlochter, C. Maintz, Depression and social functioning in general hospital in-patients. J. Psychosom. Res. 45 (1998), 117–26.
E. Feldman, R. Mayou, K. Hawton, M. Ardern, E. B. Smith, Psychiatric disorder in medical in-patients. Q. J. Med. 63 (1987), 405–12.
P. H. Silverstone, Prevalence of psychiatric disorders in medical inpatients. J. Nerv. Ment. Dis. 184 (1996), 43–51.
M. G. Nair, S. S. Pillay, Psychiatric disorder in a South African general hospital: prevalence in medical, surgical, and gynecological wards. Gen. Hosp. Psychiatry 19 (1997), 144–8.
P. H. Silverstone, T. Lemay, J. Elliott, V. Hsu, R. Starko, The prevalence of major depressive disorder and low self-esteem in medical inpatients. Can. J. Psychiatry 41 (1996), 67–74.
W. Katon, P. Ciechanowski, Impact of major depression on chronic medical illness. J. Psychosom. Res. 53 (2002), 859–63.
A. J. Carson, B. Ringbauer, L. MacKenzie, C. Warlow, M. Sharpe, Neurological disease, emotional disorder, and disability: they are related – a study of 300 consecutive new referrals to a neurology outpatient department. J. Neurol. Neurosurg. Psychiatry 68 (2000), 202–6.
B. Lowe, K. Grafe, S. Zipfel, et al., Diagnosing ICD-10 depressive episodes: superior criterion validity of the Patient Health Questionnaire. Psychother. Psychosom. 73 (2004), 386–90.
S. Kisely, D. Goldberg, G. Simon, A comparison between somatic symptoms with and without clear organic cause: results of an international study. Psychol. Med. 27 (1997), 1011–19.
T. B. Üstün, N. Sartorius, Mental Illness in General Health Care. An International Study. Chichester: John Wiley & Sons 1995.
J. Harrison, S. Barrow, L. Gask, F. Creed, Social determinants of GHQ score by postal survey. J. Public. Health. Med. 21 (1999), 283–8.
J. Neeleman, J. Ormel, R. V. Bijl, The distribution of psychiatric and somatic III health: associations with personality and socioeconomic status. Psychosom. Med. 63 (2001), 239–47.
M. S. Hansen, P. Fink, M. Frydenberg, et al., Mental disorders among internal medical inpatients: prevalence, detection, and treatment status. J. Psychosom. Res. 50 (2001), 199–204.
G. Livingston, V. Watkin, B. Milne, M. V. Manela, C. Katona, Who becomes depressed? The Islington community study of older people. J. Affect. Dis. 58 (2000), 125–33.
R. Finlay-Jones, G. W. Brown, Types of stressful life event and the onset of anxiety and depressive disorders. Psychol. Med. 11 (1981), 803–15.
E. Murphy, Social origins of depression in old age. Br. J. Psychiatry 141 (1982), 135–42.
M. G. Cole, F. Bellavance, A. Mansour, Prognosis of depression in elderly community and primary care populations: a systematic review and meta-analysis. Am. J. Psychiatry 156 (1999), 1182–9.
S. B. Patten, Long-term medical conditions and major depression in a Canadian population study at waves 1 and 2. J. Affect. Dis. 63 (2001), 35–41.
M. Hotopf, R. Mayou, M. Wadsworth, S. Wessely, Temporal relationships between physical symptoms and psychiatric disorder: results from a national birth cohort. Br. J. Psychiatry 173 (1998), 255–61.
E. Murphy, G. W. Brown, Life events, psychiatric disturbance and physical illness. Br. J. Psychiatry 136 (1980), 326–38.
H. Hemingway, M. Marmot, Evidence based cardiology: psychosocial factors in the aetiology and prognosis of coronary heart disease. Systematic review of prospective cohort studies. Br. Med. J. 318 (1999), 1460–67.
C. M. Dickens, C. Percival, L. McGowan, et al., The risk factors for depression in first myocardial infarction patients. Psychol. Med. 34 (2004), 1083–92.
G. G. Lloyd, R. H. Cawley, Distress or illness? A study of psychological symptoms after myocardial infarction. Br. J. Psychiatry 142 (1983), 120–25.
R. C. Kessler, J. Ormel, O. Demler, P. E. Stang, Comorbid mental disorders account for the role impairment of commonly occurring chronic physical disorders: results from the National Comorbidity Survey. J. Occup. Environ. Med. 45 (2003), 1257–66.
B. G. Druss, R. A. Rosenheck, W. H. Sledge, Health and disability costs of depressive illness in a major US corporation. Am. J. Psychiatry 157 (2000), 1274–8.
J. E. Ware, Jr, C. D. Sherbourne, The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care 30 (1992), 473–83.
C. A. McHorney, J. E. Ware, Jr, A. E. Raczek, The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med. Care 31 (1993), 247–63.
J. E. Ware, Jr, M. Kosinski, M. S. Bayliss, et al., Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med. Care 33 (1995), AS264–79.
P. G. Surtees, N. W. Wainwright, K. T. Khaw, N. E. Day, Functional health status, chronic medical conditions and disorders of mood. Br. J. Psychiatry 183 (2003), 299–303.
F. Creed, J. Ratcliffe, L. Fernandez, et al., Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome. Ann. Intern. Med. 134 (2001), 860–68.
E. Guthrie, J. Jackson, J. Shaffer, et al., Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn's disease. Am. J. Gastroenterol. 97 (2002), 1994–9.
C. Herrmann, S. Brand-Driehorst, B. Kaminsky, et al., Diagnostic groups and depressed mood as predictors of 22-month mortality in medical inpatients. Psychosom. Med. 60 (1998), 570–77.
L. S. Williams, S. S. Ghose, R. W. Swindle, Depression and other mental health diagnoses increase mortality risk after ischemic stroke. Am. J. Psychiatry 161 (2004), 1090–95.
A. J. Barsky, G. Wyshak, G. L. Klerman, Medical and psychiatric determinants of outpatient medical utilization. Med. Care 24 (1986), 548–60.
G. E. Simon, M. VonKorff, W. Barlow, Health care costs of primary care patients with recognized depression. Arch. Gen. Psychiatry 52 (1995), 850–56.
A. M. Van Hemert, M. W. Hengeveld, J. H. Bolk, H. G. Rooijmans, J. P. Vandenbroucke, Psychiatric disorders in relation to medical illness among patients of a general medical out-patient clinic. Psychol. Med. 23 (1993), 167–73.
C. Nimnuan, M. Hotopf, S. Wessely, Medically unexplained symptoms: an epidemiological study in seven specialities. J. Psychosom. Res. 51 (2001), 361–7.
A. Feder, M. Olfson, M. Gameroff, et al., Medically unexplained symptoms in an urban general medicine practice. Psychosomatics 42 (2001), 261–8.
C. G. Kooiman, J. H. Bolk, R. Brand, R. W. Trijsburg, H. G. Rooijmans, Is alexithymia a risk factor for unexplained physical symptoms in general medical outpatients? Psychosom. Med. 62 (2000), 768–78.
J. J. Strik, A. Honig, R. Lousberg, J. Denollet, Sensitivity and specificity of observer and self-report questionnaires in major and minor depression following myocardial infarction. Psychosomatics 42 (2001), 423–8.
J. I. Escobar, M. Gara, R. C. Silver, H. Waitzkin, A. Holman, W. Compton, Somatisation disorder in primary care. Br. J. Psychiatry 173 (1998), 262–6.
J. I. Escobar, H. Waitzkin, R. C. Silver, M. Gara, A. Holman, Abridged somatization: a study in primary care. Psychosom. Med. 60 (1998), 466–72.

Reference Title: REFERENCES

Reference Type: reference-list

M. M. Weissman, G. L. Klerman, Sex differences and the epidemiology of depression. Arch. Gen. Psychiatry 34 (1977), 98–111.
T. B. Ustun, Cross-national epidemiology of depression and gender. J. Gend. Specif. Med. 3 (2000), 54–8.
M. Piccinelli, G. Wilkinson, Gender differences in depression: critical review. Br. J. Psychiatry 177 (2000), 486–92.
B. Rodgers, Pathways between parental divorce and adult depression. J. Child Psychol. Psychiatry 35 (1994), 1289–308.
K. S. Kendler, M. Neale, R. Kessler, A. Heath, L. Eaves, A twin study of recent life events and difficulties. Arch. Gen. Psychiatry 50 (1993), 789–96.
N. Breslau, L. Schultz, E. Peterson, Sex differences in depression: a role for preexisting anxiety. Psychiatry Res. 58 (1995), 1–12.
J. Y. Nazroo, A. C. Edwards, G. W. Brown, Gender differences in the onset of depression following a shared life event: a study of couples. Psychol. Med. 27 (1997), 9–19.
P. Moen, Social integration and longevity: an event history analysis of women's roles and resilience. Am. Sociol. Rev. 54 (1989), 635–47.
M. R. Frone, Work–family conflict and employee psychiatric disorders: the National Comorbidity Survey. J. Appl. Psychol. 85 (2000), 888–95.
S. Stansfeld, J. Head, V. Cattell, J. Wardle, R. Fuhrer, Work, partner's employment status and depressive symptoms in women. Trends Evidence Based Neuropsychiatry 6 (2004), 31–6.
E. M. Hall, Double exposure: the combined impact of the home and work environments on psychosomatic strain in Swedish women and men. Int. J. Health Serv. 22 (1992), 239–60.
C. Schooler, Work for the household: its nature and consequences for husbands and wives. Am. J. Sociol. 90 (1984), 97–124.
E. M. Hall, J. V. Johnson, Depression in unemployed Swedish women. Soc. Sci. Med. 27 (1988), 1349–55.
S. Weich, A. Sloggett, G. Lewis, Social roles and gender difference in the prevalence of common mental disorders. Br. J. Psychiatry 173 (1998), 489–93.
R. Jenkins, Sex differences in minor psychiatric morbidity. Psychol. Med. Monogr. Suppl. 7 (1985), 1–53.
S. Wyke, G. Ford, Competing explanations for associations between marital status and health. Soc. Sci. Med. 34 (1992), 523–32.
P. E. Bebbington, Sex and depression. Psychol. Med. 28 (1998), 1–8.
I. Waldron, M. E. Hughes, T. L. Brooks, Marriage protection and marriage selection: prospective evidence for reciprocal effects of marital status and health. Soc. Sci. Med. 43 (1996), 113–23.
C. A. Mathews, V. I. Reus, Assortative mating in the affective disorders: a systematic review and meta-analysis. Compr. Psychiatry 42 (2001), 257–62.
D. Melzer, T. Fryers, R. Jenkins, T. Brugha, B. McWilliams, Social position and the common mental disorders with disability: estimates from the National Psychiatric Survey of Great Britain. Soc. Psychiatry Psychiatr. Epidemiol. 38 (2003), 238–43.
D. Melzer, T. Fryers, R. Jenkins, Social Inequalities and the Distribution of the Common Mental Disorders (Hove: Psychology Press, 2004).
J. M. Murphy, D. C. Olivier, R. R. Monson, et al. Depression and anxiety in relation to social status: a prospective epidemiologic study. Arch. Gen. Psychiatry 48 (1991), 223–9.
V. Lorant, D. Deliege, W. Eaton, et al., Socioeconomic inequalities in depression: a meta-analysis. Am. J. Epidemiol. 157 (2003), 98–112.
S. Aro, H. Aro, I. Keskimaki, Socio-economic mobility among patients with schizophrenia or major affective disorder: a 17-year retrospective follow-up. Br. J. Psychiatry 166 (1995), 759–67.
S. Weich, G. Lewis, Material standard of living, social class, and the prevalence of the common mental disorders in Great Britain. J. Epidemiol. Community Health 52 (1998), 8–14.
S. Weich, G. Lewis, Poverty, unemployment, and common mental disorders: population based cohort study. Br. Med. J. 317 (1998), 115–19.
T. Fryers, D. Melzer, R. Jenkins, Social inequalities and the common mental disorders: a systematic review of the evidence. Soc. Psychiatry Psychiatr. Epidemiol. 38 (2003), 229–37.
B. P. Dohrenwend, I. Levav, P. E. Shrout, et al., Socioeconomic status and psychiatric disorders: the causation-selection issue. Science 255 (1992), 946–52.
J. K. Myers, J. J. Lindenthal, M. P. Pepper, D. R. Ostrander, Social class, life events and psychiatric symptoms: a longitudinal study. In Stressful Life Events: Their Nature and Effects, ed. B. S. Dohrenwend and B. P. Dohrenwend. (New York: John Wiley & Sons, 1974), pp. 91–206.
R. C. Kessler, K. A. McGonagle, S. Zhao, et al., Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch. Gen. Psychiatry 51 (1994), 8–19.
R. S. Kahn, P. H. Wise, B. P. Kennedy, I. Kawachi, State income inequality, household income, and maternal mental and physical health: cross sectional national survey. Br. Med. J. 321 (2000), 1311–15.
S. A. Everson, S. C. Maty, J. W. Lynch, G. A. Kaplan, Epidemiologic evidence for the relation between socioeconomic status and depression, obesity, and diabetes. J. Psychosom. Res. 53 (2002), 891–5.
M. Broese, I. van Groenou, [Unequal chances for reaching ‘a good old age’: socio-economic health differences among older adults from a life course perspective.] Tijdschr. Gerontol. Geriatr. 34 (2003), 196–207.
M. Benzeval, K. Judge, Income and health: the time dimension. Soc. Sci. Med. 52 (2001), 1371–90.
S. E. Gilman, I. Kawachi, G. M. Fitzmaurice, S. L. Buka, Socioeconomic status in childhood and the lifetime risk of major depression. Int. J. Epidemiol. 31 (2002), 359–67.
M. Marmot, M. Shipley, E. Brunner, H. Hemingway, Relative contribution of early life and adult socioeconomic factors to adult morbidity in the Whitehall II study. J. Epidemiol. Community Health 55 (2001), 301–7.
E. Goodman, The role of socioeconomic status gradients in explaining differences in US adolescents' health. Am. J. Public Health 89 (1999), 1522–8.
J. E. Ritsher, V. Warner, J. G. Johnson, B. P. Dohrenwend, Inter-generational longitudinal study of social class and depression: a test of social causation and social selection models. Br. J. Psychiatry Suppl. 40 (2001), 584–90.
R. J. Turner, F. Marino, Social support and social structure: a descriptive epidemiology. J. Health Soc. Behav. 35 (1994), 193–212.
B. H. Brummett, J. C. Barefoot, P. P. Vitaliano, I. C. Siegler, Associations among social support, income, and symptoms of depression in an educated sample: the UNC Alumni Heart Study. Int. J. Behav. Med. 10 (2003), 239–50.
R. J. Turner, D. A. Lloyd, P. Roszell, Personal resources and the social distribution of depression. Am. J. Community Psychol. 27 (1999), 643–72.
S. A. Stansfeld, J. Head, M. G. Marmot, Explaining social class differences in depression and well-being. Soc. Psychiatry Psychiatr. Epidemiol. 33 (1998), 1–9.
B. P. Dohrenwend, The role of adversity and stress in psychopathology: some evidence and its implications for theory and research. J. Health Soc. Behav. 41 (2000), 1–19.
R. Finlay-Jones, G. W. Brown, Types of stressful life event and the onset of anxiety and depressive disorders. Psychol. Med. 11 (1981), 803–15.
G. W. Brown, T. O. Harris, Social Origins of Depression: A Study of Psychiatric Disorder in Women (London: Tavistock, 1978).
E. S. Paykel, Contribution of life events to causation of psychiatric illness. Psychol. Med. 8 (1978), 245–53.
E. S. Paykel, Life events and affective disorder. Acta Psychiatr. Scand. Suppl. 418 (2003), 61–6.
E. Frank, B. Anderson, C. F. Reynolds, III, A. Ritenour, D. J. Kupfer, Life events and the research diagnostic criteria endogenous subtype: a confirmation of the distinction using the Bedford College methods. Arch. Gen. Psychiatry 51 (1994), 519–24.
G. W. Brown, T. O. Harris, C. Hepworth, Loss, humiliation and entrapment among women developing depression: a patient and non-patient comparison. Psychol. Med. 25 (1995), 7–21.
M. E. P. Seligman, Helplesssness. (San Francisco, CA: Freeman, 1975).
G. W. Brown, L. Lemyre, A. Bifulco, Social factors and recovery from anxiety and depressive disorders: a test of specificity. Br. J. Psychiatry 161 (1992), 44–54.
A. S. Leenstra, J. Ormel, R. Giel, Positive life change and recovery from depression and anxiety: a three-stage longitudinal study of primary care attenders. Br. J. Psychiatry 166 (1995), 333–43.
T. Harris, Recent developments in understanding the psychosocial aspects of depression. Br. Med. Bull. 57 (2001), 17–32.
M. L. Bruce, K. M. Kim, Differences in the effects of divorce on major depression in men and women. Am. J. Psychiatry 149 (1992), 914–17.
K. S. Kendler, L. M. Thornton, C. A. Prescott, Gender differences in the rates of exposure to stressful life events and sensitivity to their depressogenic effects. Am. J. Psychiatry 158 (2001), 587–93.
R. Fuhrer, S. A. Stansfeld, J. Chemali, M. J. Shipley, Gender, social relations and mental health: prospective findings from an occupational cohort (Whitehall II study). Soc. Sci. Med. 48 (1999), 77–87.
G. W. Brown, P. M. Moran, Single mothers, poverty and depression. Psychol. Med. 27 (1997), 21–33.
R. Plomin, P. Lichtenstein, N. L. Pedersen, G. E. McClearn, J. R. Nesselroade, Genetic influence on life events during the last half of the life span. Psychol. Aging 5 (1990), 25–30.
K. L. Harkness, S. M. Monroe, A. D. Simons, M. Thase, The generation of life events in recurrent and non-recurrent depression. Psychol. Med. 29 (1999), 135–44.
L. A. Champion, G. Goodall, M. Rutter, Behaviour problems in childhood and stressors in early adult life: I. A 20 year follow-up of London school children. Psychol. Med. 25 (1995), 231–46.
A. Caspi, K. Sugden, T. E. Moffitt, et al., Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301 (2003), 386–9.
G. W. Brown, B. Andrews, T. Harris, Z. Adler, L. Bridge, Social support, self-esteem and depression. Psychol. Med. 16 (1986), 813–31.
B. Andrews, G. W. Brown, Self-esteem and vulnerability to depression: the concurrent validity of interview and questionnaire measures. J. Abnorm. Psychol. 102 (1993), 565–72.
B. Andrews, G. W. Brown, Stability and change in low self-esteem: the role of psychosocial factors. Psychol. Med. 25 (1995), 23–31.
G. Parker, Parental ‘affectionless control’ as an antecedent to adult depression: a risk factor delineated. Arch. Gen. Psychiatry 40 (1983), 956–60.
C. Tennant, P. Bebbington, J. Hurry, Parental death in childhood and risk of adult depressive disorders: a review. Psychol. Med. 10 (1980), 289–99.
G. W. Brown, T. O. Harris, M. J. Eales, Aetiology of anxiety and depressive disorders in an inner-city population: 2. Comorbidity and adversity. Psychol. Med. 23 (1993), 155–65.
A. Bifulco, G. W. Brown, T. O. Harris, Childhood Experience of Care and Abuse (CECA): a retrospective interview measure. J. Child. Psychol. Psychiatry 35 (1994), 1419–35.
J. Hill, R. Davis, M. Byatt, et al., Childhood sexual abuse and affective symptoms in women: a general population study. Psychol. Med. 30 (2000), 1283–91.
A. Bifulco, G. W. Brown, P. Moran, C. Ball, C. Campbell, Predicting depression in women: the role of past and present vulnerability. Psychol. Med. 28 (1998), 39–50.
G. W. Brown, P. Moran, Clinical and psychosocial origins of chronic depressive episodes: I. A community survey. Br. J. Psychiatry 165 (1994), 447–56.
S. E. Gilman, I. Kawachi, G. M. Fitzmaurice, L. Buka, Socio-economic status, family disruption and residential stability in childhood: relation to onset, recurrence and remission of major depression. Psychol. Med. 33 (2003), 1341–55.
B. Andrews, G. W. Brown, L. Creasey, Intergenerational links between psychiatric disorder in mothers and daughters: the role of parenting experiences. J. Child. Psychol. Psychiatry 31 (1990), 1115–29.
G. Parker, K. Wilhelm, A. Asghari, Depressed mood states and their inter-relationship with clinical depression. Soc. Psychiatry Psychiatr. Epidemiol. 33 (1998) 10–15.
S. Cohen, S. L. Syme, Social Support and Health (London: Academic Press, 1985).
S. Cobb, Presidential address – 1976: social support as a moderator of life stress. Psychosom. Med. 38 (1976), 300–314.
S. Cohen, T. A. Wills, Stress, social support and the buffering hypothesis. Psychol. Bull. (1985), 310–57.
R. C. Kessler, J. D. McLeod, Social Support and Mental Health in Community Samples (New York: Academic Press, 1985).
B. A. Husaini, J. A. Neff, J. R. Newborough, M. C. Moore, The stress-buffering role of social support and personal competence among the rural married. J. Commun. Psychol. 10 (1982), 409–26.
R. C. Kessler, M. Essex, Marital status and depression: the role of coping resources. Social Forces 61 (1982), 484–507.
A. S. Henderson, Social relationships, adversity and neurosis: an analysis of prospective observations. Br. J. Psychiatry 138 (1981), 391–8.
L. I. Pearlin, M. A. Lieberman, E. G. Menaghan, J. T. Mullan, The stress process. J. Health Soc. Behav. 22 (1981), 337–56.
C. Tennant, P. Bebbington, The social causation of depression: a critique of the work of Brown and his colleagues. Psychol. Med. 8 (1978), 565–75.
R. C. Kessler, W. J. Magee, Childhood family violence and adult recurrent depression. J. Health Soc. Behav. 35 (1994), 13–27.
W. Bolton, K. Oatley, A longitudinal study of social support and depression in unemployed men. Psychol. Med. 17 (1987), 453–60.
T. S. Brugha, H. M. Sharp, S. A. Cooper, et al., The Leicester 500 project: social support and the development of postnatal depressive symptoms – a prospective cohort survey. Psychol. Med. 28 (1998), 63–79.
S. A. Stansfeld, R. Fuhrer, M. J. Shipley, Types of social support as predictors of psychiatric morbidity in a cohort of British civil servants (Whitehall II Study). Psychol. Med. 28 (1998), 881–92.
T. L. Schuster, R. C. Kessler, R. H. Aseltine, Jr, Supportive interactions, negative interactions, and depressed mood. Am. J. Community Psychol. 18 (1990), 423–38.
K. S. Rook, The negative side of social interaction: impact on psychological well-being. J. Pers. Soc. Psychol. 46 (1984), 1097–108.
M. M. Burg, T. E. Seeman, Families and health: the negative side of social ties. Ann. Behav. Med. 16 (1994), 109–15.
T. E. Oxman, L. F. Berkman, S. Kasl, D. H. Freeman, Jr, J. Barrett, Social support and depressive symptoms in the elderly. Am. J. Epidemiol. 135 (1992), 356–68.
B. Andrews, G. W. Brown, Social support, onset of depression and personality: an exploratory analysis. Soc. Psychiatry Psychiatr. Epidemiol. 23 (1988), 99–108.
D. Quinton, M. Rutter, C. Liddle, Institutional rearing, parenting difficulties and marital support. Psychol. Med. 14 (1984), 107–24.
T. S. Brugha, P. E. Bebbington, B. MacCarthy, et al., Gender, social support and recovery from depressive disorders: a prospective clinical study. Psychol. Med. 20 (1990), 147–56.
M. J. Prince, R. H. Harwood, A. Thomas, A. H. Mann, A prospective population-based cohort study of the effects of disablement and social milieu on the onset and maintenance of late-life depression: the Gospel Oak Project VII. Psychol. Med. 28 (1998), 337–50.
H. O. Veiel, C. Kuhner, Relatives and depressive relapse: the critical period after discharge from in-patient treatment. Psychol. Med. 20 (1990), 977–84.
G. Fadden, P. Bebbington, L. Kuipers, Caring and its burdens: a study of the spouses of depressed patients. Br. J. Psychiatry 151 (1987), 660–6.
J. Y. Nazroo, Ethnicity and Mental Health (London: Policy Studies Institute, 1997).
R. Cochrane, S. S. Bal, Ethnic density is unrelated to incidence of schizophrenia. Br. J. Psychiatry 153 (1988), 363–6.
D. Bhugra, Setting up psychiatric services: cross-cultural issues in planning and delivery. Int. J. Soc. Psychiatry 43 (1997), 16–28.
K. Sproston J. Y. Nazroo, Ethnic Minority Psychiatric Illness Rates in the Community (EMPIRIC): Quantitative Report (London, The Stationery Office, 2002).
D. R. Williams, Race, stress and mental health. In Minority Health in America: Findings and Policy Implications from the Commonwealth Fund Minority Health Survey, ed. C. J. R. Hogue, M. A. Hargreaves, K. S. Collins (Baltimore, MD: John Hopkins Press, 2000), pp. 194–208.
D. Halpern, Minorities and mental health. Soc. Sci. Med. 36 (1993), 597–607.
R. E. Faris, H. W. Dunham, Mental Disorders in Urban Areas (Chicago, IL: University of Chicago Press, 1939).
L. Levy, L. Rowitz, The Ecology of Mental Disorder (New York: Behavioral Publications, 1973).
J. G. Rabkin, Ethnic density and psychiatric hospitalisation: hazards of minority status. Am. J. Psychiatry 136 (1979), 1562–6.
G. L. Mulhin, Mental hospitalisation of the foreign born and the role of cultural isolation. Int. J. Soc. Psychiatry 25 (1979), 258–66.
D. Halpern, J. Y. Nazroo, The ethnic density effect: results from a national community survey of England and Wales. Int. J. Soc. Psychiatry 46 (1999), 34–46.
M. Stopes-Roe, R. Cochrane, Support networks of Asian and British families: comparisons between ethnicities and between generations. Soc. Behav. 5 (1990), 71–85.
S. K. Hoppe, R. L. Leon, J. P. Realini, Depression and anxiety among Mexican Americans in a family health center. Soc. Psychiatry Psychiatr. Epidemiol. 24 (1989), 63–8.
T. Joiner, J. C. Coyne, The Interactive Nature of Depression: Advances in Interpersonal Approaches (Washington, DC: American Psychological Association, 1999).
C. J. Holahan, R. H. Moos, C. K. Holahan, R. C. Cronkite, Resource loss, resource gain, and depressive symptoms: a 10-year model. J. Pers. Soc. Psychol. 77 (1999), 620–9.
C. J. Holahan, R. H. Moos, C. K. Holahan, R. C. Cronkite, Long-term posttreatment functioning among patients with unipolar depression: an integrative model. J. Consult. Clin. Psychol. 68 (2000), 226–32.
S. E. Hobfoll, R. J. Johnson, N. Ennis, A. P. Jackson, Resource loss, resource gain, and emotional outcomes among inner city women. J. Pers. Soc. Psychol. 84 (2003), 632–43.
H. R. Markus, S. Kitayama, Culture and the self: implications for cognition, emotion and motivation. Psychol. Rev. 98 (1991), 224–53.
G. Marin, H. C. Triandis, Allocentrism as an important characteristic of the behavior of Latin Americans and Hispanics. In ed. Cross-cultural and National Studies in Social Psychology, ed. R. Diaz-Guerrero (Amsterdam: North-Holland, 1985), pp. 85–104.
E. A. Plant, N. Sachs-Ericsson, Racial and ethnic differences in depression: the roles of social support and meeting basic needs. J. Consult. Clin. Psychol. 72 (2004), 41–52.
D. R. Williams, D. T. Takeuchi, R. K. Adair, Marital status and psychiatric disorders among blacks and whites. J. Health Soc. Behav. 33 (1992), 140–57.
R. J. Taylor, C. B. Hardison, L. M. Chatters, Kin and non-kin as sources of informal assistance. In Mental Health in Black America, ed. H. W. Neighbours, J. S. Jackson (Thousand Oaks, CA: Sage, 1996), pp. 130–45.
US Department of Health and Human Sciences. Mental Health: Culture, Race and Ethnicity. A Supplement to Mental Health: A Report of the Surgeon General (Rockville, MD: Substance Abuse and Mental Health Services Administration, Centre for Mental Health Services, 2001).
C. J. Holahan, R. H. Moos, Risk, resistance, and psychological distress: a longitudinal analysis with adults and children. J. Abnorm. Psychol. 96 (1987), 3–13.
N. E. Ennis, S. E. Hobfoll, K. E. Schroder, Money doesn't talk, it swears: how economic stress and resistance resources impact inner-city women's depressive mood. Am. J. Community Psychol. 28 (2000), 149–73.
J. D. Hovey, Religion and suicidal ideation in a sample of Latin American immigrants. Psychol. Rep. 85 (1999), 171–7.
W. J. Strawbridge, S. J. Shema, R. D. Cohen, G. A. Kaplan, Religious attendance increases survival by improving and maintaining good health behaviors, mental health, and social relationships. Ann. Behav. Med. 23 (2001), 68–74.
K. S. Kendler, X. Q. Liu, C. O. Gardner, M. E. McCullough, D. Larson, C. A. Prescott, Dimensions of religiosity and their relationship to lifetime psychiatric and substance use disorders. Am. J. Psychiatry 160 (2003), 496–503.
D. Bhugra, O. Ayonrinde, Depression in migrants and ethnic minorities. Adv. Psychiatr. Treat. 10 (2004), 13–17.
A. Kleinman, Anthropology and psychiatry: the role of culture in cross-cultural research on illness. Br. J. Psychiatry 151 (1987), 447–54.
N. Beale, S. Nethercott, The nature of unemployment morbidity. 2. Description. J. R. Coll. Gen. Pract. 38 (1988), 200–202.
S. Platt, N. Kreitman, Long term trends in parasuicide and unemployment in Edinburgh, 1968–87. Soc. Psychiatry Psychiatr. Epidemiol. 25 (1990), 56–61.
R. C. Kessler, J. S. House, J. B. Turner, Unemployment and health in a community sample. J. Health Soc. Behav. 28 (1987), 51–9.
R. A. Karasek, Job demands, job decision latitude and mental strain: implications for job redesign. Admin. Sci. Q. 24 (1979), 285–306.
R. Karasek, T. Theorell, Healthy Work: Stress, Productivity and the Reconstruction of Working Life (New York: Basic Books, 1990).
J. Siegrist, Adverse health effects of high-effort/low-reward conditions. J. Occup. Health Psychol. 1 (1996), 27–41.
D. E. Broadbent, The clinical impact of job design. Br. J. Clin. Psychol. 24 (1985), 33–44.
M. Estryn-Behar, M. Kaminski, E. Peigne, et al., Stress at work and mental health status among female hospital workers. Br. J. Ind. Med. 47 (1990), 20–28.
E. J. Bromet, M. A. Dew, D. K. Parkinson, S. Cohen, J. E. Schwartz, Effects of occupational stress on the physical and psychological health of women in a microelectronics plant. Soc. Sci. Med 34 (1992), 1377–83.
N. Kawakami, T. Haratani, S. Araki, Effects of perceived job stress on depressive symptoms in blue-collar workers of an electrical factory in Japan. Scand. J. Work Environ. Health 18 (1992), 195–200.
K. R. Parkes, C. A. Mendham, C. Von Rabenau, Social support and the demand–discretion model of job stress: tests of additive and interactive effects in two samples. J. Voc. Behav. 44 (1994), 91–113.
S. A. Stansfeld, R. Fuhrer, J. Head, J. Ferrie, M. Shipley, Work and psychiatric disorder in the Whitehall II study. J. Psychosom. Res. 43 (1997), 73–81.
I. Niedhammer, M. Goldberg, A. Leclerc, I. Bugel, S. David, Psychosocial factors at work and subsequent depressive symptoms in the Gazel cohort. Scand. J. Work Environ. Health 24 (1998), 197–205.
Y. Mino, J. Shigemi, T. Tsuda, N. Yasuda, P. Bebbington, Perceived job stress and mental health in precision machine workers of Japan: a 2 year cohort study. Occup. Environ. Med. 56 (1999), 41–5.
S. A. Stansfeld, R. Fuhrer, M. J. Shipley, M. G. Marmot, Work characteristics predict psychiatric disorder: prospective results from the Whitehall II study. Occup. Environ. Med. 56 (1999), 302–7.
A. Weinberg, F. Creed, Stress and psychiatric disorder in healthcare professionals and hospital staff. Lancet 355 (2000), 533–7.
B. Hesketh, G. Shouksmith, Job and non-job activities, job satisfaction and mental health among veterinarians. J. Occup. Behav. 7 (1986), 325–9.
P. B. Warr, Decision latitude, job demands and employee well being. Work Stress 4 (1990), 285–94.
H. Mausner-Dorsch, W. W. Eaton, Psychosocial work environment and depression: epidemiologic assessment of the demand-control model. Am. J. Public Health 90 (2000), 1765–70.
M. Cropley, A. Steptoe, K. Joekes, Job strain and psychiatric morbidity. Psychol. Med. 29 (1999), 1411–16.
A. P. Brief, M. J. Burke, J. M. George, B. S. Robinson, J. Webster, Should negative affectivity remain an unmeasured variable in the study of job stress? J. Appl. Psychol. 73 (1988), 193–8.
S. Paterniti, I. Niedhammer, T. Lang, S. M. Consoli, Psychosocial factors at work, personality traits and depressive symptoms: longitudinal results from the GAZEL study. Br. J. Psychiatry 181 (2002), 111–17.
D. A. Regier, J. H. Boyd, J. D. Burke, Jr, et al., One-month prevalence of mental disorders in the United States: based on five epidemiologic catchment area sites. Arch. Gen. Psychiatry 45 (1988), 977–86.
A. S. Henderson, A. E. Korten, P. A. Jacomb, et al., The course of depression in the elderly: a longitudinal community-based study in Australia. Psychol. Med. 27 (1997), 119–29.
R. C. Baldwin, J. O'Brien, Vascular basis of late-onset depressive disorder. Br. J. Psychiatry 180 (2002), 157–60.
M. J. Karel, Aging and depression: vulnerability and stress across adulthood. Clin. Psychol. Rev. 17 (1997), 847–79.
R. C. Kessler, C. Foster, P. S. Webster, J. S. House, The relationship between age and depressive symptoms in two national surveys. Psychol. Aging 7 (1992), 119–26.
M. D. Blumenthal, Depressive illness in old age: getting behind the mask. Geriatrics 35 (1980), 34–43.
B. H. Mulsant, M. Ganguli, Epidemiology and diagnosis of depression in late life. J. Clin. Psychiatry 60: Suppl 20 (1999), 9–15.
M. L. Bruce, Psychosocial risk factors for depressive disorders in late life. Biol. Psychiatry 52 (2002), 175–84.
E. Murphy, Social origins of depression in old age. Br. J. Psychiatry 141 (1982), 135–42.
E. I. Brilman, J. Ormel, Life events, difficulties and onset of depressive episodes in later life. Psychol. Med. 31 (2001), 859–69.
C. M. Mazure, P. K. Maciejewski, S. C. Jacobs, M. L. Bruce, Stressful life events interacting with cognitive/personality styles to predict late-onset major depression. Am. J. Geriatr. Psychiatry 10 (2002), 297–304.
R. A. Schoevers, A. T. Beekman, D. J. Deeg, et al., Risk factors for depression in later life: results of a prospective community based study (AMSTEL). J. Affect. Disord. 59 (2000), 127–37.
B. Pitt, Loss in late life. Br. Med. J. 316 (1998), 1452–4.
C. L. Turvey, Y. Conwell, M. P. Jones, et al., Risk factors for late-life suicide: a prospective, community-based study. Am. J. Geriatr. Psychiatry 10 (2002), 398–406.
M. Marmot, T. Theorell, J. Siegrist, Work and coronary heart disease. In Stress and the Heart: Psychosocial Pathways to Coronary Heart Disease, ed. S. A. Stansfeld, M. G. Marmot (London: BMJ Books, 2002), pp. 50–71.
S. A. Stansfeld, R. Fuhrer, Depression and coronary heart disease. In Stress and the Heart: Psychosocial Pathways to Coronary Heart Disease, ed. S. A. Stansfeld, M. G. Marmot (London: BMJ Books, 2002), pp. 101–23.
S. A. Stansfeld, J. Head, R. Fuhrer, J. Wardle, V. Cattell, Social inequalities in depressive symptoms and physical functioning in the Whitehall II study: exploring a common cause explanation. J. Epidemiol. Community Health 57 (2003), 361–7.

Reference Title: REFERENCES

Reference Type: reference-list

C. B. Nemeroff, D. L. Musselman, Are platelets the link between depression and ischemic heart disease? Am. Heart J. 140 (2000), 57–62.
P. H. Black, L. D. Garbutt, Stress, inflammation and cardiovascular disease. J. Psychosom. Res. 52 (2002), 1–23.
S. Rajagopalan, R. Brook, M. Rubenfire, et al., Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. Am. J. Cardiol. 88 (2001), 196–8, A7.
L. L. Watkins, P. Grossman, Association of depressive symptoms with reduced baroreflex cardiac control in coronary artery disease. Am. Heart J. 137 (1999), 453–7.
R. M. Carney, J. A. Blumenthal, P. K. Stein, et al., Depression, heart rate variability, and acute myocardial infarction. Circulation 104 (2001), 2024–8.
E. S. Brown, F. P. Varghese, B. S. McEwen, Association of depression with medical illness: does cortisol play a role? Biol. Psychiatry 55 (2004), 1–9.
A. Rosengren, S. Hawken, S. Ounpuu, et al., Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case–control study. Lancet 364 (2004), 953–62.
K. Davidson, B. S. Jonas, K. E. Dixon, J. H. Markovitz, Do depression symptoms predict early hypertension incidence in young adults in the CARDIA study? Coronary Artery Risk Development in Young Adults. Arch. Intern. Med. 160 (2000), 1495–500.
A. W. Zieske, G. T. Malcom, J. P. Strong, Natural history and risk factors of atherosclerosis in children and youth: the PDAY study. Pediatr. Pathol. Mol. Med. 21 (2002), 213–37.
R. Rugulies, Depression as a predictor for coronary heart disease: a review and meta-analysis. Am. J. Prev. Med. 23 (2002), 51–61.
H. S. Lett, J. A. Blumenthal, M. A. Babyak, et al., Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom. Med. 66 (2004), 305–15.
H. Hemingway, H. Kuper, M. Marmot, Psychosocial factors in the primary and secondary prevention of coronary heart disease: an updated systematic review of prospective cohort studies. In Evidence-Based Cardiology, 2nd edn, ed. S. Yusuf, J. A. Cairns, A. J. Camm, E. L. Fallen, B. J. Gersh (London: BMJ Books, 2003), pp. 181–218.
A. P. Haines, J. D. Imeson, T. W. Meade, Phobic anxiety and ischaemic heart disease. Br. Med. J. 295 (1987), 297–9.
C. F. Mendes de Leon, H. M. Krumholz, T. S. Seeman, et al., Depression and risk of coronary heart disease in elderly men and women: New Haven EPESE, 1982–1991. Established Populations for the Epidemiologic Studies of the Elderly. Arch. Intern. Med. 158 (1998), 2341–8.
H. D. Sesso, I. Kawachi, P. S. Vokonas, D. Sparrow, Depression and the risk of coronary heart disease in the Normative Aging Study. Am. J. Cardiol. 82 (1998), 851–6.
R. Anda, D. Williamson, D. Jones, et al., Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U. S. adults. Epidemiology 4 (1993), 285–94.
H. Luukinen, P. Laippala, H. V. Huikuri, Depressive symptoms and the risk of sudden cardiac death among the elderly. Eur. Heart J. 24 (2003), 2021–6.
C. Marzari, S. Maggi, E. Manzato, et al., Depressive symptoms and development of coronary heart disease events: the Italian longitudinal study on aging. J. Gerontol. A Biol. Sci. Med. Sci. 60 (2005), 85–92.
J. P. Empana, D. H. Sykes, G. Luc, et al., Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 111 (2005), 2299–305.
A. A. Ariyo, M. Haan, C. M. Tangen, et al., Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans: Cardiovascular Health Study Collaborative Research Group. Circulation 102 (2000), 1773–9.
B. W. Penninx, J. M. Guralnik, C. F. Mendes, de Leon, et al., Cardiovascular events and mortality in newly and chronically depressed persons > 70 years of age. Am. J. Cardiol. 81 (1998), 988–94.
B. W. Penninx, A. T. Beekman, A. Honig, et al., Depression and cardiac mortality: results from a community-based longitudinal study. Arch. Gen. Psychiatry 58 (2001), 221–7.
S. Wassertheil-Smoller, W. B. Applegate, K. Berge, et al., Change in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group (Systolic Hypertension in the Elderly). Arch. Intern. Med. 156 (1996), 553–61.
S. Wassertheil-Smoller, S. Shumaker, J. Ockene, et al., Depression and cardiovascular sequelae in postmenopausal women: the Women's Health Initiative (WHI). Arch. Intern. Med. 164 (2004), 289–98.
P. J. Rowan, D. Haas, J. A. Campbell, D. R. Maclean, K. W. Davidson, Depressive symptoms have an independent, gradient risk for coronary heart disease incidence in a random, population-based sample. Ann. Epidemiol. 15 (2005), 316–20.
A. Haines, J. Cooper, T. W. Meade, Psychological characteristics and fatal ischaemic heart disease. Heart 85 (2001), 385–9.
A. Aromaa, R. Raitasalo, A. Reunanen, et al., Depression and cardiovascular diseases. Acta Psychiatr. Scand. Suppl. 377 (1994), 77–82.
D. E. Ford, L. A. Mead, P. P. Chang, et al., Depression is a risk factor for coronary artery disease in men: the precursors study. Arch Intern. Med. 158 (1998), 1422–6.
L. A. Pratt, D. E. Ford, R. M. Crum, H. K. Armenian, J. J. Gallo, W. W. Eaton, Depression, psychotropic medication, and risk of myocardial infarction: prospective data from the Baltimore ECA follow-up. Circulation 94 (1996), 3123–9.
S. A. Everson, D. E. Goldberg, G. A. Kaplan, et al., Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosom. Med. 58 (1996), 113–21.
A. Appels, P. Mulder, Excess fatigue as a precursor of myocardial infarction. Eur. Heart J. 9 (1988), 758–64.
E. Prescott, C. Holst, M. Gronbaek, et al., Vital exhaustion as a risk factor for ischaemic heart disease and all-cause mortality in a community sample: a prospective study of 4084 men and 5479 women in the Copenhagen City Heart Study. Int. J. Epidemiol. 32 (2003), 990–97.
B. Norton, L. J. Whalley, Mortality of a lithium-treated population. Br. J. Psychiatry 145 (1984), 277–82.
B. Ahrens, B. Muller-Oerlinghausen, M. Schou, et al., Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis. J. Affect. Disord. 33 (1995), 67–75.
D. W. Black, G. Warrack, G. Winokur, Excess mortality among psychiatric patients: the Iowa Record-Linkage Study. J. Am. Med. Assoc. 253 (1985), 58–61.
J. M. Murphy, R. R. Monson, D. C. Olivier, A. M. Sobol, A. H. Leighton, Affective disorders and mortality: a general population study. Arch. Gen. Psychiatry 44 (1987), 473–80.
C. Allgulander, Suicide and mortality patterns in anxiety neurosis and depressive neurosis. Arch. Gen. Psychiatry 51 (1994), 708–12.
W. Coryell, C. Turvey, A. Leon, et al., Persistence of depressive symptoms and cardiovascular death among patients with affective disorder. Psychosom. Med. 61 (1999), 755–61.
B. G. Druss, D. W. Bradford, R. A. Rosenheck, M. J. Radford, H. M. Krumholz, Mental disorders and use of cardiovascular procedures after myocardial infarction. J. Am. Med. Assoc. 283 (2000), 506–11.
J. Hippisley-Cox, M. Pringle, V. Hammersley, et al., Antidepressants as risk factor for ischaemic heart disease: case–control study in primary care. Br. Med. J. 323 (2001), 666–9.
H. W. Cohen, G. Gibson, M. H. Alderman, Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am. J. Med. 108 (2000), 2–8.
S. A. Everson-Rose, T. T. Lewis, Psychological factors and cardiovascular diseases. Annu. Rev. Public Health 26 (2005), 469–500.
A. K. Ferketich, P. F. Binkley, Psychological distress and cardiovascular disease: results from the 2002 National Health Interview Survey. Eur. Heart J. 26 (2005), 1923–9.
S. A. Stansfeld, R. Fuhrer, M. J. Shipley, M. G. Marmot, Psychological distress as a risk factor for coronary heart disease in the Whitehall II study. Int. J. Epidemiol. 31 (2002), 248–55.
K. L. Robinson, J. McBeth, G. J. Macfarlane, Psychological distress and premature mortality in the general population: a prospective study. Ann. Epidemiol. 14 (2004), 467–72.
I. Kawachi, G. A. Colditz, A. Ascherio, et al., Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation 89 (1994), 1992–7.
F. Rasul, S. A. Stansfeld, C. L. Hart, C. R. Gillis, G. D. Smith, Psychological distress, physical illness and mortality risk. J. Psychosom. Res. 57 (2004), 231–6.
C. M. Albert, C. U. Chae, K. M. Rexrode, J. E. Manson, I. Kawachi, Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women. Circulation 111 (2005), 480–87.
F. Rasul, S. A. Stansfeld, C. L. Hart, G. Davey Smith, Psychological distress, physical illness, and risk of coronary heart disease. J. Epidemiol. Community Health 59 (2005), 140–45.
I. Kawachi, D. Sparrow, P. S. Vokonas, S. T. Weiss, Symptoms of anxiety and risk of coronary heart disease: the Normative Aging Study. Circulation 90 (1994), 2225–9.
H. Iso, C. Date, A. Yamamoto, et al., Perceived mental stress and mortality from cardiovascular disease among Japanese men and women: the Japan Collaborative Cohort Study for Evaluation of Cancer Risk Sponsored by Monbusho (JACC Study). Circulation 106 (2002), 1229–36.
B. Ohlin, P. M. Nilsson, J. A. Nilsson, G. Berglund, Chronic psychosocial stress predicts long-term cardiovascular morbidity and mortality in middle-aged men. Eur. Heart J. 25 (2004), 867–73.
J. Macleod, Davey G. Smith, P. Heslop, et al., Psychological stress and cardiovascular disease: empirical demonstration of bias in a prospective observational study of Scottish men. Br. Med. J. 324 (2002), 1247–51.
D. H. O'Leary, J. F. Polak, R. A. Kronmal, et al., Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults: Cardiovascular Health Study Collaborative Research Group. N. Engl. J. Med. 340 (1999), 14–22.
M. L. Bots, J. M. Dijk, A. Oren, D. E. Grobbee, Carotid intima-media thickness, arterial stiffness and risk of cardiovascular disease: current evidence. J. Hypertens. 20 (2002), 2317–25.
S. A. Everson, J. W. Lynch, M. A. Chesney, et al., Interaction of workplace demands and cardiovascular reactivity in progression of carotid atherosclerosis: population based study. Br. Med. J. 314 (1997), 553–8.
M. Rosvall, P. O. Ostergren, B. Hedblad, et al., Occupational status, educational level, and the prevalence of carotid atherosclerosis in a general population sample of middle-aged Swedish men and women: results from the Malmo Diet and Cancer Study. Am. J. Epidemiol. 152 (2000), 334–46.
J. R. Jennings, T. W. Kamarck, S. A. Everson-Rose, et al., Exaggerated blood pressure responses during mental stress are prospectively related to enhanced carotid atherosclerosis in middle-aged Finnish men. Circulation 110 (2004), 2198–203.
D. J. Jones, J. T. Bromberger, K. Sutton-Tyrrell, K. A. Matthews, Lifetime history of depression and carotid atherosclerosis in middle-aged women. Arch. Gen. Psychiatry 60 (2003), 153–60.
D. C. Haas, K. W. Davidson, D. J. Schwartz, et al., Depressive symptoms are independently predictive of carotid atherosclerosis. Am. J. Cardiol. 95 (2005), 547–50.
M. J. Pletcher, J. A. Tice, M. Pignone, W. S. Browner, Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis. Arch. Intern. Med. 164 (2004), 1285–92.
O'Malley PG, D. L. Jones, I. M. Feuerstein, A. J. Taylor, Lack of correlation between psychological factors and subclinical coronary artery disease. N. Engl. J. Med. 343 (2000), 1298–304.
H. Tiemeier, W. van Dijck, A. Hofman, et al., Relationship between atherosclerosis and late-life depression: the Rotterdam Study. Arch. Gen. Psychiatry 61 (2004), 369–76.
P. K. Agatisa, K. A. Matthews, J. T. Bromberger, et al., Coronary and aortic calcification in women with a history of major depression. Arch. Intern. Med. 165 (2005), 1229–36.
S. Paterniti, M. Zureik, P. Ducimetiere, et al., Sustained anxiety and 4-year progression of carotid atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 21 (2001), 136–41.
B. Wolff, H. J. Grabe, H. Volzke, et al., Relationship between psychological strain and carotid atherosclerosis in a general population. Heart 91 (2005), 460–64.
K. A. Matthews, J. F. Owens, L. H. Kuller, K. Sutton-Tyrrell, L. Jansen-McWilliams, Are hostility and anxiety associated with carotid atherosclerosis in healthy postmenopausal women? Psychosom. Med. 60 (1998), 633–8.
F. Lesperance, N. Frasure-Smithxs, M. Talajic, Major depression before and after myocardial infarction: its nature and consequences. Psychosom. Med. 58 (1996), 99–110.
C. M. Dickens, L. McGowan, C. Percival, et al., Lack of a close confidant, but not depression, predicts further cardiac events after myocardial infarction. Heart 90 (2004), 518–22.
P. C. Strike, A. Steptoe, Behavioral and emotional triggers of acute coronary syndromes: a systematic review and critique. Psychosom. Med. 67 (2005), 179–86.
M. Naghavi, P. Libby, E. Falk, et al., From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation 108 (2003), 1664–72.
M. Maclure, M. A. Mittleman, Should we use a case-crossover design? Ann. Rev. Public Health 21 (2000), 193–221.
M. A. Mittleman, M. Maclure, J. B. Sherwood, et al., Triggering of acute myocardial infarction onset by episodes of anger. Circulation 92 (1995), 1720–25.
S. N. Willich, M. Lewis, H. Lowel, et al., Physical exertion as a trigger of acute myocardial infarction. N. Engl. J. Med. 329 (1993), 1684–90.
A. Steptoe, D. L. Whitehead, Depression, stress and coronary heart disease: the need for more complex models. Heart 91 (2005), 419–20.
A. K. Ferketich, J. A. Schwartzbaum, D. J. Frid, M. L. Moeschberger, Depression as an antecedent to heart disease among women and men in the NHANES I study. Arch. Intern. Med. 160 (2000), 1261–8.
S. A. Everson, G. A. Kaplan, D. E. Goldberg, J. T. Salonen, Hypertension incidence is predicted by high levels of hopelessness in Finnish men. Hypertension 35 (2000), 561–7.
R. Ross, Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 340 (1999), 115–26.
M. J. Jarvisalo, A. Harmoinen, M. Hakanen, et al., Elevated serum C-reactive protein levels and early arterial changes in healthy children. Arterioscler. Thromb. Vasc. Biol. 22 (2002), 1323–8.
O. T. Raitakari, M. Juonala, M. Kahonen, et al., Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. J. Am. Med. Assoc. 290 (2003), 2277–83.
W. E. Chrapko, P. Jurasz, M. W. Radomski, et al., Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder. Biol. Psychiatry 56 (2004), 129–34.
A. J. Broadley, A. Korszun, C. J. Jones, M. P. Frenneaux, Arterial endothelial function is impaired in treated depression. Heart 88 (2002), 521–3.
L. Ghiadoni, A. Donald, M. Cropley, et al., Mental stress induces transient endothelial dysfunction in humans. Circulation 102 (2000), 2473–8.
M. Cesari, B. W. Penninx, A. B. Newman, et al., Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 108 (2003), 2317–22.
L. Lind, Circulating markers of inflammation and atherosclerosis. Atherosclerosis 169 (2003), 203–14.
P. M. Ridker, C. H. Hennekens, J. E. Buring, N. Rifai, C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342 (2000), 836–43.
G. E. Miller, C. A. Stetler, R. M. Carney, K. E. Freedland, W. A. Banks, Clinical depression and inflammatory risk markers for coronary heart disease. Am. J. Cardiol. 90 (2002), 1279–83.
E. C. Suarez, Joint effect of hostility and severity of depressive symptoms on plasma interleukin-6 concentration. Psychosom. Med. 65 (2003), 523–7.
A. N. Dentino, C. F. Pieper, M. K. Rao, et al., Association of interleukin-6 and other biologic variables with depression in older people living in the community. J. Am. Geriatr. Soc. 47 (1999), 6–11.
B. W. Penninx, S. B. Kritchevsky, K. Yaffe, et al., Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biol. Psychiatry 54 (2003), 566–72.
D. B. Panagiotakos, C. Pitsavos, C. Chrysohoou, et al., Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people: the ATTICA study. Eur. Heart J. 25 (2004), 492–9.
W. J. Kop, J. S. Gottdiener, C. M. Tangen, et al., Inflammation and coagulation factors in persons > 65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am. J. Cardiol. 89 (2002), 419–24.
A. Steptoe, S. R. Kunz-Ebrecht, N. Owen, Lack of association between depressive symptoms and markers of immune and vascular inflammation in middle-aged men and women. Psychol. Med. 33 (2003), 667–74.
H. Tiemeier, A. Hofman, H. R. van Tuijl, et al., Inflammatory proteins and depression in the elderly. Epidemiology 14 (2003), 103–7.
M. J. Davies, Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. Circulation 94 (1996), 2013–20.
W. Casscells, M. Naghavi, J. T. Willerson, Vulnerable atherosclerotic plaque: a multifocal disease. Circulation 107 (2003), 2072–5.
J. Danesh, R. Collins, R. Peto, G. D. Lowe, Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease. Eur. Heart J. 21 (2000), 515–20.
J. Danesh, P. Whincup, M. Walker, et al., Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis. Circulation 103 (2001), 2323–7.
P. H. Whincup, J. Danesh, M. Walker, et al., Von Willebrand factor and coronary heart disease: prospective study and meta-analysis. Eur. Heart. J. 23 (2002), 1764–70.
C. Monaco, A. Mathur, J. F. Martin, What causes acute coronary syndromes? Applying Koch's postulates. Atherosclerosis 179 (2005), 1–15.
R. von Kanel, P. J. Mills, C. Fainman, J. E. Dimsdale, Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease? Psychosom. Med. 63 (2001), 531–44.
A. Steptoe, S. Kunz-Ebrecht, A. Rumley, G. D. Lowe, Prolonged elevations in haemostatic and rheological responses following psychological stress in low socioeconomic status men and women. Thromb. Haemost. 89 (2003), 83–90.
A. Steptoe, K. Magid, S. Edwards, et al., The influence of psychological stress and socioeconomic status on platelet activation in men. Atherosclerosis 168 (2003), 57–63.
R. von Kanel, Platelet hyperactivity in clinical depression and the beneficial effect of antidepressant drug treatment: how strong is the evidence? Acta Psychiatr. Scand. 110 (2004), 163–77.
R. von Kanel, J. E. Dimsdale, K. A. Adler, et al., Effects of depressive symptoms and anxiety on hemostatic responses to acute mental stress and recovery in the elderly. Psychiatry Res. 126 (2004), 253–64.
T. Ljung, B. Andersson, B. A. Bengtsson, P. Bjorntorp, P. Marin, Inhibition of cortisol secretion by dexamethosone in relation to body fat distribution. Obes. Res. 4 (1996), 277–82.
R. Pasquali, B. Ambrosi, D. Armanini, et al., Cortisol and ACTH response to oral dexamethasone in obesity and effects of sex, body fat distribution, and dexamethasone concentrations: a dose–response study. J. Clin. Endocrinol. Metab. 87 (2002), 166–75.
V. Vicennati, R. Pasquali, Abnormalities of the hypothalamic-pituitary-adrenal axis in nondepressed women with abdominal obesity and relations with insulin resistance: evidence for a central and a peripheral alteration. J. Clin. Endocrinol. Metab. 85 (2000), 4093–8.
J. R. Seckl, N. M. Morton, K. E. Chapman, B. R. Walker, Glucocorticoids and 11beta-hydroxysteroid dehydrogenase in adipose tissue. Recent Prog. Horm. Res. 59 (2004), 359–93.
E. S. Epel, B. McEwen, T. Seeman, et al., Stress and body shape: stress-induced cortisol secretion is consistently greater among women with central fat. Psychosom. Med. 62 (2000), 623–32.
A. Steptoe, S. R. Kunz-Ebrecht, L. Brydon, J. Wardle, Central adiposity and cortisol responses to waking in middle-aged men and women. Int. J. Obes. Relat. Metab. Disord. 28 (2004), 1168–73.
E. J. Brunner, H. Hemingway, B. R. Walker, et al., Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case–control study. Circulation 106 (2002), 2659–65.
J. I. Hudson, M. S. Hudson, A. J. Rothschild, et al., Abnormal results of dexamethasone suppression tests in nondepressed patients with diabetes mellitus. Arch. Gen. Psychiatry 41 (1984), 1086–9.
M. Roy, B. Collier, A. Roy, Hypothalamic-pituitary-adrenal axis dysregulation among diabetic outpatients. Psychiatry Res. 31 (1990), 31–7.
R. Rosmond, S. Wallerius, P. Wanger, et al., A 5-year follow-up study of disease incidence in men with an abnormal hormone pattern. J. Intern. Med. 254 (2003), 386–90.
D. I. Phillips, D. J. Barker, C. H. Fall, et al., Elevated plasma cortisol concentrations: a link between low birth weight and the insulin resistance syndrome? J. Clin. Endocrinol. Metab. 83 (1998), 757–60.
H. W. Cohen, S. Madhavan, M. H. Alderman, History of treatment for depression: risk factor for myocardial infarction in hypertensive patients. Psychosom. Med. 63 (2001), 203–9.
D. A. Lawlor, G. D. Smith, S. Ebrahim, Association of insulin resistance with depression: cross sectional findings from the British Women's Heart and Health Study. Br. Med. J. 327 (2003), 1383–4.
B. A. Golomb, L. Tenkanen, T. Alikoski, et al., Insulin sensitivity markers: predictors of accidents and suicides in Helsinki Heart Study screenees. J. Clin. Epidemiol. 55 (2002), 767–73.
S. A. Everson-Rose, P. M. Meyer, L. H. Powell, et al., Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife. Diabetes Care 27 (2004), 2856–62.
M. Timonen, M. Laakso, J. Jokelainen, et al., Insulin resistance and depression: cross sectional study. Br. Med. J. 330 (2005), 17–18.
A. J. Dunn, A. H. Swiergiel, V. Palamarchouk, Brain circuits involved in corticotropin-releasing factor–norepinephrine interactions during stress. Ann. N. Y. Acad. Sci. 1018 (2004), 25–34.
W. R. Lovallo Stress and Health: Biological and Psychological Interactions, 2nd edn. (Thousand Oaks, CA: Sage, 2004).
M. A. Gimbrone, Jr, J. N. Topper, T. Nagel, K. R. Anderson, G. Garcia-Cardena, Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann. N. Y. Acad. Sci. 902 (2000), 230–39.
C. Cheng, R. de Crom, R. van Haperen, et al., The role of shear stress in atherosclerosis: action through gene expression and inflammation? Cell Biochem. Biophys. 41 (2004), 279–94.
A. R. Dyer, V. Persky, J. Stamler, et al., Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am. J. Epidemiol. 112 (1980), 736–49.
W. B. Kannel, C. Kannel, R. S. Paffenbarger, Jr, L. A. Cupples, Heart rate and cardiovascular mortality: the Framingham Study. Am. Heart J. 113 (1987), 1489–94.
M. P. Frenneaux, Autonomic changes in patients with heart failure and in post-myocardial infarction patients. Heart 90 (2004), 1248–55.
D. Liao, J. Cai, W. D. Rosamond, et al., Cardiac autonomic function and incident coronary heart disease: a population-based case–cohort study. Am. J. Epidemiol. 145 (1997), 696–706.
M. T. La Rovere, J. T. Bigger, Jr, F. I. Marcus, A. Mortara, P. J. Schwartz, Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 351 (1998), 478–84.
C. R. Lake, D. Pickar, M. G. Ziegler, et al., High plasma norepinephrine levels in patients with major affective disorder. Am. J. Psychiatry 139 (1982), 1315–18.
R. C. Veith, N. Lewis, O. A. Linares, et al., Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics. Arch. Gen. Psychiatry 51 (1994), 411–22.
J. W. Hughes, L. Watkins, J. A. Blumenthal, C. Kuhn, A. Sherwood, Depression and anxiety symptoms are related to increased 24-hour urinary norepinephrine excretion among healthy middle-aged women. J. Psychosom. Res. 57 (2004), 353–8.
I. T. Meredith, A. Broughton, G. L. Jennings, M. D. Esler, Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N. Engl. J. Med. 325 (1991), 618–24.
M. Moser, M. Lehofer, R. Hoehn-Saric, et al., Increased heart rate in depressed subjects in spite of unchanged autonomic balance? J. Affect. Disord. 48 (1998), 115–24.
M. W. Agelink, C. Boz, H. Ullrich, J. Andrich, Relationship between major depression and heart rate variability: clinical consequences and implications for antidepressive treatment. Psychiatry Res. 113 (2002), 139–49.
A. C. Volkers, J. H. Tulen, W. W. van den Broek, et al., Motor activity and autonomic cardiac functioning in major depressive disorder. J. Affect. Disord. 76 (2003), 23–30.
V. K. Yeragani, R. Pohl, R. Balon, et al., Heart rate variability in patients with major depression. Psychiatry Res. 37 (1991), 35–46.
A. J. Broadley, M. P. Frenneaux, V. Moskvina, C. J. H. Jones, A. Korszun, Baroreflex sensitivity is reduced in depression. Psychosom. Med. 67 (2005), 648–51.
L. L. Watkins, P. Grossman, R. Krishnan, J. A. Blumenthal, Anxiety reduces baroreflex cardiac control in older adults with major depression. Psychosom. Med. 61 (1999), 334–40.
M. Horsten, M. Ericson, A. Perski, et al., Psychosocial factors and heart rate variability in healthy women. Psychosom. Med. 61 (1999), 49–57.
C. K. Kim, S. P. McGorray, B. A. Bartholomew, et al., Depressive symptoms and heart rate variability in postmenopausal women. Arch. Intern. Med. 165 (2005), 1239–44.
A. Gehi, D. Mangano, S. Pipkin, W. S. Browner, M. A. Whooley, Depression and heart rate variability in patients with stable coronary heart disease: findings from the Heart and Soul Study. Arch. Gen. Psychiatry 62 (2005), 661–6.
H. Hemingway, M. Marmot, Evidence based cardiology: psychosocial factors in the aetiology and prognosis of coronary heart disease – systematic review of prospective cohort studies. Br. Med. J. 318 (1999), 1460–67.
J. W. Lynch, G. A. Kaplan, R. D. Cohen, J. Tuomilehto, J. Salonen, Do cardiovascular risk factors explain the relation between socio-economic status, risk of all-cause mortality, cardiovascular mortality, and acute myocardial infarction? Am. J. Epidemiol. 144 (1996), 934–42.
F. J. Van Lenthe, E. Gevers, I. M. Joung, H. Bosma, J. P. Mackenbach, Material and behavioral factors in the explanation of educational differences in incidence of acute myocardial infarction: the Globe study. Ann. Epidemiol. 12 (2002), 535–42.
S. P. Wamala, M. A. Mittleman, K. Schenck-Gustafsson, K. Orth-Gomer, Potential explanations for the educational gradient in coronary heart disease: a population-based case–control study of Swedish women. Am. J. Public Health 89 (1999), 315–21.
M. Juonala, J. S. Viikari, T. Laitinen, et al., Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the Cardiovascular Risk in Young Finns Study. Circulation 110 (2004), 2918–23.
A. M. Ostfeld, B. Z. Lebovits, R. B. Shekelle, O. Paul, A prospective study of the relationship between personality and coronary heart disease. J. Chronic Dis. 17 (1964), 265–76.
T. Hallstrom, L. Lapidus, C. Bengtsson, K. Edstrom, Psychosocial factors and risk of ischaemic heart disease and death in women: a twelve-year follow-up of participants in the population study of women in Gothenburg, Sweden. J. Psychosom. Res. 30 (1986), 451–9.
J. C. Barefoot, M. Schroll, Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 93 (1996), 1976–80.
S. W. Schwartz, J. Cornoni-Huntley, S. R. Cole, et al., Are sleep complaints an independent risk factor for myocardial infarction? Ann. Epidemiol. 8 (1998), 384–92.
M. A. Whooley, W. S. Browner, Association between depressive symptoms and mortality in older women. Arch. Intern. Med. 158 (1998), 2129–35.
S. R. Cole, I. Kawachi, H. D. Sesso, R. S. Paffenbarger, I. M. Lee, Sense of exhaustion and coronary heart disease among college alumni. Am. J. Cardiol. 84 (1999), 1401–5.
M. Chang, R. A. Hahn, S. M. Teutsch, L. C. Hutwagner, Multiple risk factors and population attributable risk for ischemic heart disease mortality in the United States, 1971–1992. J. Clin. Epidemiol. 54 (2001), 634–44.
N. Yasuda, Y. Mino, S. Koda, H. Ohara, The differential influence of distinct clusters of psychiatric symptoms, as assessed by the general health questionnaire, on cause of death in older persons living in a rural community of Japan. J. Am. Geriatr. Soc. 50 (2002), 313–20.
S. A. Everson-Rose, J. S. House, R. P. Mero, Depressive symptoms and mortality risk in a national sample: confounding effects of health status. Psychosom. Med. 66 (2004), 823–30.
B. B. Gump, K. A. Matthews, L. E. Eberly, Y. F. Chang, Depressive symptoms and mortality in men: results from the Multiple Risk Factor Intervention Trial. Stroke 36 (2005), 98–102.
E. D. Eaker, J. Pinsky, W. P. Castelli, Myocardial infarction and coronary death among women: psychosocial predictors from a 20-year follow-up of women in the Framingham Study. Am. J. Epidemiol. 135 (1992), 854–64.
L. D. Kubzansky, I. Kawachi, A. Spiro, et al., Is worrying bad for your heart? A prospective study of worry and coronary heart disease in the Normative Aging Study. Circulation 95 (1997), 818–24.

Reference Title: REFERENCES

Reference Type: reference-list

M. Rayner, S. Petersen, European Cardiovascular Disease Statistics (London: British Heart Foundation, 2000).
American Heart Association. Heart Disease and Stroke Statistics: 2004 Update (Dallas, TX; American Heart Association, 2003).
K. B. Wells, A. Stewart, R. D. Hays, et al., The functioning and well-being of depressed patients: results from the Medical Outcomes Study. J. Am. Med. Assoc. 262 (1989), 914–19.
S. Murrell, S. Himmelfarb, K. Wright, Prevalence of depression and its correlates in older adults. Am. J. Epidemiol. 117 (1983), 173.
J. J. Schwab, N. D. Traven, G. J. Warheit, Relationships between physical and mental illness. Psychosomatics 19 (1978), 458–63.
S. Borson, R. A. Barnes, Symptomatic depression in elderly medical outpatients: I. Prevalence, demography, and health service utilization. J. Am. Geriatr. Soc. 34 (1986), 341–7.
B. W. Rovner, P. S. German, L. J. Brant, et al., Depression and mortality in nursing homes. J. Am. Med. Assoc. 265 (1991), 993–6.
J. Johnson, M. M. Weissman, G. L. Klerman, Service utilization and social morbidity associated with depressive symptoms in the community. J. Am. Med. Assoc. 267 (1992), 1478–83.
R. C. Kessler, K. A. McGonagle, C. B. Nelson, et al., Sex and depression in the National Comorbidity Survey: II. Cohort effects. J. Affect. Disord. 30 (1994), 15–26.
G. L. Klerman, M. M. Weissman, Increasing rates of depression. J. Am. Med. Assoc. 261 (1989), 2229–35.
H. Lett, J. Blumenthal, M. Babyak, et al., Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom. Med. 66 (2004), 305–15.
K. W. Davidson, N. Rieckman, F. Lesperance, Psychological theories of depression: potential application for the prevention of acute coronary syndrome recurrence. Psychosom. Med. 66 (2004), 165–73.
J. C. Barefoot, Depression and coronary heart disease. Cardiologia 42 (1997), 1245–50.
R. M. Carney, K. E. Freedland, Y. I. Sheline, E. S. Weiss, Depression and coronary heart disease: a review for cardiologists. Clin. Cardiol. 20 (1997), 196–200.
K. B. King, Psychologic and social aspects of cardiovascular disease. Ann. Behav. Med. 19 (1997), 264–70.
D. L. Musselman, D. L. Evans, C. B. Nemeroff, The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch. Gen. Psychiatry 55 (1998), 580–92.
A. Rozanski, J. A. Blumenthal, J. Kaplan, Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 99 (1999), 2192–217.
M. Naghavi, P. Libby, E. Falk, et al., From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation 108 (2003), 1664–72.
M. Naghavi, P. Libby, E. Falk, et al., From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation 108 (2003), 1772–8.
N. Frasure-Smith, F. Lesperance, M. Juneau, M. Talajic, M. G. Bourassa, Gender, depression, and one-year prognosis after myocardial infarction. Psychosom. Med. 61 (1999), 26–37.
R. M. Carney, J. A. Blumenthal, D. Catellier, et al., Depression as a risk factor for mortality after acute myocardial infarction. Am. J. Cardiol. 92 (2003), 1277–81.
D. Lane, D. Carroll, C. Ring, D. G. Beevers, G. Y. Lip, Effects of depression and anxiety on mortality and quality-of-life 4 months after myocardial infarction. J. Psychosom. Res. 49 (2000), 229–38.
D. Lane, D. Carroll, C. Ring, D. G. Beevers, G. Y. Lip, Do depression and anxiety predict recurrent coronary events 12 months after myocardial infarction? Q. J. Med. 93 (2000), 739–44.
D. Lane, D. Carroll, C. Ring, D. G. Beevers, G. Y. Lip, Mortality and quality of life 12 months after myocardial infarction: effects of depression and anxiety. Psychosom. Med. 63 (2001), 221–30.
D. Lane, D. Carroll, C. Ring, D. G. Beevers, G. Y. Lip, In-hospital symptoms of depression do not predict mortality 3 years after myocardial infarction. Int. J. Epidemiol. 31 (2002), 1179–82.
P. Peduzzi, J. Concato, A. R. Feinstein, T. R. Holford, Importance of events per independent variable in proportional hazards regression analysis: II. Accuracy and precision of regression estimates. J. Clin. Epidemiol. 48 (1995), 1503–10.
R. M. Carney, M. W. Rich, K. E. Freedland, et al., Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom. Med. 50 (1988), 627–33.
J. C. Barefoot, M. J. Helms, D. B. Mark, et al., Depression and long-term mortality risk in patients with coronary artery disease. Am. J. Cardiol. 78 (1996), 613–17.
I. Connerney, P. A. Shapiro, J. S. McLaughlin, E. Bagiella, R. P. Sloan, Relation between depression after coronary artery bypass surgery and 12-month outcome: a prospective study. Lancet 358 (2001), 1766–71.
R. A. Baker, M. J. Andrew, G. Schrader, J. L. Knight, Preoperative depression and mortality in coronary artery bypass surgery: preliminary findings. Aust. N. Z. J. Surg. 71 (2001), 139–42.
C. D. Saur, B. B. Granger, L. H. Muhlbaier, et al., Depressive symptoms and outcome of coronary artery bypass grafting. Am. J. Crit. Care 10 (2001), 4–10.
M. J. Underwood, R. K. Firmin, D. Jehu, Aspects of psychological and social morbidity in patients awaiting coronary artery bypass grafting. Br. Heart. J. 69 (1993), 382–4.
G. M. McKhann, L. M. Borowicz, M. A. Goldsborough, C. Enger, O. A. Selnes, Depression and cognitive decline after coronary artery bypass grafting. Lancet 349 (1997), 1282–4.
N. Timberlake, L. Klinger, P. Smith, et al., Incidence and patterns of depression following coronary artery bypass graft surgery. J. Psychosom. Res. 43 (1997), 197–207.
E. J. Burker, J. A. Blumenthal, M. Feldman, et al., Depression in male and female patients undergoing cardiac surgery. Br. J. Clin. Psychol. 34 (1995), 119–28.
M. M. Burg, C. Benedetto, R. Soufer, Depressive symptoms and mortality two years after coronary artery bypass graft surgery (CABG) in men. Psychosom. Med. 65 (2003), 508–10.
J. A. Blumenthal, H. Lett, M. Babyak, et al., Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet 362 (2003), 604–9.
M. Hautzinger, The CES-D scale: a depression-rating scale for research in the general population. Diagnostica 34 (1988), 167–73.
V. Vaccarino, H. M. Krumholz, J. Yarzebski, J. M. Gore, R. J. Goldberg, Sex differences in 2-year mortality after hospital discharge for myocardial infarction. Ann. Intern. Med. 134 (2001), 173–81.
R. V. Milani, C. J. Lavie, M. M. Cassidy, Effects of cardiac rehabilitation and exercise training programs on depression in patients after major coronary events 8. Am. Heart J. 132 (1996), 726–32.
G. T. O'Connor, J. R. Morton, M. J. Diehl, et al., Differences between men and women in hospital mortality associated with coronary artery bypass graft surgery: the Northern New England Cardiovascular Disease Study Group. Circulation 88 (1993), 1–10.
A. L. Ai, C. Peterson, R. E. Dunkle, et al., How gender affects psychological adjustment one year after coronary artery bypass graft surgery. Women Health 26 (1997), 45–65.
A. H. Con, W. Linden, J. M. Thompson, A. Ignaszewski, The psychology of men and women recovering from coronary artery bypass surgery. J. Cardpulm. Rehabil. 19 (1999), 152–61.
S. M. Czajkowski, M. Terrin, R. Lindquist, et al., Comparison of preoperative characteristics of men and women undergoing coronary artery bypass grafting (the Post Coronary Artery Bypass Graft [CABG] Biobehavioral Study). Am. J. Cardiol. 79 (1997), 1017–24.
E. D. Eaker, Psychosocial risk factors for coronary heart disease in women. Cardiol. Clin. 16 (1998), 103–11.
J. Z. Ayanian, E. Guadagnoli, P. D. Cleary, Physical and psychosocial functioning of women and men after coronary artery bypass surgery. J. Am. Med. Assoc. 274 (1995), 1767–70.
N. J. O'Connor, J. R. Morton, J. D. Birkmeyer, et al., Effect of coronary artery diameter in patients undergoing coronary bypass surgery: Northern New England Cardiovascular Disease Study Group. Circulation 93 (1996), 652–5.
W. J. Kop, A. P. Appels, C. F. Mendes de Leon, H. B. de Swart, F. W. Bar, Vital exhaustion predicts new cardiac events after successful coronary angioplasty. Psychosom. Med. 56 (1994), 281–7.
C. Welin, G. Lappas, L. Wilhelmsen, Independent importance of psychosocial factors for prognosis after myocardial infarction. J. Intern. Med. 247 (2000), 629–39.
C. M. Dickens, L. McGowan, C. Percival, et al., Lack of a close confidant, but not depression, predicts further cardiac events after myocardial infarction. Heart 90 (2004), 518–22.
J. Denollet, D. L. Brutsaert, Personality, disease severity, and the risk of long-term cardiac events in patients with a decreased ejection fraction after myocardial infarction. Circulation 97 (1998), 167–73.
I. Kawachi, D. Sparrow, L. D. Kubzansky, et al., Prospective study of a self-report type A scale and risk of coronary heart disease: test of the MMPI-2 type A scale. Circulation 98 (1998), 405–12.
P. Angerer, U. Siebert, W. Kothny, et al., Impact of social support, cynical hostility and anger expression on progression of coronary atherosclerosis. J. Am. Coll. Cardiol. 36 (2000), 1781–8.
L. A. Chaput, S. H. Adams, J. A. Simon, et al., Hostility predicts recurrent events among postmenopausal women with coronary heart disease. Am. J. Epidemiol. 156 (2002), 1092–9.
L. D. Kubzansky, I. Kawachi, Going to the heart of the matter: do negative emotions cause coronary heart disease? J. Psychosom. Res. 48 (2000), 323–37.
N. Frasure-Smith, F. Lesperance, Depression and other psychological risks following myocardial infarction. Arch. Gen. Psychiatry 60 (2003), 627–36.
N. Frasure-Smith, F. Lesperance, M. Talajic, The impact of negative emotions on prognosis following myocardial infarction: is it more than depression? Health Psychol. 14 (1995), 388–98.
J. Denollet, J. Vaes, D. L. Brutsaert, Inadequate response to treatment in coronary heart disease: adverse effects of type D personality and younger age on 5-year prognosis and quality of life. Circulation 102 (2000), 630–35.
R. A. Stewart, F. M. North, T. M. West, et al., Depression and cardiovascular morbidity and mortality: cause or consequence? Eur. Heart J. 24 (2003), 2027–37.
D. Lane, D. Carroll, G. Y. Lip, Anxiety, depression, and prognosis after myocardial infarction: is there a causal association? J. Am. Coll. Cardiol. 42 (2003), 1808–10.
J. C. Barefoot, B. H. Brummett, M. J. Helms, et al., Depressive symptoms and survival of patients with coronary artery disease. Psychosom. Med. 62 (2000), 790–95.
R. J. Anderson, K. E. Freedland, R. E. Clouse, P. J. Lustman, The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24 (2001), 1069–78.
J. H. Thakore, P. J. Richards, R. H. Reznek, A. Martin, T. G. Dinan, Increased intra-abdominal fat deposition in patients with major depressive illness as measured by computed tomography. Biol. Psychiatry 41 (1997), 1140–42.
D. L. Musselman, A. Tomer, A. K. Manatunga, et al., Exaggerated platelet reactivity in major depression. Am. J. Psychiatry 153 (1996), 1313–17.
P. L. Delgado, F. A. Moreno, Role of norepinephrine in depression. J. Clin. Psychiatry 61 (2000), 5–12.
H. Akil, R. F. Haskett, E. A. Young, et al., Multiple HPA profiles in endogenous depression: effect of age and sex on cortisol and beta-endorphin. Biol. Psychiatry 33 (1993), 73–85.
W. J. Kop, J. S. Gottdiener, C. M. Tangen, et al., Inflammation and coagulation factors in persons > 65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am. J. Cardiol. 89 (2002), 419–24.
R. M. Carney, K. E. Freedland, S. A. Eisen, M. W. Rich, A. S. Jaffe, Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol. 14 (1995), 88–90.
S. Lehto, H. Koukkunen, J. Hintikka, et al., Depression after coronary heart disease events. Scand. Cardiovasc. J. 34 (2000), 580–83.
T. C. Camacho, R. E. Roberts, N. B. Lazarus, G. A. Kaplan, R. D. Cohen, Physical activity and depression: evidence from the Alameda County Study. Am. J. Epidemiol. 134 (1991), 220–31.
J. E. Roeters van Lennep, H. T. Westerveld, D. W. Erkelens, E. E. van der Wall, Risk factors for coronary heart disease: implications of gender. Cardiovasc. Res. 53 (2002), 538–49.
S. V. Rao, M. Donahue, F. X. Pi-Sunyer, V. Fuster, Results of expert meetings: obesity and cardiovascular disease – obesity as a risk factor in coronary artery disease. Am. Heart J. 142 (2001), 1102–7.
D. L. Sprecher, G. L. Pearce, How deadly is the ‘deadly quartet’? A post-CABG evaluation. J. Am. Coll. Cardiol. 36 (2000), 1159–65.
C. Patrono, G. Renda, Platelet activation and inhibition in unstable coronary syndromes. Am. J. Cardiol. 80 (1997), 17–20E.
E. Thaulow, J. Erikssen, L. Sandvik, H. Stormorken, P. F. Cohn, Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 84 (1991), 613–17.
R. J. Gibbons, J. Abrams, K. Chatterjee, et al., ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Mangament of Patients With Chronic Stable Angina). www.acc.org/clinical/guidelines/unstable/incorporated/index.htm.
F. Laghrissi-Thode, W. R. Wagner, B. G. Pollock, P. C. Johnson, M. S. Finkel, Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol. Psychiatry 42 (1997), 290–95.
V. L. Serebruany, P. A. Gurbel, C. M. O'Connor, Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors. Pharmacol. Res. 43 (2001), 453–62.
V. L. Serebruany, C. M. O'Connor, P. A. Gurbel, Effect of selective serotonin reuptake inhibitors on platelets in patients with coronary artery disease. Am. J. Cardiol. 87 (2001), 1398–400.
F. De Clerck, Effects of serotonin on platelets and blood vessels. J. Cardiovasc. Pharmacol. 17: Suppl 5 (1991)
M. J. Owens, C. B. Nemeroff, Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin. Chem. 40 (1994), 288–95.
P. Hrdina, D. Bakish, A. Ravindran, Platelet serotonergin indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment. Psychiatry Res. 66 (1997), 73–85.
J. T. Willerson, J. F. Eidt, J. McNatt, et al., Role of thromboxane and serotonin as mediators in the development of spontaneous alterations in coronary blood flow and neointimal proliferation in canine models with chronic coronary artery stenoses and endothelial injury. J. Am. Coll. Cardiol. 17: Suppl (1991), 110B.
K. P. Lesch, G. Laux, H. M. Schulte, H. Pfuller, H. Beckmann, Corticotropin and cortisol response to human CRH as a probe for HPA system integrity in major depressive disorder. Psychiatry Res. 24 (1988), 25–34.
U. Ehlert, J. Gaab, M. Heinrichs, Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder, and stress-related bodily disorders: the role of the hypothalamus-pituitary-adrenal axis. Biol. Psychol. 57 (2001), 141–52.
P. W. Gold, F. K. Goodwin, G. P. Chrousos, Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2). N. Engl. J. Med. 319 (1988), 413–20.
P. W. Gold, J. Licinio, M. L. Wong, G. P. Chrousos, Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs. Ann. N. Y. Acad. Sci. 771 (1995), 716–29.
J. W. Kasckow, D. Baker, T. D. Geracioti, Jr, Corticotropin-releasing hormone in depression and post-traumatic stress disorder. Peptides 22 (2001), 845–51.
R. Rosmond, P. Bjorntorp, The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke. J. Intern. Med. 247 (2000), 188–97.
E. Agabiti-Rosei, C. Alicandri, M. Beschi, et al., Relationships between plasma catecholamines, renin, age and blood pressure in essential hypertension. Cardiology 70 (1983), 308–16.
M. W. Rich, J. S. Saini, R. E. Kleiger, et al., Correlation of heart rate variability with clinical and angiographic variables and late mortality after coronary angiography. Am. J. Cardiol. 62 (1988), 1–7.
R. E. Kleiger, J. P. Miller, J. T. Bigger, Jr, A. J. Moss, Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am. J. Cardiol. 59 (1987), 256–62.
J. Nolan, P. D. Batin, R. Andrews, et al., Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation 98 (1998), 1510–16.
R. M. Carney, M. W. Rich, A. Tevelde, et al., Major depressive disorder in coronary artery disease. Am. J. Cardiol. 60 (1987), 1273–5.
R. M. Carney, R. D. Saunders, K. E. Freedland, et al., Association of depression with reduced heart rate variability in coronary artery disease. Am. J. Cardiol. 76 (1995), 562–4.
R. M. Carney, J. A. Blumenthal, P. K. Stein, et al., Depression, heart rate variability, and acute myocardial infarction. Circulation 104 (2001), 2024–8.
G. Casolo, E. Balli, T. Taddei, J. Amuhasi, C. Gori, Decreased spontaneous heart rate variability in congestive heart failure. Am. J. Cardiol. 64 (1989), 1162–7.
E. P. Havranek, M. G. Ware, B. D. Lowes, Prevalence of depression in congestive heart failure. Am. J. Cardiol. 84 (1999), 348–50.
R. A. Carney, J. A. Blumenthal, K. E. Freedland, et al., Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Arch. Intern. Med. 165 (2005), 1486–91.
M. T. La Rovere, C. Bersano, M. Gnemmi, G. Specchia, P. J. Schwartz, Exercise-induced increase in baroreflex sensitivity predicts improved prognosis after myocardial infarction. Circulation 106 (2002), 945–9.
S. H. Hohnloser, T. Klingenheben, L. A. van de, et al., Reflex versus tonic vagal activity as a prognostic parameter in patients with sustained ventricular tachycardia or ventricular fibrillation. Circulation 89 (1994), 1068–73.
G. M. De Ferrari, M. Landolina, M. Mantica, et al., Baroreflex sensitivity, but not heart rate variability, is reduced in patients with life-threatening ventricular arrhythmias long after myocardial infarction. Am. Heart J. 130 (1995), 473-80.
G. E. Billman, P. J. Schwartz, H. L. Stone, Baroreceptor reflex control of heart rate: a predictor of sudden cardiac death. Circulation 66 (1982), 874–80.
G. J. Kennedy, M. A. Hofer, D. Cohen, R. Shindledecker, J. D. Fisher, Significance of depression and cognitive impairment in patients undergoing programed stimulation of cardiac arrhythmias. Psychosom. Med. 49 (1987), 410–21.
N. Frasure-Smith, F. Lesperance, M. Talajic, Depression and 18-month prognosis after myocardial infarction. Circulation 91 (1995), 999–1005.
G. Brevetti, A. Silvestro, V. Schiano, M. Chiariello, Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation 108 (2003), 2093–8.
P. O. Bonetti, L. O. Lerman, A. Lerman, Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler., Thromb. Vasc. Biol. 23 (2003), 168–75.
D. S. Celermajer, K. E. Sorensen, V. M. Gooch, et al., Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340 (1992), 1111–15.
D. S. Celermajer, K. E. Sorensen, C. Bull, J. Robinson, J. E. Deanfield, Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J. Am. Coll. Cardiol. 24 (1994), 1468–74.
T. Neunteufl, S. Heher, R. Katzenschlager, et al., Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am. J. Cardiol. 86 (2000), 207–10.
T. Heitzer, T. Schlinzig, K. Krohn, T. Meinertz, T. Munzel, Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104 (2001), 2673–8.
F. Perticone, R. Ceravolo, A. Pujia, et al., Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 104 (2001), 191–6.
N. Gokce, J. F. Keaney, J., L. M. Hunter, et al., Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J. Am. Coll. Cardiol. 41 (2003), 1769–75.
G. B. Mancini, Vascular structure versus function: is endothelial dysfunction of independent prognostic importance or not? J. Am. Coll. Cardiol. 43 (2004), 624–8.
J. A. Vita, J. F. Keaney, Jr, Endothelial function: a barometer for cardiovascular risk? Circulation 106 (2002), 640–42.
S. Rajagopalan, R. Brook, M. Rubenfire, et al., Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. Am. J. Cardiol. 88 (2001), 196–8.
A. J. Broadley, A. Korszun, C. J. Jones, M. P. Frenneaux, Arterial endothelial function is impaired in treated depression. Heart 88 (2002), 521–3.
K. F. Harris, K. A. Matthews, K. Sutton-Tyrrell, L. H. Kuller, Associations between psychological traits and endothelial function in postmenopausal women. Psychosom. Med. 65 (2003), 402–9.
M. B. Pepys, G. M. Hirschfield, C-reactive protein: a critical update. J. Clin. Invest. 111 (2003), 1805–12.
P. M. Ridker, N. Rifai, L. Rose, J. E. Buring, N. R. Cook, Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med. 347 (2002), 1557–65.
A. R. Tall, C-reactive protein reassessed. N. Engl. J. Med. 350 (2004), 1450–52.
M. Maes, W. J. Stevens, L. S. Declerck, et al., Significantly increased expression of T-cell activation markers (interleukin-2 and HLA-DR) in depression: further evidence for an inflammatory process during that illness. Prog. Neuropsychopharmacol. Biol. Psychiatry 17 (1993), 241–55.
A. Appels, F. W. Bar, J. Bar, C. Bruggeman, M. de Baets, Inflammation, depressive symptomtology, and coronary artery disease. Psychosom. Med. 62 (2000), 601–5.
S. M. Haffner, Metabolic syndrome, diabetes and coronary heart disease. Int. J. Clin. Pract. Suppl. (2002) 31–7.
M. Frohlich, A. Imhof, G. Berg, et al., Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 23 (2000), 1835–9.
D. E. Ford, T. P. Erlinger, Depression and C-reative protein in US adults. Arch. Intern. Med. 164 (2004), 1010–14.
B. Pennix, S. Kritchevsky, K. Yaffe, Inflammatory markers and depressed mood in older persons. Biol. Psychiatry 54 (2003), 566–72.
H. Tiemeier, A. Hofman, Inflammatory proteins and depression in the elderly. Epidemiology 14 (2003), 103–7.
M. R. DiMatteo, H. S. Lepper, T. W. Croghan, Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch. Intern. Med. 160 (2000), 2101–7.
J. A. Blumenthal, R. S. Williams, A. G. Wallace, R. B. Williams, Jr, T. L. Needles, Physiological and psychological variables predict compliance to prescribed exercise therapy in patients recovering from myocardial infarction. Psychosom. Med. 44 (1982), 519–27.
R. M. Carney, K. E. Freedland, S. A. Eisen, et al., Adherence to a prophylactic medication regimen in patients with symptomatic versus asymptomatic ischemic heart disease. Behav. Med. 24 (1998), 35–9.
R. C. Ziegelstein, J. A. Fauerbach, S. S. Stevens, et al., Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch. Intern. Med. 160 (2000), 1818–23.
Anonymous. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. N. Eng. J. Med. 303 (1980), 1038–41.
R. I. Horwitz, C. M. Viscoli, L. Berkman, et al., Treatment adherence and risk of death after a myocardial infarction. Lancet 336 (1990), 542–5.
M. M. McDermott, B. Schmitt, E. Wallner, Impact of medication nonadherence on coronary heart disease outcomes: a critical review. Arch. Intern. Med. 157 (1997), 1921–9.
R. Danker, U. Goldbourt, V. Boyko, H. Reicher-Reiss, Predictors of cardiac and noncardiac mortality among 14,697 patients with coronary heart disease. Am. J. Cardiol. 91 (2003), 121–7.
A. H. Glassman, J. E. Helzer, L. S. Covey, et al., Smoking, smoking cessation, and major depression. J. Am. Med. Assoc. 264 (1990), 1546–9.
A. L. Brosse, E. S. Sheets, H. S. Lett, J. A. Blumenthal, Exercise and the treatment of clinical depression in adults: recent findings and future directions. Sports Med. 32 (2002), 741–60.
D. B. Panagiotakos, C. Pitsavos, C. Chrysohoou, C. Stefanadis, P. Toutouzas, Risk stratification of coronary heart disease through established and emerging lifestyle factors in a Mediterranean population: CARDIO2000 epidemiological study. J. Cardiovasc. Risk 8 (2001), 329–35.
W. J. Strawbridge, S. Deleger, R. E. Roberts, G. A. Kaplan, Physical activity reduces the risk of subsequent depression for older adults. Am. J. Epidemiol. 156 (2002), 328–34.
D. Kritz-Silverstein, E. Barrett-Conno, C. Corbeau, Cross-sectional and prospective study of exercise and depressed mood in the elderly: the Rancho Bernardo study. Am. J. Epidemiol. 153 (2001), 596–603.
P. Hassmen, N. Koivula, A. Uutela, Physical exercise and psychological well-being: a population study in Finland. Prev. Med. 30 (2000), 17–25.
D. Scully, J. Kremer, M. M. Meade, R. Graham, K. Dudgeon, Physical exercise and psychological well being: a critical review. Br. J. Sports Med. 32 (1998), 111–20.
T. Stephens, Physical activity and mental health in the United States and Canada: evidence from four population surveys. Prev. Med. 17 (1988), 35–47.
N. Frasure-Smith, F. Lesperance, M. Talajic, Depression following myocardial infarction: impact on 6-month survival. J. Am. Med. Assoc. 270 (1993), 1819–25.
F. Lesperance, N. Frasure-Smith, M. Talajic, M. G. Bourassa, Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 105 (2002), 1049–53.
D. K. Ahern, L. Gorkin, J. L. Anderson, et al., Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS). Am. J. Cardiol. 66 (1990), 59–62.
C. M. Jenkinson, R. J. Madeley, J. R. Mitchell, I. D. Turner, The influence of psychosocial factors on survival after myocardial infarction. Public Health 107 (1993), 305–17.
K. H. Ladwig, M. Kieser, J. Konig, G. Breithardt, M. Borggrefe, Affective disorders and survival after acute myocardial infarction: results from the post-infarction late potential study. Eur. Heart J. 12 (1991), 959–64.
D. E. Bush, R. C. Ziegelstein, M. Tayback, et al., Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am. J. Cardiol. 88 (2001), 337–41.
M. W. Kaufmann, J. P. Fitzgibbons, E. J. Sussman, et al., Relation between myocardial infarction, depression, hostility, and death. Am. Heart J. 138 (1999), 549–54.
J. Irvine, A. Basinski, B. Baker, et al., Depression and risk of sudden cardiac death after acute myocardial infarction: testing for the confounding effects of fatigue. Psychosom. Med. 61 (1999), 729–37.
J. J. Strik, J. Denollet, R. Lousberg, A. Honig, Comparing symptoms of depression and anxiety as predictors of cardiac events and increased health care consumption after myocardial infarction. J. Am. Coll. Cardiol. 42 (2003), 1801–7.
J. J. Strik, R. Lousberg, E. C. Cheriex, A. Honig, One year cumulative incidence of depression following myocardial infarction and impact on cardiac outcome. J. Psychosom. Res. 56 (2004), 59–66.
M. Horsten, M. A. Mittleman, S. P. Wamala, K. Schenck-Gustafsson, K. Orth-Gomer, Depressive symptoms and lack of social integration in relation to prognosis of CHD in middle-aged women: the Stockholm Female Coronary Risk Study. Eur. Heart. J. 21 (2000), 1072–80.
F. Lesperance, N. Frasure-Smith, M. Juneau, P. Theroux, Depression and 1-year prognosis in unstable angina. Arch. Intern. Med. 160 (2000), 1354–60.

Reference Title: REFERENCES

Reference Type: reference-list

E. L. Cay, N. Vetter, A. E. Philip, P. Dugard, Psychological status during recovery from an acute heart attack. J. Psychosom. Res. 16 (1972), 425–35.
S. H. Croog, S. Levine, Life After Heart Attack (New York: Human Sciences Press, 1982).
H. Cassem, T. P. Hackett, Psychiatric consultation in a coronary care unit. Ann. Intern. Med. 75 (1971), 9–14.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn, text revision (Washington, DC: American Psychiatric Association, 2000).
S. J. Schleifer, M. M. Macari-Hinson, D. A. Coyle, et al., The nature and course of depression following myocardial infarction. Arch. Intern. Med. 149 (1989), 1785–9.
R. M. Carney, K. E. Freedland, A. S. Jaffe, Insomnia and depression prior to myocardial infarction. Psychosom. Med. 52 (1990), 603–9.
N. Frasure-Smith, F. Lespérance, M. Talajic, Depression following myocardial infarction: impact on 6 month survival. J. Am. Med. Assoc. 270 (1993), 1819–25.
F. Lespérance, N. Frasure-Smith, M, Taljic, Major depression before and after myocardial infarction: its nature and consequences. Psychosom. Med. 58 (1996), 99–110.
R. M. Carney, M. W. Rich, A. J. Tevelde, et al., Major depressive disorder in coronary artery disease. Am. J. Cardiol. 60 (1987), 1273–5.
M. B. Gonzalez, T. B. Snyderman, J. T. Colket, et al., Depression in patients with coronary artery disease. Depression 4 (1997), 57–62.
M. Hance, R. M. Carney, K. E. Freedland, J. Skala, Depression in patients with coronary heart disease: a twelve month follow-up. Gen. Hosp. Psychiatry 18 (1995), 61–5.
M. J. Stern, L. Pascale, J. B. McLoone, Psychosocial adaption following an acute myocardial infarction. J. Chronic. Dis. 29 (1976), 213–26.
R. Mayou, A. Foster, B. Williamson, Psychosocial adjustment in patients one year after myocardial infarction. J. Psychosom. Res. 22 (1978), 447–53.
G. G. Lloyd, R. H. Cawley, Distress or illness? A study of psychosocial symptoms after myocardial infarction. Br. J. Psychiatry 142 (1983), 120–25.
A. L. Stewart, S. Greenfield, R. D. Hays, et al., Functional status and well-being of patients with chronic conditions: results from the Medical Outcomes Study. J. Am. Med. Assoc. 262 (1989), 907–13.
K. B. Wells, A. Stewart, R. Hays, et al., The functioning and well-being of depressed patients: results from the Medical Outcomes Study. J. Am. Med. Assoc. 262 (1989), 914–19.
R. M. Carney, M. W. Rich, K. E. Freedland, et al., Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom. Med. 50 (1988), 627–33.
J. C. Barefoot, M. J. Helms, D. B. Mark, et al., Depression and long-term mortality risk in patients with coronary artery disease. Am. J. Cardiol. 78 (1996), 613–17.
I. Connerney, P. Shapiro, J. S. McLaughlin, R. P. Sloan, In hospital depression after CABG surgery predicts 12-month outcome. Psychosom. Med. 62 (2000), 106.
M. M. Burg, C. M. Benedetto, R. Rosenberg, R. Soufer, Depression prior to CABG predicts 6-month and 2-year morbidity and mortality. Psychosom. Med. 63 (2001), 103.
J. A. Blumenthal, H. S. Lett, M. A. Babyak, et al., Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet 362 (2003), 604–9.
J. Irvine, A. Basinski, B. Baker, et al., Depression and risk of sudden cardiac death after acute myocardial infarction: testing for the confounding effects of fatigue. Psychosom. Med. 61 (1999), 729–37.
D. K. Ahern, L. Gorkin, J. L. Anderson, et al., Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS). Am. J. Cardiol. 66 (1990), 59–62.
K. H. Ladwig, M. Kieser, J. Konig, G. Breithardt, M. Borggrefe, Affective disorders and survival after acute myocardial infarction. Eur. Heart. J. 12 (1991), 959–64.
R. M. Carney, J. A. Blumenthal, D. Catellier, et al., Depression as a risk factor for mortality following acute myocardial infarction. Am. J. Cardiol. 92 (2003), 1277–81.
D. E. Bush, R. C. Ziegelstein, M. Tayback, et al., Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am. J. Cardiol. 88 (2001), 337–41.
M. W. Kaufmann, J. P. Fitzgibbons, E. J. Sussman, et al., Relation between myocardial infarction, depression, hostility, and death. Am. Heart. J. 138 (1999), 549–54.
R. P. Pary, C. R. Tobias, S. Lippmann, Antidepressants and the cardiac patient: selecting an appropriate medication. Postgrad. Med. 85 (1989), 267–9.
A. H. Glassman, S. P. Roose, J. T. Bigger, The safety of tricyclic antidepressants in cardiac patients: risk/benefit reconsidered. J. Am. Med. Assoc. 269 (1993), 2673–5.
S. J. Warrington, C. Padgham, M. Lader, The cardiovascular effects of antidepressants. Psychol. Med. Monogr. Suppl. 16 (1989), 1–40.
Y. Sheline, K. E. Freedland, R. M. Carney, How safe are serotonin reuptake inhibitors for depression in patients with coronary heart disease? Am. J. Med. 102 (1997), 54–9.
M. M. Shores, M. Pascualy, R. C. Veith, Major depression and heart disease: treatment trials. Semin. Clin. Neuropsychiatry 3 (1998), 87–101.
A. H. Glassman, C. M. O'Connor, R. M. Califf, et al., Sertraline treatment of major depression in patients with acute MI or unstable angina. J. Am. Med. Assoc. 288 (2002), 701–9.
M. B. Keller, J. P. McCullough, D. N. Klein, et al., A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N. Engl. J. Med. 342 (2000), 1462–9.
A. T. Beck, A. J. Rush, B. F. Shaw, G. Emery, Cognitive Therapy of Depression (New York: Guilford Press, 1979).
G. L. Klerman, M. M. Weissman, B. J. Rounsaville, E. S. Chevron, Interpersonal Psychotherapy of Depression (New York: Basic Books, 1984).
I. Elkin, M. T. Shea, J. T. Watkins, et al., National Institute of Mental Health Treatment of Depression Collaborative Research Program: general effectiveness of treatments. Arch. Gen. Psychiatry 46 (1989), 971–82.
G. E. Murphy, A. D. Simons, R. D. Wetzel, P. J. Lustman, Cognitive therapy and pharmacotherapy, singly and together in the treatment of depression. Arch. Gen. Psychiatry 41 (1984), 33–41.
G. E. Murphy, R. M. Carney, R. D. Wetzel, M. Knesevitch, P. Whitworth, Cognitive therapy and depression: a controlled treatment outcome study. Psychol. Rep. 77 (1995), 403–20.
J. C. Markowitz, G, L. Klerman, S. W. Perry, K. F. Clougherty, A. Mayers, Interpersonal therapy of depressed HIV-seropositive patients. Hosp. Community Psychiatry 43 (1992), 885–90.
H. C. Schulberg, C. P. Scott, M. J. Madonia, S. D. Imber, Applications of interpersonal psychotherapy to depression in primary care practice. In New Applications of Interpersonal Psychotherapy, ed. G. L. Klerman, M. M. Weisman (Washington, DC: American Psychiatric Press, 1993), pp. 265–91.
J. M. Mossey, K. A. Knott, M. Higgins, K. Talerico, Effectiveness of a psychosocial intervention, interpersonal counseling, for subdysthymic depression in medically ill elderly. J. Gerontol. 51A (1996), M172–8.
J. A. Blumenthal, C. F. Emery, Rehabilitation of patients following myocardial infarction. J. Consult. Clin. Psychol. 56 (1988), 374–81.
J. van Dixhoorn, H. J. Duivenvoorden, J. Pool, F. Verhage, Psychic effects of physical training and relaxation therapy after myocardial infarction. J. Psychsom. Res. 34 (1990), 327–37.
B. Oldenburg, R. J. Perkins, G. Andrews, Controlled trial of psychological intervention in myocardial infarction. J. Consult. Clin. Psychol. 53 (1985), 852–9.
R. H. Rahe, H. W. Ward, V. Hayes, Brief group therapy in myocardial infarction rehabilitation: three to four year follow-up of a controlled trial. Psychosom. Med. 41 (1979), 229–42.
A. W. Burgess, D. J. Lerner, R. B. D'Agostino, et al., A randomized controlled trial of cardiac rehabilitation. Soc. Sci. Med. 24 (1987), 359–70.
N. B. Oldridge, G. Guyat, N. Jones, et al., Effects on quality of life of comprehensive rehabilitation after acute myocardial infarction. Am. J. Cardiol. 67 (1991), 1084–9.
D. A. Lawlor, S. W. Hopker, The effectiveness of exercise as an intervention in the management of depression: systematic review and meta-regression analysis of randomised controlled trials. Br. Med. J. 322 (2001), 1–8.
J. A. Blumenthal, M. A. Babyak, K. A. Moore, et al., Effects of exercise training on older patients with major depression. Arch. Intern. Med. 159 (1999), 2349–56.
R. V. Milani, C. J. Lavie, Prevalence and effects of cardiac rehabilitation on depression in the elderly with coronary heart disease. Am. J. Cardiol. 81 (1998), 1233–6.
C. J. Lavie, R. V. Milani, M. M. Cassidy, Y. E. Gilliland, Effects of cardiac rehabilitation and exercise training programs in women with depression. Am. J. Cardiol. 83 (1999), 1480–83.
D. Avery, G. Winokur, Mortality in depressed patients treated with electroconvulsive therapy and antidepressants. Arch. Gen. Psychiatry 33 (1976), 1029–37.
W. H. Sauer, J. A. Berlin, S. E. Kimmel, Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction. Circulation 108 (2003), 32–6.
W. H. Sauer, J. A. Berlin, S. E. Kimmel, Selective serotonin reuptake inhibitors and myocardial infarction. Circulation 104 (2001), 1894–8.
N. Hergovich, M. Aigner, H. G. Eichler, et al., Paroxetine decreases platelet serotonin storage and platelet function in human beings. Clin. Pharmacol. Ther. 68 (2000), 435–42.
V. L. Serebruany, C. M. O'Connor, P. A. Gurbel, Effect of selective serotonin reuptake inhibitors on platelets in patients with coronary artery disease. Am. J. Cardiol. 87 (2001), 1398–400.
D. L. Musselman, U. M. Marzec, A. Manatunga, et al., Platelet reactivity in depressed patients treated with paroxetine: preliminary findings. Arch. Gen. Psychiatry 57 (2000), 875–82.
F. Laghrissi-Thode, W. R. Wagner, B. G. Pollock, P. C. Johnson, M. S. Finkel, Elevated platelet factor 4 and β-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol. Psychiatry 42 (1997), 290–95.
R. M. Carney, K. E. Freedland, G. E. Miller, A. S. Jaffe, Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J. Psychosom. Res. 53 (2002), 897–902.
W. Linden, C. Stossel, J. Maurice, Psychosocial interventions for patients with coronary artery disease: a meta-analysis. Arch. Intern. Med. 156 (1999), 745–52.
L. H. Powell, Unanswered questions in the Ischemic Heart Disease Life Stress Monitoring Program. Psychosom. Med. 51 (1989), 479–84.
N. Frasure-Smith, F. Lespérance, R. Prince, et al., Randomized trial of home based psychosocial nursing intervention for patients recovering from myocardial infarction. Lancet 350 (1997), 473–9.
D. A. Jones, R. R. West, Psychological rehabilitation after myocardial infarction: multicentre randomized controlled trial. Br. Med. J. 313 (1996), 1517–21.
J. A. Blumenthal, W. Jiang, M. A. Babyak, et al., Stress management and exercise training in cardiac patients with myocardial ischemia. Arch. Intern. Med. 157 (1997), 2213–23.
ENRICHD investigators. Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD): study design and methods. Am. Heart J. 139 (2000), 1–9.
ENRICHD investigators. Effects of treating depression and low perceived social support on clinical events after a myocardial infarction: the Enhancing recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial. J. Am. Med. Assoc. 289 (2003), 3106–16.
R. M. Carney, J. A. Blumenthal, K. E. Freedland, et al., Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom. Med. 66 (2004), 466–74.
K. E. Freedland, M. W. Rich, J. A. Skala, et al., Depression in hospitalized patients with congestive heart failure. Psychosom. Med. 63 (2001), 177.

Reference Title: REFERENCES

Reference Type: reference-list

L. M. Verbrugge, A. M. Jette, The disablement process. Soc. Sci. Med. 38 (1994), 1–14.
World Health Organization. International Classification of Functioning, Disability and Health. (Geneva: WHO, 2001).
E. Kramarow, H. Lentzner, R. Rooks, J. Weeks, S. Saydah, Health, United States, 1999: Health and Aging Chartbook (Hyattsville, MD: National Center for Health Statistics, 1999).
J. M. Guralnik, L. Ferrucci, E. M. Simonsick, M. E. Salive, R. B. Wallace, Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N. Engl. J. Med. 332 (1995), 556–61.
B. W. Penninx, L. Ferrucci, S. G. Leveille, et al., Lower extremity performance in nondisabled older persons as a predictor of subsequent hospitalization. J. Gerontol. A Biol. Sci. Med. Sci. 55 (2000), M691–7.
J. M. Guralnik, L. P. Fried, M. E. Salive, Disability as a public health outcome in the aging population. Annu. Rev. Public Health 17 (1996), 25–46.
T. R. Fried, E. H. Bradley, C. S. Williams, M. E. Tinetti, Functional disability and health care expenditures for older persons. Arch. Intern. Med. 161 (2001), 2602–7.
A. T. Beekman, D. J. Deeg, A. W. Braam, J. H. Smit, W. van Tilburg, Consequences of major and minor depression in later life: a study of disability, well-being and service utilization. Psychol. Med. 27 (1997), 1397–409.
Y. Forsell, A. F. Jorm, B. Winblad, Association of age, sex, cognitive dysfunction, and disability with major depressive symptoms in an elderly sample. Am. J. Psychiatry 151 (1994), 1600–604.
H. G. Koenig, L. K. George, Depression and physical disability outcomes in depressed medically ill hospitalized older adults. Am. J. Geriatr. Psychiatry 6 (1998), 230–47.
J. M. Lyness, D. A. King, C. Cox, Z. Yoediono, E. D. Caine, The importance of subsyndromal depression in older primary care patients: prevalence and associated functional disability. J. Am. Geriatr. Soc. 47 (2001), 647–52.
P. A. Sinclair, J. M. Lyness, D. A. King, C. Cox, E. D. Caine, Depression and self-reported functional status in older primary care patients. Am. J. Psychiatry 158 (2001), 416–19.
K. B. Wells, A. Stewart, R. D. Hays, et al., The functioning and well-being of depressed patients: results from the Medical Outcomes Study. J. Am. Med. Assoc. 262 (1989), 914–19.
J. Johnson, M. M. Weissman, G. L. Klerman, Service utilization and social morbidity associated with depressive symptoms in the community. J. Am. Med. Assoc. 267 (1992), 1478–83.
J. Ormel, G. I. Kempen, D. J. Deeg, et al., Functioning, well-being, and health perception in late middle-aged and older people: comparing the effects of depressive symptoms and chronic medical conditions. J. Am. Geriatr. Soc. 46 (1998), 39–48.
B. G. Druss, S. C. Marcus, R. A. Rosenheck, et al., Understanding disability in mental and general medical conditions. Am. J. Psychiatry 157 (2000), 1485–91.
W. E. Broadhead, D. G. Blazer, L. K. George, C. K. Tse, Depression, disability days, and days lost from work in a prospective epidemiologic survey. J. Am. Med. Assoc. 264 (1990), 2524–8.
J. Ormel, M. VonKorff, T. B. Ustun, et al., Common mental disorders and disability across cultures: results from the WHO Collaborative Study on Psychological Problems in General Health Care. J. Am. Med. Assoc. 272 (1994), 1741–8.
K. B. Wells, C. D. Sherbourne, Functioning and utility for current health of patients with depression or chronic medical conditions in managed, primary care practices. Arch. Gen. Psychiatry 56 (1999), 897–904.
C. J. Murray, A. D. Lopez, Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 349 (1997), 1498–504.
G. J. Kennedy, H. R. Kelman, C. Thomas, The emergence of depressive symptoms in late life: the importance of declining health and increasing disability. J. Community Health. 15 (1990), 93–104.
R. E. Roberts, G. A. Kaplan, S. J. Shema, W. J. Strawbridge, Prevalence and correlates of depression in an aging cohort: the Alameda County Study. J. Gerontol. B. Psychol. Sci. Soc. Sci. 52 (1997), S252–8.
A. M. Zeiss, P. M. Lewinsohn, P. Rohde, J. R. Seeley, Relationship of physical disease and functional impairment to depression in older people. Psychol. Aging 11 (1996), 572–81.
M. J. Prince, R. H. Harwood, A. Thomas, A. H. Mann, A prospective population-based cohort study of the effects of disablement and social milieu on the onset and maintenance of late-life depression: the Gospel Oak Project VII. Psychol. Med. 28 (1998), 337–50.
S. W. Geerlings, A. T. Beekman, D. J. Deeg, W. van Tilburg, Physical health and the onset and persistence of depression in older adults: an eight-wave prospective community-based study. Psychol. Med. 30 (2000), 369–80.
L. F. Berkman, C. S. Berkman, S. Kasl, et al., Depressive symptoms in relation to physical health and functioning in the elderly. Am. J. Epidemiol 124 (1986), 372–88.
A. T. Beekman, D. J. Deeg, S. W. Geerlings, et al., Emergence and persistence of late life depression: a 3-year follow-up of the Longitudinal Aging Study Amsterdam. J. Affect. Disord. 65 (2001), 131–8.
J. Ormel, G. I. Kempen, B. W. Penninx, et al., Chronic medical conditions and mental health in older people: disability and psychosocial resources mediate specific mental health effects. Psychol. Med. 27 (1997), 1065–77.
R. J. Turner, S. Noh, Physical disability and depression: a longitudinal analysis. J. Health. Soc. Behav. 29 (1988), 23–37.
J. Ormel, T. Oldehinkel, E. Brilman, W. vanden Brink, Outcome of depression and anxiety in primary care: a three-wave 3 1/2-year study of psychopathology and disability. Arch. Gen. Psychiatry 50 (1993), 759–66.
M. von Korff, J. Ormel, W. Katon, E. H. Lin, Disability and depression among high utilizers of health care: a longitudinal analysis. Arch. Gen. Psychiatry 49 (1992), 91–100.
M. L. Bruce, T. E. Seeman, S. S. Merrill, D. G. Blazer, The impact of depressive symptomatology on physical disability: MacArthur Studies of Successful Aging. Am. J. Public Health 84 (1994), 1796–9.
J. J. Gallo, P. V. Rabins, C. G. Lyketsos, A. Y. Tien, J. C. Anthony, Depression without sadness: functional outcomes of nondysphoric depression in later life. J. Am. Geriatr. Soc. 45 (1997), 570–78.
B. W. Penninx, S. Leveille, L. Ferrucci, J. T. van Eijk, J. M. Guralnik, Exploring the effect of depression on physical disability: longitudinal evidence from the established populations for epidemiologic studies of the elderly. Am. J. Public Health 89 (1999), 1346–52.
D. Cronin-Stubbs, C. F. de Leon, L. A. Beckett, et al., Six-year effect of depressive symptoms on the course of physical disability in community-living older adults. Arch. Intern. Med. 160 (2000), 3074–80.
H. K. Armenian, L. A. Pratt, J. Gallo, W. W. Eaton, Psychopathology as a predictor of disability: a population-based follow-up study in Baltimore, Maryland. Am. J. Epidemiol. 148 (1998), 269–75.
E. J. Lenze, J. C. Rogers, L. M. Martire, et al., The association of late-life depression and anxiety with physical disability: a review of the literature and prospectus for future research. Am. J. Geriatr. Psychiatry 9 (2001), 113–35.
B. W. Penninx, J. M. Guralnik, L. Ferrucci, et al., Depressive symptoms and physical decline in community-dwelling older persons. J. Am. Med. Assoc. 279 (1998), 1720–26.
C. H. van Gool, G. I. Kempen, B. W. Penninx, et al., Impact of depression on disablement in late middle aged and older persons: results from the Longitudinal Aging Study Amsterdam. Soc. Sci. Med. 60 (2005), 25–36.
B. W. Penninx, D. J. Deeg, J. T. van Eijk, A. T. Beekman, J. M. Guralnik, Changes in depression and physical decline in older adults: a longitudinal perspective. J. Affect. Disord. 61 (2000), 1–12.
G. J. Kennedy, H. R. Kelman, C. Thomas, Persistence and remission of depressive symptoms in late life. Am. J. Psychiatry 148 (1991), 174–8.
J. Ormel, M. Von Korff, B. W. van den, et al., Depression, anxiety, and social disability show synchrony of change in primary care patients. Am. J. Public Health 83 (1993), 385–90.
G. I. Kempen, N. Steverink, J. Ormel, D. J. Deeg, The assessment of ADL among frail elderly in an interview survey: self-report versus performance-based tests and determinants of discrepancies. J. Gerontol. B Psychol. Sci. Soc. Sci. 51 (1996), 254–60.
L. L. Judd, H. S. Akiskal, P. J. Zeller, et al., Psychosocial disability during the long-term course of unipolar major depressive disorder. Arch. Gen. Psychiatry 57 (2000), 375–80.
J. Ormel, A. J. Oldehinkel, W. A. Nolen, W. Vollebergh, Psychosocial disability before, during, and after a major depressive episode: a 3-wave population-based study of state, scar, and trait effects. Arch. Gen. Psychiatry 61 (2004), 387–92.
R. F. Anda, D. F. Williamson, L. G. Escobedo, et al., Depression and the dynamics of smoking: a national perspective. J. Am. Med. Assoc. 264 (1990), 1541–5.
C. U. Onyike, R. M. Crum, H. B. Lee, C. G. Lyketsos, W. W. Eaton, Is obesity associated with major depression? Results from the Third National Health and Nutrition Examination Survey. Am. J. Epidemiol. 158 (2003), 1139–47.
B. W. Penninx, J. M. Guralnik, L. Ferrucci, et al., Vitamin B(12) deficiency and depression in physically disabled older women: epidemiologic evidence from the Women's Health and Aging Study. Am. J. Psychiatry 157 (2000), 715–21.
T. Stephens, Physical activity and mental health in the United States and Canada: evidence from four population surveys. Prev. Med. 17 (1988), 35–47.
B. W. Penninx, T. van Tilburg, A. J. Boeke, et al., Effects of social support and personal coping resources on depressive symptoms: different for various chronic diseases? Health Psychol. 17 (1998), 551–8.
B. G. Druss, W. D. Bradford, R. A. Rosenheck, M. J. Radford, H. M. Krumholz, Quality of medical care and excess mortality in older patients with mental disorders. Arch. Gen. Psychiatry 58 (2001), 565–72.
B. W. Penninx, T. G. van Tilburg, D. M. Kriegsman, et al., Effects of social support and personal coping resources on mortality in older age: the Longitudinal Aging Study Amsterdam. Am. J. Epidemiol. 146 (1997), 510–19.
C. B. Nemeroff, D. L. Musselman, D. L. Evans, Depression and cardiac disease. Depress. Anxiety 8 Suppl 1 (1998), 71–9.
D. L. Musselman, D. L. Evans, C. B. Nemeroff, The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch. Gen. Psychiatry 55 (1998), 580–92.
M. T. La Rovere, J. T. Bigger, Jr, F. I. Marcus, A. Mortara, P. J. Schwartz, Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction: ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) investigators. Lancet 351 (1998), 478–84.
T. G. Vrijkotte, L. J. van Doornen, E. J. de Geus, Effects of work stress on ambulatory blood pressure, heart rate, and heart rate variability. Hypertension 35 (2000), 880–86.
R. Pasquali, V. Vicennati, Activity of the hypothalamic-pituitary-adrenal axis in different obesity phenotypes. Int. J. Obes. Relat. Metab. Disord. 24 Suppl 2 (2000), 47–9.
J. L. Abelson, G. C. Curtis, Hypothalamic-pituitary-adrenal axis activity in panic disorder: 24-hour secretion of corticotropin and cortisol. Arch. Gen. Psychiatry 53 (1996), 323–31.
J. Van Snick, Interleukin-6: an overview. Annu. Rev. Immunol. 8 (1990), 253–78.
M. Maes, A. H. Lin, L. Delmeire, et al., Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. Biol. Psychiatry 45 (1999), 833–9.
R. M. Sapolsky, L. C. Krey, B. S. McEwen, The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocrinol. Rev. 7 (1986), 284–301.
A. Arimura, A. Takaki, G. Komaki, Interactions between cytokines and the hypothalamic-pituitary-adrenal axis during stress. Ann. N. Y. Acad. Sci. 739 (1994), 270–81.
S. Reichlin, Neuroendocrine-immune interactions. N. Engl. J. Med. 329 (1993), 1246–53.
M. Maes, H. Y. Meltzer, E. Bosmans, et al., Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J. Affect. Disord. 34 (1995), 301–9.
A. Sluzewska, J. Rybakowski, E. Bosmans, et al., Indicators of immune activation in major depression. Psychiatry Res. 64 (1996), 161–7.
M. Berk, A. A. Wadee, R. H. Kuschke, A. O'Neill-Kerr, Acute phase proteins in major depression. J. Psychosom. Res. 43 (1997), 529–34.
M. Hornig, D. B. Goodman, M. Kamoun, J. D. Amsterdam, Positive and negative acute phase proteins in affective subtypes. J. Affect. Disord. 49 (1998), 9–18.
B. W. Penninx, S. Kritchevsky, K. Yaffe, et al., Inflammatory markers and depressed mood in older men and women: results from the Health ABC study. Biol Psychiatry 54 (2003), 566–72.
H. Tiemeier, A. Hofman, H. R. van Tuijl, et al., Inflammatory proteins and depression in the elderly. Epidemiology 14 (2003), 103–7.
A. Steptoe, S. R. Kunz-Ebrecht, N. Owen, Lack of association between depressive symptoms and markers of immune and vascular inflammation in middle-aged men and women. Psychol. Med. 33 (2003), 667–74.
B. W. Penninx, S. B. Kritchevsky, A. B. Newman, et al., Inflammatory markers and incident mobility limitation in the elderly. J. Am. Geriatr. Soc. 52 (2004), 1105–13.
L. Ferrucci, T. B. Harris, J. M. Guralnik, et al., Serum IL-6 level and the development of disability in older persons. J. Am. Geriatr. Soc. 47 (1999), 639–46.
E. H. Lin, M. VonKorff, J. Russo, et al., Can depression treatment in primary care reduce disability? A stepped care approach. Arch. Fam. Med. 9 (2000), 1052–8.
J. L. Coulehan, H. C. Schulberg, M. R. Block, M. J. Madonia, E. Rodriguez, Treating depressed primary care patients improves their physical, mental, and social functioning. Arch. Intern. Med. 157 (1997), 1113–20.
S. Borson, G. J. McDonald, T. Gayle, et al., Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychosomatics 33 (1992), 190–201.
J. H. Heiligenstein, J. E. Ware, Jr, K. M. Beusterien, et al., Acute effects of fluoxetine versus placebo on functional health and well-being in late-life depression. Int. Psychogeriatr. 7: Suppl (1995), 125–37.
R. G. Robinson, S. K. Schultz, C. Castillo, et al., Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study. Am. J. Psychiatry 157 (2000), 351–9.
J. W. Williams, Jr, W. Katon, E. H. Lin, et al., The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann. Intern. Med. 140 (2004), 1015–24.
J. E. Carlson, G. V. Ostir, S. A. Black, et al., Disability in older adults: 2. Physical activity as prevention. Behav. Med. 24 (1999), 157–68.
B. W. Penninx, S. P. Messier, W. J. Rejeski, et al., Physical exercise and the prevention of disability in activities of daily living in older persons with osteoarthritis. Arch. Intern. Med. 161 (2001), 2309–16.
W. H. Ettinger, Jr, R. Burns, S. P. Messier, et al., A randomized trial comparing aerobic exercise and resistance exercise with a health education program in older adults with knee osteoarthritis: the Fitness Arthritis and Seniors Trial (FAST). J. Am. Med. Assoc. 277 (1997), 25–31.
M. E. Farmer, B. Z. Locke, E. K. Moscicki, et al., Physical activity and depressive symptoms: the NHANES I Epidemiologic Follow-up Study. Am. J. Epidemiol. 128 (1988), 1340–51.
T. C. Camacho, R. E. Roberts, N. B. Lazarus, G. A. Kaplan, R. D. Cohen, Physical activity and depression: evidence from the Alameda County Study. Am. J. Epidemiol. 134 (1991), 220–31.
T. C. North, P. McCullagh, Z. V. Tran, Effect of exercise on depression. Exerc. Sport. Sci. Rev. 18 (1990), 379–415.
J. H. Greist, M. H. Klein, R. R. Eischens, et al., Running as treatment for depression. Compr. Psychiatry 20 (1979), 41–54.
I. L. McCann, D. S. Holmes, Influence of aerobic exercise on depression. J. Pers. Soc. Psychol. 46 (1984), 1142–7.
E. W. Martinsen, A. Medhus, L. Sandvik, Effects of aerobic exercise on depression: a controlled study. Br. Med. J. (Clin. Res. Ed.) 291 (1985), 109.
J. A. Blumenthal, M. A. Babyak, K. A. Moore, et al., Effects of exercise training on older patients with major depression. Arch. Intern. Med. 159 (1999), 2349–56.
M. Babyak, J. A. Blumenthal, S. Herman, et al., Exercise treatment for major depression: maintenance of therapeutic benefit at 10 months. Psychosom. Med. 62 (2000), 633–8.
J. K. McNeil, E. M. LeBlanc, M. Joyner, The effect of exercise on depressive symptoms in the moderately depressed elderly. Psychol. Aging 6 (1991), 487–8.
N. A. Singh, K. M. Clements, M. A. Fiatarone, A randomized controlled trial of progressive resistance training in depressed elders. J. Gerontol. A Biol. Sci. Med. Sci. 52 (1997), M27–35.
B. W. Penninx, W. J. Rejeski, J. Pandya, et al., Exercise and depressive symptoms: a comparison of aerobic and resistance exercise effects on emotional and physical function in older persons with high and low depressive symptomatology. J. Gerontol. B Psychol. Sci. Soc. Sci. 57 (2002), 124–32.

Reference Title: REFERENCES

Reference Type: reference-list

B. Fox, Pain and its magnitude. In Pain Management: A Practical Guide for Clinicians, ed. R. S. Weiner (New York: CRS Press, 2002), pp. 3–8.
D. A. Fishbain, R. Cutler, H. L. Rosomoff, R. S. Rosomoff, Chronic pain associated depression: antecedent or consequence of chronic pain? A review. Clin. J. Pain 13 (1997), 116–37.
R. Wörz, Pain in depression – depression in pain. Pain Clin. Updates 11 (2003), 1–4.
L. von Knorring, C. Perris, M. Eisemann, U. Eriksson, H. Perris, Pain as a symptom in depressive disorders: II. Relationship to personality traits as assessed by means of KSP. Pain 17 (1983), 377–84.
J. M. Romano, J. A. Turner, Chronic pain and depression: does the evidence support a relationship? Psych. Bull. 97 (1985), 18–34.
S. M. Banks, R. D. Kerns, Explaining high rates of depression in chronic pain: a diathesis-stress framework. Psych. Bull. 119 (1996), 95–110.
D. G. Blazer, R. C. Kessler, K. A. McGonagle, M. S. Swartz, The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am. J. Psychiatry 151 (1994), 979–86.
D. J. Hawley, F. Wolfe, Depression is not more common in rheumatoid arthritis: a 10-year longitudinal study of 6,153 patients with rheumatic disease. J. Rheumatol. 20 (1993), 2025–31.
R. Melzack, P. D. Wall, Pain mechanisms: a new theory. Science 50 (1965), 971–9.
R. H. Dworkin, What do we really know about the psychological origins of chronic pain? Am. Pain Soc. Bull. 1 (1991), 7–11.
G. Engel, ‘Psychogenic’ pain and the pain-prone patient. Am. J. Med. 26 (1959), 899–918.
D. Blumer, H. Heilbronn, Chronic pain as a variant of depressive disease: the pain-prone disorder. J. Nerv. Ment. Dis. 170 (1982), 425–8.
D. C. Turk, P. Salovey, Chronic pain as a variant of depressive disease: a critical reappraisal. J. Nerv. Ment. Dis. 172 (1984), 398–404.
J. B. W. Williams, R. L. Spitzer, Idiopathic pain disorder: a critique of pain-prone disorder and a proposal for a revision of the DSM-III category psychogenic pain disorder. J. Nerv. Ment. Dis. 170 (1982), 415–19.
P. Leino, G. Magni, Depressive and distress symptoms as predictors of low back pain, neck-shoulder pain, and other musculoskeletal morbidity: a 10-year follow-up of metal industry employees. Pain 53 (1993), 89–94.
G. Magni, C. Moreschi, S. Rigatti-Luchini, H. Merskey, Prospective study on the relationship between depressive symptoms and chronic musculoskeletal pain. Pain 56 (1994), 289–97.
R. A. Sternbach, Pain Patients: Traits and Treatments (New York, Academic Press, 1974).
L. C. Campbell, D. J. Clauw, F. J. Keefe, Persistent pain and depression: a biopsychosocial perspective. Biol. Psychiatry 54 (2003), 399–409.
G. Blackburn-Munro, R. Blackburn-Munro, Chronic pain, chronic stress and depression: coincidence or consequence? J. Neuroendocrinol. 13 (2001), 1009–23.
D. J. Clauw, G. P. Chrousos, Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation 4 (1997), 134–53.
G. P. Chrousos, P. W. Gold, The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. J. Am. Med. Assoc. 267 (1992), 1244–52.
R. M. Sapolsky, Why stress is bad for your brain. Science 273 (1996), 749–50.
F. G. Keefe, G. K. Brown, K. S. Wallston, D. S. Caldwell, Coping with rheumatoid arthritis pain: catastrophizing as a maladaptive strategy. Pain 37 (1989), 51–6.
T. E. Rudy, R. D. Kerns, D. C. Turk, Chronic pain and depression: toward a cognitive-behavioral mediation model. Pain 35 (1988), 129–40.
A. T. Beck, Cognitive Therapy and the Emotional Disorders (New York: Harper & Row, 1967).
L. P. Rehm, A self-control model of depression. Behav. Ther. 8 (1977), 787–804.
C. B. Ferster, A functional analysis of depression. Am. Psychol. 28 (1973), 857–70.
P. M. Lewinsohn, Clinical and theoretical aspects of depression. In Innovative Treatment Methods in Psychopathology, ed. K. S. Calhoun, H. E. Adams, K. M. Mitchell (New York: John Wiley & Sons, 1974), pp. 121–43.
E. P. Zorrilla, L. Luborsky, J. R. McKay, et al., The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav. Immun. 15 (2001), 199–226.
L. Capuron, R. Dantzer, Cytokines and depression: the need for a new paradigm. Brain Behav. Immun. 17 (2003), S119–24.
S. Kent, R. M. Bluthe, K. W. Kelley, R. Dantzer, Sickness behavior as a new target for drug development. Trends Pharmacol. Sci. 13 (1992), 24–8.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn, text revision (Washington DC: American Psychiatric Association, 2000).
B. L. Hart, Biological basis of the behavior of sick animals. Neurosci. Biobehav. Rev. 12 (1988), 123–7.
K. W. Kelley, R. M. Bluthe, R. Dantzer, et al., Cytokine-induced sickness behavior. Brain Behav. Immun. 17: Suppl 1 (2003), 112–18.
H. Anisman, L. Kokkinidis, Z. Merali, Further evidence for the depressive effects of cytokines: anhedonia and neurochemical changes. Brain Behav. Immun. 16 (2002), 544–56.
R. M. Bluthé, S. Layé, B. Michaud, et al., Role of interleukin-1β and tumor necrosis factor-α in lipopolysaccharide-induced sickness behaviour: a study with interleukin-1 type I receptor deficient mice. Eur. J. Neurosci. 12 (2000), 4447–56.
S. F. Maier, L. R. Watkins, Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock. Brain Res. 695 (1995), 279–82.
M. Maes, H. Y. Meltzer, E. Bosmans, et al., Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2, and transferrin receptor in major depression. J. Affect. Disord. 34 (1995), 301–9.
A. Sluzewska, J. Rybakowski, E. Bosmans, et al., Indicators of immune activation in major depression. Psychiatry Res. 64 (1996), 161–7.
M. Malaguarnera, I. Di Fazio, S. Restuccia, et al., Interferon alpha-induced depression in chronic hepatitis C patients: comparison between different types of interferon alpha. Neuropsychobiology 37 (1998), 93–7.
M. Malaguarnera, I. Di Fazio, B. A. Trovato, G. Pistone, G. Mazzoleni, Alpha-interferon (IFN-α) treatment of chronic hepatitis C: analysis of some predictive factors for the response. Int. J. Clin. Pharmacol. Ther. 39 (2001), 239–45.
S. Bonaccorso, V. Marino, A. Puzella, et al., Increased depressive ratings in patients with hepatitis C receiving interferon-alpha based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system. J. Clin. Psychopharmacol. 22 (2002), 86–90.
R. de Beaurepaire. Questions raised by the cytokine hypothesis of depression. Brain Behav. Immun. 16 (2002), 610–17.
M. G. Cavallo, P. Pozzilli, R. Thorpe, Cytokines and autoimmunity. Clin. Exp. Immunol. 96 (1994), 1–7.
G. A. Hutchinson, J. E. Nehall, D. T. Simeon, Psychiatric disorders in systemic lupus erythematosus. West Indian Med. J. 45 (1996), 48–50.
T. Pincus, J. Griffith, S. Pearce, D. Isenberg, Prevalence of self-reported depression in patients with rheumatoid arthritis. Br. J. Rheumatol. 35 (1996), 879–83.
K. G. Kahl, N. Kruse, H. Faller, H. Weiss, P. Rieckmann, Expression of tumor necrosis factor-α and interferon-γ mRNA in blood cells correlates with depression scores during an acute attack in patients with multiple sclerosis. Psychoneuroendocrinology 27 (2002), 671–81.
Y. Pollak, E. Orion, I. Goshen, H. Ovadia, R. Yirmiya, Experimental autoimmune encephalomyelitis-associated behavioral syndrome as a model of ‘depression due to multiple sclerosis.’ Brain Behav. Immun. 16 (2002), 533–43.
Y. Pollak, H. Ovadia, E. Orion, R. Yirmiya. The EAE-associated behavioral syndrome II. Modulation by anti-inflammatory treatments. J. Neuroimmunol. 137 (2003), 100–108.
P. D. Wall, Dorsal horn electrophysiology. In Handbook of Sensory Physiology: Somatosensory System ed. A. Igg. (Berlin: Springer-Verlag, 1973), pp. 253–70.
D. D. Price, Psychological and Neural Mechanisms of Pain (New York, Raven, 1988).
A. D. Craig, The functional anatomy of lamina I and its role in post-stroke central pain. In Nervous System Plasticity and Chronic Pain, ed. J. Sandkuhler, B. Bromm, G. F. Gebhart (Amsterdam: Elsevier, 2000), pp. 137–51.
A. D. Craig, Pain mechanisms: labeled lines versus convergence in central processing. Annu. Rev. Neurosci. 26 (2003), 1–30.
S. F. Maier, E. P. Wiertelak, D. Martin, L. R. Watkins, Interleukin-1 mediates behavioral hyperalgesia produced by lithium chloride and endotoxin. Brain Res. 623 (1993), 321–4.
L. R. Watkins, S. F. Maier, Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol. Rev. 82 (2002), 981–1011.
Y. B. Abramov, A. Y. Kozlocv, O. S. Sinel'shchikova, G. V. Torgovanova, Nociceptive reactions during stimulation of immunity in rats with different individual sensitivities to stress. Neurosci. Behav. Physiol. 33 (2003), 821–6.
A. J. Zautra, D. C. Yocum, I. Villanueva, et al., Immune activation and depression in women with rheumatoid arthritis. J. Rheumatol. 31 (2004), 457–63.
A. J. Zautra, B. W. Smith, Depression and reactivity to stress in older women with rheumatoid arthritis and osteoarthritis. Psychosom. Med. 63 (2001), 687–96.
L. R. Watkins, S. F. Maier, L. E. Goehler, Cytokine-to-brain communication: a review and analysis of alternative mechanisms. Life Sci. 57 (1995), 1011–26.
L. R. Watkins, S. F. Maier, Implications of immune-to-brain communication for sickness and pain. Proc. Natl. Acad. Sci. U. S. A. 96 (1999), 7710–13.
N. Castanon, R. M. Bluthe, R. Dantzer, Chronic treatment with the atypical antidepressant tianeptine attenuates sickness behavior induced by peripheral but not central lipopolysaccharide and interleukin-1β in the rat. Psychopharmacology 154 (2001), 50–60.
R. Yirmiya, Y. Pollak, O. Barak, et al., Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents. Neuropsychopharmacology 24 (2001), 531–44.
D. L. Musselman, D. H. Lawson, J. F. Gumnick, et al., Paroxetine for the prevention of depression induced by high-dose interferon-α. N. Engl. J. Med. 344 (2001), 961–6.
Z. Xia, J. W. DePierre, L. Nässberger, Tricyclic antidepressants inhibit IL-6, IL-1β and TNF-α release in human blood monocytes and IL-2 and interferon-γ in T-cells. Immunopharmacology 34 (1996), 27–37.
M. Maes, C. Song, A. H. Lin, et al., Negative immunoregulatory effects of antidepressants inhibition of interferon-gamma and stimulation of interleukin-10 secretion. Neuropsychopharmacology 20 (1999), 370–79.
J. Sawynok, Antidepressants as analgesics: an introduction. J. Psychiatry. Neurosci. 26 (2001), 20.
J. Sawynok, M. J. Esser, A. R. Reid, Antidepressants as analgesics an overview of central and peripheral mechanisms of action. J. Psychiatry Neurosci 26 (2001), 21–9.
R. Lee, P. S. Spencer, Antidepressants and pain: a review of the pharmacological data supporting the use of certain tricyclics in chronic pain. J. Int. Med. Res. 5: Suppl 1 (1977), 146–56.
A. E. Panerai, M. Bianchi, P. Sacerdote, et al., Antidepressants in cancer care. J. Palliat. Care 7 (1991), 42–4.
J. S. McDaniel, D. L. Musselman, M. R. Porter, D. A. Reed, C. B. Nemeroff, Depression in patients with cancer diagnosis, biology, and treatment. Arch. Gen. Psychiatry 52 (1995), 88–99.
M. E. Lynch, Antidepressants as analgesics a review of randomized controlled trials. J. Psychiatry Neurosci. 26 (2001), 30–36.
A. J. Cook, C. J. Woolf, P. D. Wall, S. B. McMahon, Dynamic receptive field plasticity in rat spinal cord dorsal horn following C-primary afferent input. Nature 325 (1987), 151–3.
J. Ru-Rong, T. Kohno, K. A. Moore, C. J. Woolf, Central sensitization and LTP do pain and memory share similar mechanisms? Trends Neurosci. 26 (2003), 696–705.
B. A. Winkelstein, Mechanisms of central sensitization, neuroimmunology and injury biomechanics in persistent pain: implications for musculoskeletal disorders. J. Electromyogr. Kinesiol. 14 (2004), 87–93.
M. B. Keller, D. N. Klein, R. M. A. Hirshfeld, et al., Results of the DSM-IV mood disorders field trial. Am. J. Psychiatry 152 (1995), 843–9.
T. E. Joiner, Depression's vicious scar self-propagating and erosive processes in depression chronicity. Clin. Psychol. Sci. Pract. 7 (2000), 203–18.
S. Nolen-Hoeksema, J. S. Girgus, M. E. P. Seligman, Learned helplessness in children: a longitudinal study of depression, achievement, and explanatory style. J. Pers. Soc. Psychol. 51 (1986), 435–42.
K. S. Kendler, L. M. Thornton, C. O. Gardner, Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the ‘kindling’ hypothesis. Am. J. Psychiatry 157 (2000), 1243–51.
H. Anisman, Z. Merali, S. Hayley, Sensitization associated with stressors and cytokine treatments. Brain Behav. Immun. 17 (2003), 86–93.
F. J. H. Tilders, E. D. Schmidt, Cross-sensitization between immune and non-immune stressors: a role in the etiology of depression? Adv. Exp. Med. Biol. 461 (1999), 179–97.
S. Hayley, K. Brebner, S. Lacosta, Z. Merali, H. Anisman, Sensitization to the effects of tumor necrosis factor-α: neuroendocrine, central monoamine and behavioral variations. J. Neurosci. 19 (1999), 5654–65.
D. S. Charney, Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress. Am. J. Psychiatry 161 (2004), 195–216.
B. S. McEwen, E. Stellar, Stress and the individual: mechanisms leading to disease. Arch. Intern. Med. 153 (1993), 2093–101.
E. Diener, R. A. Emmons, The independence of positive and negative affect. J. Pers. Soc. Psychol. 47 (1984), 1105–17.
D. Watson Mood and Temperment (New York: Guilford Press, 2000).
A. Zautra, B. Smith, G. Affleck, H. Tennen, Examinations of chronic pain and affect relationships: applications of a dynamic model of affect. J. Consult. Clin. Psychol. 69 (2001), 786–95.
A. J. Zautra Emotions, Stress, and Health (New York: Oxford University Press, 2003).
G. Affleck, H. Tennen, S. Urrows, P. Higgins, Individual differences in the day-to-day experience of chronic pain: a prospective daily study of rheumatoid arthritis patients. Health Psychol. 10 (1991), 419–26.
A. J. Zautra, M. H. Burleson, C. A. Smith, et al., Arthritis and perceptions of quality of life: an examination of positive and negative affect in rheumatoid arthritis patients. Health Psychol. 14 (1995), 399–408.
A. J. Zautra, J. J. Marbach, K. G. Raphael, et al., The examination of myofascial face pain and its relationship to psychological distress among women. Health Psychol. 14 (1995), 223–31.
M. C. Davis, A. J. Zautra, B. W. Smith, Chronic pain, stress and the dynamics of affective differentiation. J. Person. 72 (2004), 1133–59.
J. W. Reich, A. J. Zautra, M. C. Davis, Dimensions of affect relationships: models and their integrative implications. Rev. Gen. Psychol. 7 (2003), 66–83.
A. J. Zautra, L. Johnson, M. C. Davis, Positive affect as a source of resilience for women in chronic pain. J. Consult. Clin. Psychol. 73 (2005), 212–20.
M. M. Tugade, B. L. Frederickson, Resilient individuals use positive emotions to bounce back from negative emotional experiences. J. Pers. Soc. Psychol. 86 (2004), 320–33.
J. Joorman, M. Siemer, Memory accessibility, mood regulation, and dysphoria: difficulties in repairing sad mood with happy memories? J. Abnorm. Psychol. 113 (2004), 179–88.
A. A. Stone, J. M. Neale, D. S. Cox, et al., Daily events are associated with a secretory immune response to an oral antigen in men. Health Psychol. 13 (1994), 440–46.
S. L. Goldman, D. T. Kraemer, P. Salovey, Beliefs about mood moderate the relationship of stress to illness and symptom reporting. J. Psychosom. Res. 41 (1996), 115–28.
C. McFarlan, R. Buehler, The impact of negative affect on autobiographical memory: the role of self-focused attention to moods. J. Pers. Soc. Psychol. 75 (1998), 1424–40.
L. Felman Barrett, J. Gross, T. C. Christensen, M. Benvenuto, Knowing what you're feeling and knowing what to do about it: mapping the relation between emotion differentiation and emotion regulation. Cogn. Emotion 15 (2001), 713–24.
L. A. Bradley, L. D. Young, K. O. Anderson, et al., Effects of psychological therapy on pain behavior or rheumatoid arthritis patients. Arthritis Rheum. 30 (1987), 1105–14.
J. C. Parker, K. L. Smarr, S. P. Buckelew, et al., Effects of stress management on clinical outcomes in rheumatoid arthritis. Arthritis Rheum. 38 (1995), 1807–18.
V. Radojevic, P. Nicassio, M. Weisman, Behavior therapy with and without family support for rheumatoid arthritis. Behavi. Ther. 2 (1992), 13–30.
P. M. Nicassio, M. A. Greenberg, Psychosocial management of chronic pain in arthritis. In Treatment of Rheumatic Diseases, 2nd edn, ed. M. H. Weisman, M. Weinblatt, J. Louie (Orlando, FL: William Saunders, 2001), pp. 147–61.

Reference Title: REFERENCES

Reference Type: reference-list

World Health Organization. Diabetes: The Cost of Diabetes (Geneva: World Health Organization, 2002).
Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329 (1993), 977–86.
R. Klein, B. E. K. Klein, S. E. Moss, M. D. Davis, D. L. DeMets, The Wisconsin Epidemiologic Study of Diabetes Retinopathy III: prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch. Opthalmol. 102 (1984), 527–32.
Associated Press. Estimate of Americans with pre-diabetes doubles. Wall Street Journal, April 29, 2004.
World Health Organization. Laboratory Diagnosis and Monitoring of Diabetes Mellitus (Geneva: World Health Organization, 2002).
Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee. Guidelines for the management of mild hypertension. Hypertension 22 (1993), 392–403.
J. S. McDaniel, D. L. Musselman, M. R. Porter, D. A. Reed, C. B. Nemeroff, Depression in the cancer patient: a commentary on diagnosis, biology, and treatment. Arch. Gen. Psychiatry 52 (1995), 89–99.
C. Bradley, The well-being questionnaire. In Handbook of Psychology and Diabetes, ed. C. Bradley (chur, Switzerland: Harwood Academic Publishers, 1994), pp. 89–109.
P. J. Lustman, H. Amado, R. D. Wetzel, Depression in diabetics: a critical appraisal. Comp. Psychiatry 1 (1983), 65–74.
A. T. Beck, C. H. Ward, M. Mendelson, J. Mock, J. Erbaugh, An inventory for measuring depression. Arch. Gen. Psychiatry 4 (1961), 561–71.
P. J. Lustman, L. S. Griffith, J. A. Gavard, R. E. Clouse, Depression in adults with diabetes. Diabetes Care 15 (1992), 1631–9.
P. J. Lustman, K. E. Freedland, R. M. Carney, B. A. Hong, R. E. Clouse, Similarity of depression in diabetic and psychiatric patients. Psychosom. Med. 54 (1992), 602–11.
P. J Lustman, L. S. Griffith, R. E. Clouse, et al., Effects of nortriptyline on depression and glucose regulation in diabetes: results of a double-blind, placebo-controlled trial. Psychosom. Med. 59 (1997), 241–50.
P. Ciechanowski, W. Katon, J. Russo, The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. Diabetes Care 25 (2002), 731–6.
L. E. Edge, D. Zheng, K. Simpson, Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care 25 (2002), 464–70.
J. A. Gavard, P. J. Lustman, R. E. Clouse, Prevalence of depression in adults with diabetes: an epidemiological evaluation. Diabetes Care 16 (1993), 1167–78.
R. J. Anderson, K. E. Freedland, R. E. Clouse, P. J. Lustman, The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24 (2001), 1069–78.
T. L. Gary, R. M. Crum, L. Cooper-Patrick, D. Ford, F. L. Brancati, Depressive symptoms and metabolic control in African-Americans with type 2 diabetes. Diabetes Care 23 (2000), 23–9.
S. A. Black, J. S. Goodwin, K. S. Markides, The association between chronic diseases and depressive symptomatology in older Mexican Americans. J. Gerontol. A Biol. Sci. Med. Sci. 53A (1998), M188–94.
A. Grandinetti, J. K. Kaholokula, K. M. Crabbe, et al., Relationship between depressive symptoms and diabetes among native Hawaiians. Psychoneuroendocrinology 25 (2000), 239–46.
J. K. Warnock, E. M. Mutzig, Diabetes mellitus and major depression: considerations for treatment of Native Americans. J. Okla. State Med. Assoc. 91 (1998), 488–93.
K. Ostler, C. Thompson, A. L. Kinmonth, et al., Influence of socio-economic deprivation on the prevalence and outcome of depression in primary care: the Hampshire Depression project. Br. J. Psychiatry 178 (2001), 12–17.
S. A. Everson, S. C. Saty, J. W. Lynch, G. A. Kaplan, Epidemiologic evidence for the relation between socioeconomic status and depression, obesity, and diabetes. J. Psychosom. Res. 53 (2002), 891–5.
J. W. Lynch, G. A. Kaplan, S. J. Shema, Cumulative impact of sustained economic hardship on physical, cognitive, psychological, and social functioning. N. Engl. J. Med. 337 (1997), 1889–95.
C. E. Ross, Neighborhood disadvantage and adult depression. J. Health Soc. Behav. 41 (2000), 177–87.
C. Saul, N. Payne, How does the prevalence of specific morbidities compare with measures of socio-economic status at small area level? J. Public Health Med. 21 (1999), 340–47.
L. Fisher, C. A. Chesla, J. T. Mullan, M. M. Skaff, R. A. Kanter, Contributors to depression in Latino and European-American patients with type 2 diabetes. Diabetes Care 24 (2001), 1751–7.
M. Peyrot, R. R. Rubin, Levels and risk of depression and anxiety symptomatology among diabetic adults. Diabetes Care 20 (1997), 585–90.
P. J. Lustman, L. S. Griffith, R. E. Clouse, P. E. Cryer, Psychiatric illness in diabetes: relationship to symptoms and glucose control. J. Nerv. Ment. Dis. 174 (1986), 736–42.
C. E. Lloyd, K. A. Matthews, R. R. Wing, T. J. Orchard, Psychosocial factors and complications of IDDM: the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 15 (1992), 166–72.
P. J. Lustman, L. S. Griffith, R. E. Clouse, Depression in adults with diabetes: results of 5-year follow-up study. Diabetes Care 11 (1988), 605–12.
P. J. Lustman, R. J. Anderson, K. E. Freedland, et al., Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 23 (2000), 934–42.
D. C. Ziemer, S. F. Ferguson, R. L. Kieltyka, W. Slocum, Barriers to appointment keeping in a municipal hospital diabetes clinic. Diabetes 47, Suppl 1 (1998), A144.
M. de Groot, R. Anderson, K. E. Freedland, R. E. Clouse, P. J. Lustman, Association of depression and diabetes complications: a meta-analysis. Psychosom. Med. 63 (2001), 619–30.
H. Vinnamaki, L. Niskanen, M. Uusitupa, Mental well-being in people with non-insulin dependent diabetes. Acta Psychiatr. Scand. 92 (1995), 392–7.
R. S. Mazze, D. Lucido, H. Shamoon, Psychological and social correlates of glycemic control. Diabetes Care 7 (1984), 360–66.
M. A. Testa, D. C. Simonson, Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus. J. Am. Med. Assoc. 280 (1998), 1490–96.
C. Hayward, Psychiatric illness and cardiovascular disease risk. Epidemiol. Rev. 17 (1995), 129–38.
W. W. Eaton, H. Armenian, J. Gallo, L. Pratt, E. Ford, Depression and risk for onset of type II diabetes: a prospective population-based study. Diabetes Care 22 (1996), 1097–102.
L. N. Robins, J. E. Helzer, J. L. Croughan, J. B. W. Williams, R. L. Spitzer, The NIMH Diagnostic Interview Schedule, Version III (Washington, DC: Public Health Service [HSS], 1981).
W. W. Zung, A self-rating depression scale. Arch. Gen. Psychiatry 12 (1965), 63–70.
S. A. Everson-Rose, P. M. Meyer, L. H. Powell, et al., Depressive symptoms, insulin resistance, and risk of diabetes in women in midlife. Diabetes Care 27 (2004), 2856–62.
L. S. Radloff, The CES-D scale: a self-report depression scale for research in the general population. J. Appl. Psychol. Meas. 1 (1977), 385–401.
N. Kawakami, N. Tkatsuka, H. Shimizu, H. Ishibashi, Depressive symptoms and occurrence of type 2 diabetes among Japanese men. Diabetes Care 22 (1999), 1071–6.
P. S. Ciechanowski, W. J. Katon, J. E. Russo, Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch. Intern. Med. 1160 (2000), 3278–85.
W. J. Katon, M. Von Korff, E. Lin, et al., Population-based care of depression: effective disease management strategies to decrease prevalence. Gen. Hosp. Psychiatry 19 (1997), 169–78.
L. E. Egede, D. Zheng, K. Simpson, Comorbid depression is associated with increased health care use and expenditure in individuals with diabetes. Diabetes Care 25 (2002), 464–70.
R. E. Clouse, P. J. Lustman, K. E. Freedland, et al., Depression and coronary heart disease in women with diabetes. Psychosom. Med. 65 (2003), 376–83.
N. Frasure-Smith, F. Lesperance, M. Juneau, M. Talajic, M. G. Bourassa, Gender, depression, and one-year prognosis after myocardial infarction. Psychosom. Med. 61 (1999), 26–37.
R. M. Sapolsky, L. M. Romero, A. U. Munck, How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulator and preparative actions. Endocrinol. Rev. 21 (2000), 55–89.
D. L. Musselman, C. DeBatista, K. I. Nathan, et al., Biology of mood disorders. In Textbook of Psychopharmacology, 2nd edn, ed. A. F. Schatzberg, C. B. Nemeroff (Washington, DC: American Psychiatric Press, 1998), pp. 550–88.
A. Munck, A. Naray-Fejes-Toth, Glucocorticoid action: physiology. In Endocrinology, ed. L. J. de Groot (Philadelphia: W. B. Saunders, 1995), pp. 1642–56.
N. Eigler, L. Sacca, R. S. Sherwin, Synergistic interactions of physiologic increments of glucagon, epinephrine and cortisol in the dog: a model for stress-induced hyperglycemia. J. Clin. Invest. 63 (1979), 114–23.
R. DeFronzo, R. S. Sherwin, P. Felig, Synergistic interactions of counterregulatory hormones: a mechanism for stress hyperglycemia. Acta Chir. Scand. Suppl. 498 (1980), 33–9.
D. N. Brindley, Y. Rolland, Possible connections between stress, diabetes, obesity, hypertension and altered lipoprotein metabolism that may result in atherosclerosis. Clin. Sci. (Land.) 77 (1989), 453–61.
M. F. Dallman, A. M. Strack, S. F. Akana, et al., Feast and famine: critical role of glucocorticoids with insulin in daily energy flow. Front. Neuroendocrinol. 14 (1993), 303–47.
S. P. Weinstein, T. Paquin, A. Pritsker, R. A. Haber, Glucocorticoid-induced insulin resistance: dexamethsone inhibits the activation of glucose transport in rat skeletal muscle by both insulin- and non-insulin-related stimuli. Diabetes 44 (1995), 441–5.
P. S. Mueller, G. R. Heninger, R. K. McDonald, Intravenous glucose tolerance test in depression. Arch. Gen. Psychiatry 21 (1968), 470–77.
J. H. Wright, J. J. Jacisin, N. S. Radin, Glucose metabolism in unipolar depression. Br. J. Psychiatry 132 (1978), 386–93.
A. Winokur, G. Maislin, J. L. Phillips, J. D. Amsterdam, Insulin resistance after oral glucose tolerance testing in patients with major depression. Am. J. Psychiatry 145 (1988), 325–30.
E. J. Sachar, J. Finkelstein, L. Hellman, Growth hormone responses in depressive illness: 1. Response to insulin tolerance test. Arch. Gen. Psychiatry 25 (1971), 263–9.
R. C. Casper, J. M. Davis, G. Pandey, D. Garver, H. Dekirmenjian, Neuroendocrine and amine studies in affective illness. Psychoneuroendocrinology 2 (1977), 105–13.
R. Duelli, W. Kuschinsky, Brain glucose transporters: relationship to local energy demand. N. Physiol. Sci. 16 (2001), 71–6.
L. R. Baxter, M. E. Phelps, J. C. Mazziotta, et al., Cerebral metabolic rates for glucose in mood disorders studied with positron emission tomography (PET) and (F-18)-fluro-2-deoxyglucose (FDG). Arch. Gen. Psychiatry 42 (1985), 441–7.
L. R. Baxter, J. M. Schwartz, M. E. Phelps, et al., Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch. Gen. Psychiatry 46 (1989), 243–50.
J. L. Martinot, P. Hardy, A. Feline, et al., Left prefrontal glucose metabolism in the depressed state: a confirmation. Am. J. Psychiatry 147 (1990), 1313–17.
I. A. Simpson, K. R. Chundru, T. Davies-Hill, W. G. Honer, P. Davies, Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease. Ann. Neurol. 35 (1994), 511–12.
W. C. Gamberino, W. A. Brennan, Jr, Glucose transporter isoform expression in Huntington's disease brain. J. Neurochem. 63 (1994), 1392–7.
D. E. Kuhl, M. E. Phelps, C. H. Markham, et al., Cerebral metabolism and atrophy in Huntington's disease. Ann. Neurol. 12 (1982), 425–34.
D. L. Rothman, I. Magnusson, G. Cline, et al., Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. U. S. A. 92 (1995), 983–7.
K. F. Petersen, G. I. Shulman, Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus. Am. J. Cardiol. 90 (2002), 11–18G.
G. I. Shulman, D. L. Rothman, T. Jue, et al., Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin dependent diabetes mellitus by 13C nuclear magnetic resonance spectroscopy. N. Engl. J. Med. 322 (1990), 223–8.
R. Ross, Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 340 (1999), 115–26.
S. K. Fried, D. A. Bunkin, A. S. Greenburg, Omental and subcutaneous adipose tissue of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J. Clin. Endocrinol. Metab. 83 (1998), 847–50.
J. M. Fernandez-Real, M. Vayred, C. Richart, et al., Circulating interleukin 6 levels, blood pressure, and insulin insensitivity in apparently healthy men and women. J. Clin. Endocrinol. Metab. 86 (2001), 1154–9.
G. Paolisso, M. R. Rizzo, G. Mazziotti, et al., Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha. Am. J. Physiol. 275 (1998), E294–9.
G. S. Hotamisligil, N. S. Shargill, B. M. Spiegelman, Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (1993), 87–91.
G. S. Hotamisligil, A. Budavari, D. Murray, B. M. Spiegelman, Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. J. Clin. Invest. 94 (1994), 1543–9.
G. S. Hotamisligil, B. M. Spiegelman, Tumor necrosis factor a: a key component of the obesity-diabetes link. Diabetes 43 (1994), 1271–8.
G. S. Hotamisligil, P. Arner, J. F. Caro, R. L. Atkinson, B. M. Spiegelman, Increased adipose tissue expression of tumor necrosis factor-a in human obesity and insulin resistance. J. Clin. Invest. 95 (1995), 2409–15.
P. A. Kern, M. Szaghizadah, J. M. Ong, et al., The expression of tumor necrosis factor in human adipose tissue: regulation by obesity, weight loss, and relationship to lipoprotein lipase. J. Clin. Invest. 95 (1995), 2111–19.
G. S. Hotamisligil, P. Peraldi, A. Budavari, et al., IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271 (1996), 665–8.
M. Saghizadeh, J. M. Ong, W. T. Garvey, R. R. Henry, P. A. Kern, The expression of TNFa by human muscle: relationship to insulin resistance. J. Clin. Invest. 97 (1996), 1111–16.
S. Kent, R. M. Bluthe, K. W. Kelley, R. Dantzer, Sickness behavior as a new target for drug development. Trends Pharmacol. Sci. 13 (1992), 24–8.
R. Yirmiya, Endotoxin produces a depressive-like episode in rats. Brain Res. 711 (1996), 163–74.
M. Maes, S. Scharpe, H. Y. Meltzer, et al., Increased neopterin and interferon-gamma secretion and lower availability of l-tryptophan in major depression: further evidence for an immune response. Psychiatr. Res. 54 (1994), 143–60.
M. Maes, E. Vendoolaeghe, R. Ranjan, et al., Increased serum interleukin-1-receptor-antagonist concentrations in major depression. J. Affect. Dis. 36 (1995), 2–36.
M. Maes, R. Smith, A. Christophe, et al., Fatty acid composition in major depression: decreased omega 3 fractions in cholesteryl esters and increased C20:4 omega-6/C20:5 omega-3 ratio in cholesteryl esters and phospholipids. J. Affect. Dis. 38 (1996), 35–46.
M. Berk, A. A. Wadee, R. H. Kuschke, A. O'Neill-Kerr, Acute-phase proteins in major depression. J. Psychosom. Res. 43 (1997), 529–34.
U. H. Frommberger, J. Bauer, P. Haselbauer, et al., Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur. Arch. Psychiatry Clin. Neurosci. 247 (1997), 228–33.
G. E. Miller, C. A. Stetler, R. M. Carney, K. E. Freedland, W. A. Banks, Clinical depression and inflammatory risk markers for coronary heart disease. Am. J. Cardiol. 90 (2002), 1279–83.
D. L. Musselman, A. H. Miller, M. R. Porter, et al., Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am. J. Psychiatry 158 (2001), 1252–7.
F. J. Snoek, T. C. Skinner, Psychological counselling in problematic diabetes: does it help? Diabetes Med. 19 (2002), 265–73.
P. J. Lustman, L. S. Griffith, K. E. Freedland, S. S. Kissel, R. E. Clouse, Cognitive behavior therapy for depression in type 2 diabetes mellitus: a randomized, controlled trial. Ann. Intern. Med. 129 (1998), 613–21.
Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329 (1993), 977–86.
L. M. Thaler, D. C. Ziemer, D. L. Gallina, et al., Availability of rapid HbA1c measurements enhances clinical decision-making. Diabetes Care 22 (1999), 1415–21.
P. J. Lustman, G. W. Harper, Nonpsychiatric physicians' identification and treatment of depression in patients with diabetes. Comp. Psychiatry 28 (1987), 22–7.
C. B. Cook, L. S. Phillips, I. M. El-Kebbi, et al., Diabetes in urban African-Americans: XVII. Improved diabetes management over five years with nurse provider-led care at a large municipal hospital. Diabetes Care 22 (1999), 1494–500.
C. D. Miller, L. S. Phillips, D. C. Ziemer, et al., Hypoglycemia in patients with type 2 diabetes. Arch. Intern. Med. 161 (2001), 1653–9.
W. Slocum, D. C. Ziemer, S. D. Culler, C. Cook, S. Y. Ferguson, Poor appointment keeping behavior worsens glycemic control. Diabetes 48: Suppl 1 (1999), A197.
P. J. Goodnick, J. H. Henry, V. M. V. Buki, Treatment of depression in patients with diabetes mellitus. J. Clin. Psychiatry 56 (1995), 128–36.
H. M. van Praag, B. Leijnse, Depression, glucose tolerance, peripheral glucose uptake and their alterations under the influence of anti-depressive drugs of the hydrazine type. Psychopharmacologia 8 (1965), 67–78.
M. B. Max, R. Kishore-Kumar, S. C. Schafer, et al., Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial. Pain 45 (1991), 3–9.
M. B. Max, S. A. Lynch, J. Muir, et al., Effects of desipramine, amitriptyline, and fluoxetine in diabetic neuropathy. N. Engl. J. Med. 326 (1992), 1250–56.
J. Rabkin, F. Quitkin, W. Harrison, P. McGrath, E. Tricamo, Adverse reactions to monoamine oxidase inhibitors: I. A comparative study. J. Clin. Psychopharmacol. 4 (1984), 270–78.
P. R. Muskin, A. H. Glassman, The use of tricyclic antidepressants in a medical setting. In Consultation-liaison Psychiatry: Current Trends and Future Perspectives, ed. J. B. Finkel (New York: Grune & Stratton, 1983), pp. 137–58.
S. P. Roose, G. W. Dalack, Treating the depressed patient with cardiovascular problems. J. Clin. Psychiatry 53 (1992), 25–31.
S. H. Sindrup, L. F. Gram, K. Brosen, O. Eshoj, E. F. Mogensen, The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 42 (1990), 135–44.
C. L. DeVane, J. S. Markowitz, Psychoactive drug interactions with pharmacotherapy for diabetes. Psychopharmacol. Bull. 36 (2002), 40–52.
L. M. Tremaine, K. D. Wilner, S. H. Preskorn, A study of the potential effect of sertraline on the pharmacokinetics and protein binding of tolbutamide. Clin. Pharmacokinet. 32: Suppl 1 (1992), 31–6.
N. Sussman, D. L. Ginsberg, J. Bikoff, Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor-and imipramine-controlled trials. J. Clin. Psychiatry 62 (2001), 256–60.
M. Fava, Weight gain and antidepressants. J. Clin. Psychiatry 61: Suppl 11 (2000), 37–41.
M. D. Marcus, R. R. Wing, J. Guare, E. H. Blaire, A. Jawad, Lifetime prevalence of major depression and its effect on treatment outcome in obese type II diabetic patients. Diabetes Care 15 (1992), 253–5.
D. L. Rowland, L. Myers, A. Culver, J. M. Davidson, Bupropion and sexual function: a placebo-controlled prospective study on diabetic men with erectile dysfunction. J. Clin. Psychopharmacol. 17 (1997), 350–57.
C. E. Koro, D. O. Fedder, G. J. L'Italien, et al., Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case–control study. Br. Med. J. 325 (2002), 243–7.
P. S. Masand, Atypical antipsychotics and DKA: issues and controversies. Thomson Professional Postgraduate Services 2 (2002), 1–3.
M. J. Serynak, D. L. Leslie, R. D. Alarcon, M. F. Losonczy, R. Rosenheck, Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. Am. J. Psychiatry 159 (2002), 561–6.
J. I. Isojarvi, J. Rattya, V. V. Myllyla, et al., Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. Ann. Neurol. 43 (1998), 446–51.
H. Jin, J. M. Meyer, D. V. Jeste, Phenomenology of and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: an analysis of 45 published cases. Ann. Clin. Psychiatry 14 (2002), 59–64.
Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26: Suppl 1 (2003), 5–20.
M. O'Kane, P. G. Wiles, J. K. Wales, Fluoxetine in the treatment of obese type 2 diabetic patients. Diabetes Med. 11 (1994), 105–10.
L. Breum, U. Bjerre, J. F. Bak, S. Jacobsen, A. Astrup, Long-term effects of fluoxetine on glycemic control in obese patients with non-insulin-dependent diabetes mellitus or glucose intolerance: influence on muscle glycogen synthase and insulin receptor kinase activity. Metabolism 44 (1995), 1570–76.
P. Mahuex, F. Ducros, J. Bourque, J. Garon, J.-L. Chiasson, Fluoxetine improves insulin sensitivity in obese patients with non-insulin-dependent diabetes mellitus independently of weight loss. Int. J. Obes. 21 (1997), 97–102.
B. J. P. van Loon, J. K. Radder, M. Frolich, Fluoxetine increases insulin action in obese nondiabetic and in obese noninsulin-dependent diabetic individuals. Int. J. Obes. 16 (1992), 79–85.
S. L. Norris, J. Lau, S. J. Smith, C. H. Schmid, M. M. Engelgau, Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care 25 (2002), 1159–71.
B. A. Hamburg, G. E. Inoff, Coping with predictable crises of diabetes. Diabetes Care 6 (1983), 409–16.
J. D. Lane, C. C. McCaskill, S. L. Ross, M. N. Feinglos, R. S. Surwit, Relaxation training for NIDDM: predicting who may benefit. Diabetes Care 16 (1993), 1087–94.
K. Spiess, G. Sachs, P. Pietschmann, R. Prager, A program to reduce onset distress in unselected type I diabetic patients: effects on psychological variables and metabolic control. Eur. J. Endocrinol. 132 (1995), 580–86.
F. Pouwer, F. J. Snoek, H. M. van der Ploeg, H. J. Ader, R. J. Heine, Monitoring of psychological well-being in outpatients with diabetes: effects on mood, HbA(1c), and the patient's evaluation of the quality of diabetes care: a randomized controlled trial. Diabetes Care 24 (2001), 1929–35.
R. S. Surwit, M. A. L. Van Tilburg, N. Zucker, et al., Stress management improves long-term glycemic control in type 2 diabetes. Diabetes Care 25 (2002), 30–34.
J. W. Williams, Jr, W. Katon, E. H. Lin, et al., The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann. Intern. Med. 140 (2004), 1015–24.
L. N. Robins, J. E. Helzer, J. Croughnan, J. B. W. Williams, R. L. Spitzer, NIMH Diagnostic Interview Schedule: Version III-R (Rockville, MD: National Institutes of Mental Health, 1987).
American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, 4th edn. (Washington, DC: American Psychiatric Association, 1994).
E. S. Paykel, Methodology of live events research. Adv. Psychosom. Med. 17 (1987), 13–29.
W. A. Arrundell, SCL-90: Manual for a Multi-dimensional Indicator of Psychopathology (Lisse: Swets and Zeitinger, 1986).
C. D. Spielberger, R. L. Gorsuch, R. Luschene, Test Manual for the State-Trait Anxiety Inventory (Palo Alto, CA: Consulting Psychologists Press, 1970).
M. B. Keller, J. P. McCullough, D. N. Klein, et al., A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N. Engl. J. Med. 342 (2000), 1462–70.
H. C. Schulberg, W. Katon, G. E. Simon, J. Rush, Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research Practice Guidelines. Arch. Gen. Psychiatry 55 (1998), 1121–7.
R. S. Surwit, R. B. Williams, I. C. Siegler, J. D. Lane, M. Helms, Hostility, race, and glucose metabolism in nondiabetic individuals. Diabetes Care 25 (2002), 835–9.
V. W. Persky, J. Kempthorne-Rawson, R. B. Shekelle, Personality and risk of cancer: 20-year follow-up of the Western Electric study. Psychosom. Med. 49 (1987), 435–49.
P. J. Lustman, L. S. Griffith, R. E. Clouse, et al., Improvement in depression is associated with improvement in glycemic control. Diabetes 4: Suppl 1 (1995), 27A.
R. Sinha, G. Fisch, B. Teague, et al., Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N. Engl. J. Med. 346 (2002), 802–10.
B. S. McEwen, A. M. Magarinos, L. P. Reagan, Studies of hormone action in the hippocampal formation: possible relevance to depression and diabetes. J. Psychosom. Res. 53 (2002), 883–90.
W. H. Gispen, G.-J. Biessels, Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci. 23 (2000), 542–9.
B. E. Levin, A. A. Dunn-Meynell, V. H. Routh, Brain glucose sensing and body energy homeostasis: role in obesity and diabetes. Am. J. Physiol. Endocrinol. Metab. 276 (1999), R1223–31.
B. E. Levin, Glucosensing neurons do more than just sense glucose. Int. J. Obes. 25: Suppl 5 (2001), 68–72.
A. A. Dunn-Meyell, N. E. Rawson, B. E. Levin, Distribution and phenotype of neurons containing the ATP-sensitive K+ channel. Brain Res. 814 (1998), 41–54.
P. J. Lustman, K. E. Freedland, L. S. Griffith, R. E. Clouse, Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care 23 (2000), 618–23.

Reference Title: REFERENCES

Reference Type: reference-list

S. C. Wessely, M. Hotopf, M. Sharpe., Chronic Fatigue and its Syndromes (Oxford: Oxford University Press, 1998).
T. Pawlikowska, T. Chalder, S. R. Hirsch, et al., Population based study of fatigue and psychological distress. Br. Med. J. 308 (1994), 763–6.
W. Cullen, Y. Kearney, G. Bury, Prevalence of fatigue in general practice. Ir. J. Med. Sci. 171 (2002), 10–12.
E. Kenter, I. Okkes, S. Oskam, H. Lamberts, Tiredness in Dutch family practice: data on patients complaining of and/or diagnosed with ‘tiredness’. Fam. Pract. 20 (2003), 434–40.
A. M. Gallagher, J. M. Thomas, W. T. Hamilton, P. D. White, The incidence of fatigue symptoms and diagnoses presenting in UK primary care from 1990 to 2001. J. R. Soc. Med. 97 (2004), 571–5.
M. K. Chen, The epidemiology of self-perceived fatigue among adults. Prev. Med. 15 (1986), 74–81.
P. D. White, J. M. Thomas, J. Amess, et al., Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever. Br. J. Psychiatry 173 (1998), 475–81.
L. Darbishire, L. Ridsdale, P. T. Seed, Distinguishing patients with chronic fatigue from those with chronic fatigue syndrome: a diagnostic study in UK primary care. Br. J. Gen. Pract. 53 (2003), 441–5.
Royal College of Psychiatrists. Royal College of Physicians and Royal College of General Practitioners, Chronic Fatigue Syndrome: Report of a Joint Working Group of the Royal Colleges of Physicians, Psychiatrists and General Practitioners (London, Royal College of Physicians, 1996)
CFS/ME working group. Report of the CFS/ME Working Group to the Chief Medical Officer, 2001. www.dh.gov.uk/assetroot/04/05/95/06/04059506.pdf
W. C. Reeves, A. Lloyd, S. D. Vernon, et al., Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Serv Res 3 (2003), 25.
L. A. Jason, S. R. Torres-Harding, A. W. Carrico, R. R. Taylor, Symptom occurrence in persons with chronic fatigue syndrome. Biol. Psychol. 59 (2002), 15–27.
A. Lloyd, D. Wakefield, J. Dwyer, C. Boughton, What is myalgic encephalomyelitis? Lancet 1 (1988), 1286–7.
M. C. Sharpe, L. C. Archard, J. E. Banatvala, et al., A report: chronic fatigue syndrome – guidelines for research. J. R. Soc. Med. 84 (1991), 118–21.
K. Fukuda, S. E. Straus, I. Hickie, et al., The chronic fatigue syndrome: a comprehensive approach to its definition and study: International Chronic Fatigue Syndrome Study Group. Ann. Intern. Med. 21 (1994), 953–9.
I. Hickie, K. Kirk, N. Martin, Unique genetic and environmental determinants of prolonged fatigue: a twin study. Psychol. Med. 29 (1999), 259–68.
R. Powell, J. Ren, G. Lewith, et al., Identification of novel expressed sequences, up-regulated in the leucocytes of chronic fatigue syndrome patients. Clin. Exper. Allergy 33 (2003), 1450–56.
A. Wilson, I. Hickie, A. Lloyd, et al., Longitudinal study of the outcome of chronic fatigue syndrome. Br. Med. J. 308 (1994), 756–60.
M. Clark, W. Katon, J. Russo, et al., Chronic fatigue: risk factors for symptom persistence in a 2.5-year follow up study. Am. J. Med. 98 (1995), 187–95.
J. Vercoulen, C. Swanink, J. Fennis, et al., Prognosis in chronic fatigue syndrome: a prospective study on the natural course. J. Neurol. Neurosurg. Psychiatry 60 (1996), 489–94.
R. P. Bentall, P. Powell, F. J. Nye, R. H. Edwards, Predictors of response to treatment for chronic fatigue syndrome. Br. J. Psychiatry 181 (2002), 248–52.
J. B. Prins, E. Bazelmans, S. Van der Werf, J. W. M. Van der Meer, G. Bleijenberg, Cognitive behaviour therapy for chronic fatigue syndrome: predictors of treatment outcome. In Psycho-neuro-endocrinology: A Common Language for the Whole Human Body, ed. T. Sivik, D. Byrne, D. R. Lipsitt, et al. (Amstrerdam: Elsevier, 2002), pp. 131–5.
N. M. Hadler, If you have to prove you are ill, you can't get well: the object lesson of fibromyalgia. Spine 21 (1996), 2397–400.
S. Peters, I. Stanley, M. Rose, P. Salmon, Patients with medically unexplained symptoms: sources of patients' authority and implication for demands on medical care. Soc. Sci. Med. 46 (1998), 559–65.
L. Page, S. Wessely, Medically unexplained symptoms: exacerbating factors in the doctor–patient encounter. J. R. Soc. Med. 96 (2003), 223–7.
R. Schweitzer, D. I. Robertson, B. Kelly, J. Whiting, Illness behaviour of patients with chronic fatigue syndrome. J. Psychosom. Res. 38 (1994), 41–9.
P. Trigwell, S. Hatcher, M. Johnson, P. Stanley, A. House, ‘Abnormal’ illness behaviour in chronic fatigue syndrome and multiple sclerosis. Br. Med. J. 311 (1995), 15–18.
G. H. Hall, W. T. Hamilton, A. P. Round, Increased illness experience preceding chronic fatigue syndrome: a case control study. J. R. Coll. Physicians Lond. 32 (1998), 44–8.
C. M. T. van Wijk, A. T. Kolk, Sex differences in physical symptoms: the contribution of symptom perception theory. Soc. Sci. Med. 45 (1997), 231–46.
J. Joyce, M. Hotopf, S. Wessely, The prognosis of chronic fatigue and chronic fatigue syndrome: a systematic review. Q. J. Med. 90 (1997), 223–33.
W. T. Hamilton, G. H. Hall, A. P. Round, Frequency of attendance in general practice and symptoms before development of chronic fatigue syndrome: a case–control study. Br. J. Gen. Pract. 51 (2001), 553–8.
World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines (Geneva: World Health Organization, 1992).
American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, 4th edn (Washington, DC: American Psychiatric Association, 1994).
R. H. Jindal, M. E. Thase, A. L. Fasiczka, et al., Electroencephalographic sleep profiles in single-episode and recurrent unipolar forms of major depression II. Comparison during remission. Biol. Psychiatry 51 (2002), 230–36.
N. F. Watson, V. Kapur, L. M. Arguelles et al., Comparison of subjective and objective measures of insomnia in monozygotic twins discordant for chronic fatigue syndrome. Sleep 26, (2003), 324–8.
A. R. Lloyd, Chronic fatigue and chronic fatigue syndrome: shifting boundaries and attributions. Am. J. Med. 105 (1998), S7–10.
K. J. Looper, L. J. Kirmayer, Perceived stigma in functional somatic syndromes and comparable medical conditions. J. Psychosom Res. 57 (2004), 373–8.
G. Van der Linden, T. Chalder, I. Hickie, et al., Fatigue and psychiatric disorder: different or the same? Psychol. Med. 29 (1999), 863–8.
I. Hickie, A. Koschera, D. Hadzi-Pavlovic, B. Bennett, A. Lloyd, The temporal stability and co-morbidity of prolonged fatigue: a longitudinal study in primary care. Psychol. Med. 29 (1999), 855–61.
L. A. Aaron, R. Herrell, S. Ashton, et al., Comorbid clinical conditions in chronic fatigue: a co-twin control study. J. Gen. Intern. Med. 16 (2001), 24–31.
P. Skapinakis, G. Lewis, V. Mavreas, Temporal relations between unexplained fatigue and depression: longitudinal data from an international study in primary care. Psychosom. Med. 66 (2004), 330–35.
S. Wessely, C. Nimnuan, M. Sharpe, Functional somatic syndromes: one or many? Lancet 354 (1999), 936–9.
P. D. White, Physical or mental? A perspective on chronic fatigue syndrome. Adv. Psychiatr. Treat. 8 (2002), 363–5.
S. Wessely, P. D. White, In debate: there is only one functional somatic syndrome. Br. J. Psychiatry 185 (2004), 95–6.
I. Hickie, A. Lloyd, D. Hadzi-Pavlovic, et al., Can the chronic fatigue syndrome be defined by distinct clinical features? Psychol. Med. 25 (1995), 925–35.
A. Wilson, I. Hickie, D. Hadzi-Pavlovic, et al., What is chronic fatigue syndrome? Heterogeneity within an international multicentre study. Aust. N. Z. J. Psychiatry 35 (2001), 520–27.
R. R. Taylor, L. A. Jason, M. E. Schoeny, Evaluating latent variable models of functional somatic distress in a community sample. J. Ment. Health 10 (2001), 335–49.
I. Petersen, J. M. Thomas, W. T. Hamilton, P. D. White, Risk and predictors of fatigue after infectious mononucleosis in a large primary-care cohort. Q. J. Red. 99 (2006), 49–55.
G. J. Berelowitz, A. P. Burgess, T. Thanabalasingham, I. M. Murray-Lyon, D. J. Wright, Post-hepatitis syndrome revisited. J. Viral Hepatol. 2 (1995), 133–8.
M. Hotopf, N. Noah, S. Wessely, Chronic fatigue and psychiatric morbidity following viral meningitis: a controlled study. J. Neurol. Neurosurg. Psychiatry 60 (1996), 495–503.
J. G. Ayres, N. Flint, E. G. Smith, et al., Post-infection fatigue syndrome following Q fever. Q. J. Med. 91 (1998), 105–23.
S. Lambore, J. McSherry, A. S. Kraus, Acute and chronic symptoms of mononucleosis. J. Fam. Pract. 33 (1991), 33–7.
P. D. White, J. M. Thomas, J. Amess, et al., The existence of a fatigue syndrome after glandular fever. Psychol. Med. 25 (1995), 907–16.
P. D. White, S. A. Grover, H. O. Kangro, et al., The validity and reliability of the fatigue syndrome that follows glandular fever. Psychol. Med. 25 (1995), 917–24.
R. Dantzer, Cytokine-induced sickness behavior: where do we stand? Brain Behav. Immun. 15 (2001), 7–24.
P. D. White, J. M. Thomas, H. O. Kangro, et al., Predictions and associations of fatigue syndromes and mood disorders that occur after infectious mononucleosis. Lancet 358 (2001), 1946–54.
B. Candy, T. Chalder, A. J. Cleare, et al., Predictors of fatigue following the onset of infectious mononucleosis. Psychol. Med. 33 (2003), 847–55.
T. D. Rea, J. E. Russo, W. Katon, R. L. Ashley, D. S. Buchwald, Prospective study of the natural history of infectious mononucleosis caused by Epstein–Barr virus. J. Am. Board Fam. Pract. 14 (2001), 234–42.
D. S. Buchwald, T. D. Rea, W. J. Katon, J. E. Russo, R. L. Ashley, Acute infectious mononucleosis: characteristics of patients who report failure to recover. Am. J. Med. 109 (2000), 531–7.
W. Katon, J. Russo, R. L. Ashley, D. Buchwald, Infectious mononucleosis: psychological symptoms during acute and subacute phases of illness. Gen. Hosp. Psychiatry 21 (2000), 21–9.
P. D. White, J. M. Thomas, P. F. Sullivan, D. Buchwald, The nosology of sub-acute and chronic fatigue syndromes that follow infectious mononucleosis. Psychol. Med. 34 (2004), 499–507.
A. Appels, Exhaustion and coronary heart disease the history of a scientific quest. Patient Educ. Couns. 55 (2004), 223–9.
M. S. Kopp, P. R. Falger, A. Appels, S. Szedmák, Depressive symptomatology and vital exhaustion are differentially related to behavioral risk factors for coronary artery disease. Psychosom. Med. 60 (1998), 752–8.
A. Appels, W. J. Kop, E. Schouten, The nature of the depressive symptomatology preceding myocardial infarction. Behav. Med. 26 (2000), 86–9.
F. L. Wojciechowski, J. J. Strik, P. Falger, R. Lousberg, A. Honig, The relationship between depressive and vital exhaustion symptomatology post-myocardial infarction. Acta Psychiatr. Scand. 102 (2000), 359–65.
L. McGowan, C. Dickens, C. Percival, et al., The relationship between vital exhaustion, depression and comorbid illnesses in patients following first myocardial infarction. J. Psychosom. Res. 57 (2004), 183–8.
E. Prescott, C. Holst, M. Gr⊘nbaek, et al., Vital exhaustion as a risk factor for ischaemic heart disease and all-cause mortality in a community sample: a prospective study of 4084 men and 5479 women in the Copenhagen City Heart Study. Int. J. Epidemiol. 32 (2003), 990–97.
W. J. Kop, K. Hamulyák, C. Pernot, A. Appels, Relationship of blood coagulation and fibrinolysis to vital exhaustion. Psychosom. Med. 60 (1998), 352–8.
A. Van der Ven, R. van Diest, K. Hamulyák, et al., Herpes viruses, cytokines, and altered hemostasis in vital exhaustion. Psychosom. Med. 65 (2003), 194–200.
P. Jeanmonod, R. von Känel, F. E. Maly, J. E. Fischer, Elevated plasma C-reactive protein in chronically distressed subjects who carry the A allele of the TNF-alpha-308 G/A polymorphism. Psychosom. Med. 66 (2004), 501–6.
R. Van Diest, W. P. Appels, Sleep physiological characteristics of exhausted men. Psychosom. Med. 56 (1994), 28–35.
A. J. Cleare, D. Blair, S. Chambers, S. Wessely, Urinary free cortisol in chronic fatigue syndrome. Am. J. Psychiatry 158 (2001), 641–3.
A. J. Cleare, The neuroendocrinology of chronic fatigue syndrome. Endocr. Rev. 24 (2003), 236–52.
J. W. Kasckow, D. Baker, T. D. Geracioti, Jr, Corticotropin-releasing hormone in depression and post-traumatic stress disorder. Peptides 22 (2001), 845–51.
P. E. Mullen, C. R. Linsell, D. Parker, Influence of sleep disruption and calorie restriction on biological markers for depression. Lancet 2 (1986), 1051–5.
G. Leese, P. Chattington, W. Fraser, et al., Short-term night-shift working mimics the pituitary-adrenocortical dysfunction in chronic fatigue syndrome. J. Clin. Endocrinol. Metabol. 81 (1996), 1867–70.
A. J. Cleare, The HPA axis and the genesis of chronic fatigue syndrome. Trends Endocrinol. Metabol. 15 (2004), 55–9.
J. Gaab, V. Engert, V. Heitz, et al., Associations between neuroendocrine responses to the insulin tolerance test and patient characteristics in chronic fatigue syndrome. J. Psychosom. Res. 56 (2004), 419–24.
D. E. Giles, D. J. Kupfer, A. J. Rush, H. P. Roffwarg, Controlled comparison of electrophysiological sleep in families of probands with unipolar depression. Am. J. Psychiatry 155 (1998), 192–9.
A. Korszun, V. Moskvina, S. Brewster, et al., Familiality of symptom dimensions in depression. Arch. Gen. Psychiatry 61 (2004), 468–74.
M. Irwin, Psychoneuroimmunology of depression: clinical implications. Brain Behav. Immun. 16 (2002), 1–16.
M. Lyall, M. Peakman, S. Wessely, A systematic review and critical evaluation of the immunology of chronic fatigue syndrome. J. Psychosom. Res. 55 (2003), 79–90.
A. Skowera, A. Cleare, D. Blair, et al., High levels of type 2 cytokine-producing cells in chronic fatigue syndrome. Clin. Exp. Immunol. 135 (2004), 294–302.
M. Wichers, M. Maes, The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. Int. J. Neuropsychopharmacol. 5 (2002), 375–88.
K. W. Kelley, R. M. Bluthe, R. Dantzer, et al., Cytokine-induced sickness behavior. Brain Behav. Immun. 17: Suppl 1 (2003), 112–18.
M. Peakman, A. Deale, R. Field, M. Mahalingam, S. Wessely, Clinical improvement in chronic fatigue syndrome is not associated with lymphocyte subsets of function or activation. Clin. Immunol. Immunopathol. 82 (1997), 83–91.
M. Irwin, Effects of sleep and sleep loss on immunity and cytokines. Brain Behav. Immun. 16 (2002), 503–12.
P. Whiting, A. M. Bagnall, A. J. Sowden, et al., Interventions for the treatment and management of chronic fatigue syndrome: a systematic review. J. Am. Med. Assoc. 286 (2001), 1360–68.
D. A. Lawlor, S. W. Hopker, The effectiveness of exercise as an intervention in the management of depression: systematic review and meta-regression analysis of randomised controlled trials. Br. Med. J. 322 (2001), 763–7.
K. Y. Fulcher, P. D. White, Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome. Br. Med. J. 314 (1997), 1647–52.
K. Y. Fulcher, P. D. White, Strength and physiological response to exercise in patients with the chronic fatigue syndrome. J. Neurol. Neurosurg. Psychiatry 69 (2000), 302–7.
B. W. Penninx, W. J. Rejeski, J. Pandya, et al., Exercise and depressive symptoms: a comparison of aerobic and resistance exercise effects on emotional and physical function in older persons with high and low depressive symptomatology. J. Gerontol. B Psychol. Sci. Soc. Sci. 57 (2002), 124–32.
R. Raine, A. Haines, T. Sensky et al., Systematic review of mental health interventions for patients with common somatic: can research evidence from secondary care be extrapolated to primary care? Br. Med. J. 325 (2002), 1082–5.
D. Veale, K. Le Fevre, C. Pantelis, et al., Aerobic exercise in the adjunctive treatment of depression: a randomized controlled trial. J. R. Soc. Med. 85 (1992), 541–4.
V. Valim, L. Oliveira, A. Suda, et al., Aerobic fitness effects in fibromyalgia. J. Rheumatol. 30 (2003), 1060–69.
G. Kempermann, H. van Praag, F. H. Gage, Activity-dependent regulation of neuronal plasticity and self repair. Progr. Brain Res. 127 (2000), 35–48.
C. Ekdahl, R. Ekman, S. I. Andersson, A. Melander, B. Svensson, Dynamic training and circulating levels of corticotropin-releasing factor, beta-lipotropin and beta-endorphin in rheumatoid arthritis. Pain 40 (1990), 35–42.
J. Vercoulen, C. M. A. Swanink, F. G. Zitman, et al., Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet 347 (1996), 858–61.
L. M. Arnold, P. E. Keck, J. A. Welge, Antidepressant treatment of fibromyalgia: a meta-analysis and review. Psychosomatics 41 (2000), 104–13.
J. H. Vercoulen, C. M. Swanink, J. M. Galama, et al., The persistence of fatigue in chronic fatigue syndrome and multiple sclerosis: development of a model. J. Psychosom. Res. 45 (1998), 507–17.
C. M. Tench, I. McCurdie, P. D. White, D. P. D'Cruz, The prevalence and associations of fatigue in systemic lupus erythematosus. Rheumatology (Oxford) 39 (2000), 1249–54.
C. Tench, D. Bentley, V. Vleck, et al., Aerobic fitness, fatigue, and physical disability in systemic lupus erythematosus. J. Rheumatol. 29 (2002), 474–81.
P. Servaes, J. Prins, C. Verhagen, G. Bleijenberg, Fatigue after breast cancer and in chronic fatigue syndrome, similarities and differences. J. Psychsom. Res. 52 (2002), 453–9.
F. Dimeo, A. Schmittel, T. Fietz, et al., Physical performance, depression, immune status and fatigue in patients with hematological malignancies after treatment. Ann. Oncol. 15 (2004), 1237–42.
A. Romani, R. Bergamaschi, E. Candeloro, et al., Fatigue in multiple sclerosis: multidimensional assessment and response to symptomatic treatment. Mult. Scler. 10 (2004), 462–8.
K. Reuter, M. Harter, The concepts of fatigue and depression in cancer. Eur. J. Cancer Care 13 (2004), 127–34.
M. C. Tartaglia, S. Narayanan, S. J. Francis, et al., The relationship between diffuse axonal damage and fatigue in multiple sclerosis. Arch. Neurol. 61 (2004), 201–7.
P. Flachenecker, T. Kümpfel, B. Kallmann, et al., Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters. Mult. Scler. 8 (2002), 523–6.
P. Flachenecker, I. Bihler, F. Weber, et al., Cytokine mRNA expression in patients with multiple sclerosis and fatigue. Mult. Scler. 10 (2004), 165–9.
D. C. Kroencke, S. G. Lynch, D. R. Denney, Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern. Mult. Scler. 6 (2000), 131–6.
H. P. Attarian, K. M. Brown, S. P. Duntley, J. D. Carter, A. H. Cross, The relationship of sleep disturbances and fatigue in multiple sclerosis. Arch. Neurol. 61 (2004), 525–8.
G. R. Morrow, J. T. Hickok, J. A. Roscoe, et al., Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial. J. Clin. Oncol. 21 (2003), 4635–41.
D. C. Mohr, S. L. Hart, A. Goldberg, Effects of treatment for depression on fatigue in multiple sclerosis. Psychosom. Med. 65 (2003), 542–7.

Reference Title: REFERENCES

Reference Type: reference-list

D. Stockton, T. Davies, N. Day, J. McCann, Retrospective study of reasons for improved survival in patients with breast cancer in East Anglia: earlier diagnosis or better treatment. Br. Med. J. 314 (1997), 472–5.
C. S. McArdle, D. J. Hole, Outcome following surgery for colorectal cancer. Br. Med. Bull. 64 (2002), 119–25.
M. Coleman, P. Babb, P. Damiecki, et al., Cancer Survival Trends in England and Wales, 1971–1995 (London: The Stationary Office, 1999).
American Cancer Society. Cancer Facts and Figures. (Atlanta, GA: American Cancer Society, 2005).
M. McMenamin, H. Barry, A. M. Lennon, et al., A survey of breast cancer awareness and knowledge in a Western population: lots of light but little illumination. Eur. J. Cancer 41 (2005), 393–7.
K. McCaffery, J. Wardle, J. Waller, Knowledge, attitudes, and behavioral intentions in relation to the early detection of colorectal cancer in the United Kingdom. Prev. Med. 36 (2003), 525–35.
D. Spiegel, J. Giese-Davis, Depression and cancer: mechanisms and disease progression. Biol. Psychiatry 54 (2003), 269–82.
W. F. Pirl, Evidence report on the occurrence, assessment, and treatment of depression in cancer patients. J. Natl. Cancer Inst. Monogr. (2004), 32–9.
M. J. Massie, Prevalence of depression in patients with cancer. J. Natl. Cancer Inst. Monogr. (2004), 57–71.
J. C. Coyne, S. C. Palmer, P. J. Shapiro, R. Thompson, A. DeMichele, Distress, psychiatric morbidity, and prescriptions for psychotropic medication in a breast cancer waiting room sample. Gen. Hosp. Psychiatry 26 (2004), 121–8.
M. Harter, K. Reuter, A. Aschenbrenner, et al., Psychiatric disorders and associated factors in cancer: results of an interview study with patients in inpatient, rehabilitation and outpatient treatment. Eur. J. Cancer 37 (2001), 1385–93.
D. W. Kissane, D. M. Clarke, J. Ikin, et al., Psychological morbidity and quality of life in Australian women with early-stage breast cancer: a cross-sectional survey. Med. J. Aust. 169 (1998), 192–6.
M. Sharpe, V. Strong, K. Allen, et al., Major depression in outpatients attending a regional cancer centre: screening and unmet treatment needs. Br. J. Cancer 90 (2004), 314–20.
C. Burgess, V. Cornelius, S. Love, et al., Depression and anxiety in women with early breast cancer: five year observational cohort study. Br. Med. J. 330 (2005), 702.
M. Hotopf, J. Chidgey, J. J. Addington-Hall, K. L. Ly. Depression in advanced disease: a systematic review. Part 1. Prevalence and case finding. Palliat. Med. 16 (2002), 81–97.
C. Classen, L. D. Butler, C. Koopman, et al., Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial. Arch. Gen. Psychiatry 58 (2001), 494–501.
M. E. Lynch. The assessment and prevalence of affective disorders in advanced cancer. J. Palliat. Care 11 (1995), 10–18.
O. Evans, N. Singleton, H. Meltzer, R. Stewart, M. Prince. The Mental Health of Older People (London: The Stationery Office, 2003).
N. Singleton, R. Bumpstead, M. O'Brien, A. Lee, H. Meltzer Psychiatric Morbidity among Adults Living in Private Households 2000 (London: The Stationery Office, 2001).
R. C. Kessler, P. Berglund, O. Demler, et al., The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). J. Am. Med. Assoc. 289 (2003), 3095–105.
A. van't Spijker, R. W. Trijsburg, H. J. Duivenvoorden, Psychological sequelae of cancer diagnosis: a meta-analytical review of 58 studies after 1980. Psychosom. Med. 59 (1997), 280–93.
C. L. Raison, A. H. Miller, Depression in cancer: new developments regarding diagnosis and treatment. Biol. Psychiatry 54 (2003), 283–94.
D. Polsky, J. A. Doshi, S. Marcus, et al., Long-term risk for depressive symptoms after a medical diagnosis. Arch. Intern. Med. 165 (2005), 1260–66.
J. E. Barrett, J. A. Barrett, T. E. Oxman, P. D. Gerber, The prevalence of psychiatric disorders in a primary care practice. Arch. Gen. Psychiatry 45 (1988), 1100–106.
J. C. Coyne. Self-reported distress: analog or Ersatz depression? Psychol. Bull. 116 (1994), 29–45.
L. G. Kessler, P. D. Cleary, J. D. Burke, Jr, Psychiatric disorders in primary care. Results of a follow-up study. Arch. Gen. Psychiatry 42 (1985), 583–7.
H. C. Schulberg, M. McClelland, B. J. Burns, Depression and physical illness: the prevalence, causation and diagnosis of co-morbidity. Clin. Psychol. Rev. 7 (1987), 145–67.
W. Katon, The epidemiology of depression in medical care. Int. J. Psychiatry Med. 17 (1987), 93–112.
K. Reuter, M. Harter, The concepts of fatigue and depression in cancer. Eur. J. Cancer Care 13 (2004), 127–34.
J. C. Coyne, S. C. Palmer, P. A. Sullivan, Screening for depression in adults. Ann. Intern. Med. 138 (2003), 767–8.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn (Washington, DC: American Psychiatric Association, 1994).
W. Katon, Depression: somatic symptoms and medical disorders in primary care. Compr. Psychiatry 23 (1982), 274–87.
S. Cavanaugh, D. C. Clark, R. D. Gibbons, Diagnosing depression in the hospitalized medically ill. Psychosomatics 24 (1983), 809–15.
D. A. Clark, A. Cook, D. Snow, Depressive symptom differences in hospitalized, medically ill, depressed psychiatric inpatients and nonmedical controls. J. Abnorm. Psychol. 107 (1998), 38–48.
D. C. Clark, C. S. vonAmmon, R. D. Gibbons, The core symptoms of depression in medical and psychiatric patients. J. Nerv. Ment. Dis. 171 (1983), 705–13.
S. A. Cohen-Cole, A. Stoudemire, Major depression and physical illness. Special considerations in diagnosis and biologic treatment. Psychiatr. Clin. North Am. 10 (1987), 1–17.
M. K. Popkin, A. L. Callies, E. A. Colon, A framework for the study of medical depression. Psychosomatics 28 (1987), 27–33.
P. C. Trask, Assessment of depression in cancer patients. J. Natl. Cancer Inst. Monogr. (2004), 80–92.
R. G. Kathol, A. Mutgi, J. Williams, G. Clamon, R. Noyes, Jr, Diagnosis of major depression in cancer patients according to four sets of criteria. Am. J. Psychiatry 147 (1990), 1021–4.
J. Endicott, Measurement of depression in patients with cancer. Cancer 53 (1984), 2243–9.
H. G. Koenig, L. K. George, B. L. Peterson, C. F. Pieper, Depression in medically ill hospitalized older adults: prevalence, characteristics, and course of symptoms according to six diagnostic schemes. Am. J. Psychiatry 154 (1997), 1376–83.
J. C. Coyne, C. M. Pepper, H. Flynn, Significance of prior episodes of depression in two patient populations. J. Consult. Clin. Psychol. 67 (1999), 76–81.
H. G. Koenig, P. Pappas, T. Holsinger, J. R. Bachar, Assessing diagnostic approaches to depression in medically ill older adults: how reliably can mental health professionals make judgments about the cause of symptoms? J. Am. Geriatr. Soc. 43 (1995), 472–8.
K. Honda, R. D. Goodwin, Cancer and mental disorders in a national community sample: findings from the national comorbidity survey. Psychother. Psychosom. 73 (2004), 235–42.
J. C. Coyne, S. C. Palmer, National Comorbidity Survey data concerning cancer and depression lack credibility. Psychother. Psychosom. 74 (2005), 260–61.
J. Zabora, K. BrintzenhofeSzoc, B. Curbow, C. Hooker, The prevalence of psychological distress by cancer site. Psychooncology 10 (2001), 19–28.
M. Stommel, M. E. Kurtz, J. C. Kurtz, C. W. Given, B. A. Given, A longitudinal analysis of the course of depressive symptomatology in geriatric patients with cancer of the breast, colon, lung, or prostate. Health Psychol. 23 (2004), 564–73.
R. H. Osborne, G. R. Elsworth, J. L. Hopper, Age-specific norms and determinants of anxiety and depression in 731 women with breast cancer recruited through a population-based cancer registry. Eur. J. Cancer 39 (2003), 755–62.
J. Gallagher, M. Parle, D. Cairns, Appraisal and psychological distress six months after diagnosis of breast cancer. Br. J. Health Psychol. 7 (2002), 365–76.
K. Shimozuma, P. A. Ganz, L. Petersen, K. Hirji, Quality of life in the first year after breast cancer surgery rehabilitation needs and patterns of recovery. Breast Cancer Res. Treat. 56 (1999), 45–57.
D. W. Kissane, B. Grabsch, A. Love, et al., Psychiatric disorder in women with early stage and advanced breast cancer a comparative analysis. Aust. N. Z. J. Psychiatry 38 (2004), 320–26.
E. M. Bleiker, F. Pouwer, H. M. van der Ploeg, J. W. Leer, H. J. Ader, Psychological distress two years after diagnosis of breast cancer: frequency and prediction. Patient. Educ. Couns. 40 (2000), 209–17.
J. Norum, Adjuvant chemotherapy in Dukes' B and C colorectal cancer has only a minor influence on psychological distress. Support. Care Cancer 5 (1997), 318–21.
J. C. Weeks, E. F. Cook, S. J. O'Day, et al., Relationship between cancer patients' predictions of prognosis and their treatment preferences. J. Am. Med. Assoc. 279 (1998), 1709–14.
C. F. Quirt, W. J. Mackillop, A. D. Ginsburg, et al., Do doctors know when their patients don't? A survey of doctor–patient communication in lung cancer. Lung Cancer 18 (1997), 1–20.
E. Chow, L. Andersson, R. Wong, et al., Patients with advanced cancer: a survey of the understanding of their illness and expectations from palliative radiotherapy for symptomatic metastases. Clin. Oncol. (R. Coll. Radiol.) 13 (2001), 204–8.
M. Gattellari, P. N. Butow, M. H. Tattersall, S. M. Dunn, C. A. MacLeod, Misunderstanding in cancer patients: why shoot the messenger? Ann. Oncol. 10 (1999), 39–46.
L. Capuron, A. Ravaud, N. Gualde, et al., Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy. Psychoneuroendocrinology 26 (2001), 797–808.
D. L. Musselman, D. H. Lawson, J. F. Gumnick et al., Paroxetine for the prevention of depression induced by high-dose interferon alfa. N. Engl. J. Med. 344 (2001), 961–6.
A. G. Paterson, P. C. Trask, L. I. Wagner, P. Esper, B. Redman, Validation of the FACT-BRM with interferon-alpha treated melanoma patients. Qual. Life Res. 14 (2005), 133–9.
B. Holzner, G. Kemmler, D. Cella, et al., Normative data for functional assessment of cancer therapy: general scale and its use for the interpretation of quality of life scores in cancer survivors. Acta Oncol. 43 (2004), 153–60.
C. S. Neitzert, P. Ritvo, J. Dancey, et al., The psychosocial impact of bone marrow transplantation a review of the literature. Bone Marrow Transplant. 22 (1998), 409–22.
R. Illescas-Rico, F. Amaya-Ayala, J. L. Jimenez-Lopez, M. E. Caballero-Mendez, J. Gonzalez-Llaven, Increased incidence of anxiety and depression during bone marrow transplantation. Arch. Med. Res. 33 (2002), 144–7.
R. K. Portenoy, H. T. Thaler, A. B. Kornblith, et al., Symptom prevalence, characteristics and distress in a cancer population. Qual. Life Res. 3 (1994), 183–9.
P. Hopwood, R. J. Stephens, Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. J. Clin. Oncol. 18 (2000), 893–903.
B. Bennett, D. Goldstein, A. Lloyd, T. Davenport, I. Hickie, Fatigue and psychological distress: exploring the relationship in women treated for breast cancer. Eur. J. Cancer 40 (2004), 1689–95.
B. L. Andersen, Psychological interventions for cancer patients to enhance the quality of life. J. Consult Clin. Psychol. 60 (1992), 552–68.
E. Maunsell, J. Brisson, L. Deschenes, Psychological distress after initial treatment of breast cancer: assessment of potential risk factors. Cancer 70 (1992), 120–25.
A. J. Ramirez, M. A. Richards, S. R. Jarrett, I. S. Fentiman, Can mood disorder in women with breast cancer be identified preoperatively? Br. J. Cancer 72 (1995), 1509–12.
E. Maunsell, J. Brisson, L. Deschenes, N. Frasure-Smith, Randomized trial of a psychologic distress screening program after breast cancer: effects on quality of life. J. Clin. Oncol. 14 (1996), 2747–55.
J. C. Coyne, R. Thompson, M. S. Klinkman, D. E. Nease, Jr, Emotional disorders in primary care. J. Consult. Clin. Psychol. 70 (2002), 798–809.
L. Fallowfield, D. Ratcliffe, V. Jenkins, J. Saul, Psychiatric morbidity and its recognition by doctors in patients with cancer. Br. J. Cancer 84 (2001), 1011–15.
S. D. Passik, W. Dugan, M. V. McDonald, et al., Oncologists' recognition of depression in their patients with cancer. J. Clin. Oncol. 16 (1998), 1594–600.
M. V. McDonald, S. D. Passik, W. Dugan, et al., Nurses' recognition of depression in their patients with cancer. Oncol. Nurs. Forum 26 (1999), 593–9.
B. M. Hoffman, M. A. Zevon, M. C. D'Arrigo, T. B. Cecchini, Screening for distress in cancer patients: the NCCN rapid-screening measure. Psychooncology 13 (2004), 792–9.
L. E. Carlson, B. D. Bultz, Efficacy and medical cost offset of psychosocial interventions in cancer care: making the case for economic analyses. Psychooncology 13 (2004), 837–49.
N. Akizuki, T. Akechi, T. Nakanishi, et al., Development of a brief screening interview for adjustment disorders and major depression in patients with cancer. Cancer 97 (2003), 2605–13.
P. B. Jacobsen, K. A. Donovan, P. C. Trask, et al., Screening for psychologic distress in ambulatory cancer patients. Cancer 103 (2005), 1494–502.
L. S. Radloff, The CES-D scale: a self-report depression scale for research in the general population. Appl. Psychol. Meas. 1 (1977), 385–401.
L. R. Derogatis, N. Melisaratos, The Brief Symptom Inventory: an introductory report. Psychol. Med. 13 (1983), 595–605.
A. Zigmond, R. Snaith, The Hospital Anxiety and Depression Scale. Acta Psychiatr. Scand. 67 (1983), 361–70.
B. Lowe, K. Kroenke, K. Grafe, Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J. Psychosom. Res. 58 (2005), 163–71.
B. Lowe, J. Unutzer, C. M. Callahan, A. J. Perkins, K. Kroenke, Monitoring depression treatment outcomes with the patient health questionnaire-9. Med. Care 42 (2004), 1194–201.
V. Henkel, R. Mergl, J. C. Coyne, et al., Screening for depression in primary care: will one or two items suffice? Eur. Arch. Psychiatry Clin. Neurosci. 254 (2004), 215–23.
R. L. Spitzer, J. B. Williams, K. Kroenke, et al., Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1000 study. J. Am. Med. Assoc. 272 (1994), 1749–56.
A. C. Leon, J. E. Kelsey, A. Pleil, et al., An evaluation of a computer assisted telephone interview for screening for mental disorders among primary care patients. J. Nerv. Ment. Dis. 187 (1999), 308–11.
S. Fechner-Bates, J. C. Coyne, T. L. Schwenk, The relationship of self-reported distress to depressive disorders and other psychopathology. J. Consult. Clin. Psychol. 62 (1994), 550–9.
K. Shimizu, T. Akechi, M. Okamura, et al., Usefulness of the nurse-assisted screening and psychiatric referral program. Cancer 103 (2005), 1949–56.
S. A. McLachlan, A. Allenby, J. Matthews, et al., Randomized trial of coordinated psychosocial interventions based on patient self-assessments versus standard care to improve the psychosocial functioning of patients with cancer. J. Clin. Oncol. 19 (2001), 4117–25.
S. C. Palmer, J. C. Coyne, Screening for depression in medical care: pitfalls, alternatives, and revised priorities. J. Psychosom. Res. 54 (2003), 279–87.
A. J. Roth, A. B. Kornblith, L. Batel-Copel, et al., Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer 82 (1998), 1904–8.
P. Maguire, Improving communication with cancer patients. Eur. J. Cancer 35 (1999), 1415–22.
C. Dean, Psychiatric morbidity following mastectomy: preoperative predictors and types of illness. J. Psychosom. Res. 31 (1987), 385–92.
J. Harrison, P. Maguire, Predictors of psychiatric morbidity in cancer patients. Br. J. Psychiatry 165 (1994), 593–8.
J. S. McDaniel, D. L. Musselman, C. B. Nemerof, Cancer and depression: Theory and treatment. Psychiatr. Ann. 27 (1997), 360–64.
D. L. Evans, D. S. Charney, L. Lewis, et al., Mood disorders in the medically ill: scientific review and recommendations. Biol. Psychiaty 58 (2005), 175–89.
D. Razavi, J. F. Allilaire, M. Smith, et al., The effect of fluoxetine on anxiety and depression symptoms in cancer patients. Acta Psychiatr. Scand. 94 (1996), 205–10.
A. K. Koike, J. Unutzer, K. B. Wells, Improving the care for depression in patients with comorbid medical illness. Am. J. Psychiatry 159 (2002), 1738–45.
T. Sheard, P. Maguire, The effect of psychological interventions on anxiety and depression in cancer patients results of two meta-analyses. Br. J. Cancer 80 (1999), 1770–80.
A. M. Nezu, C. M. Nezu, S. H. Felgoise, K. S. McClure, P. S. Houts, Project Genesis: assessing the efficacy of problem-solving therapy for distressed adult cancer patients. J. Consult. Clin. Psychol. 71 (2003), 1036–48.
M. J. Fisch, P. J. Loehrer, J. Kristeller, et al., Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier Oncology Group. J. Clin. Oncol. 21 (2003), 1937–43.
J. C. Coyne, S. C. Palmer, P. J. Shapiro, Prescribing antidepressants to advanced cancer patients with mild depressive symptoms is not justified. J. Clin. Oncol. 22 (2004), 205–6.
B. A. Erwin, P. A. Sullivan, T. R. ten Have, Trial of antidepressants for mildly depressed cancer patients should have been reported in a manner allowing independent evaluation of investigators' claims. J. Clin. Oncol. 22 (2004), 753–4.
C. Moynihan, J. M. Bliss, J. Davidson, L. Burchell, A. Horwich, Evaluation of adjuvant psychological therapy in patients with testicular cancer: randomised controlled trial. Br. Med. J. 316 (1998), 429–35.
M. Sharpe, V. Strong, K. Allen, et al., Management of major depression in outpatients attending a cancer centre: a preliminary evaluation of a multicomponent cancer nurse-delivered intervention. Br. J. Cancer 90 (2004), 310–13.
W. Sollner, S. Maislinger, A. Konig, A. Devries, P. Lukas, Providing psychosocial support for breast cancer patients based on screening for distress within a consultation-liaison service. Psychooncology. 13 (2004), 893–7.
P. J. Shapiro, J. C. Coyne, L. K. Kruus, et al., Interest in services among prostate cancer patients receiving androgen deprivation therapy. Psychooncology 13 (2004), 512–25.
E. G. Eakin, L. A. Strycker, Awareness and barriers to use of cancer support and information resources by HMO patients with breast, prostate, or colon cancer: patient and provider perspectives. Psychooncology 10 (2001), 103–13.
J. C. Holland, History of psycho-oncology overcoming attitudinal and conceptual barriers. Psychosom. Med. 64 (2002), 206–21.
M. Beutel, G. Henrich, A. Sellschopp, M. Keller, W. Adermayer, Needs and utilization of ambulatory psychosocial services by cancer patients – exemplified by the oncologic day clinic. Psychother. Psychosom. Med. Psychol. 46 (1996), 304–11.
R. E. Gray, M. Fitch, C. Davis, C. Phillips, Interviews with men with prostate cancer about their self-help group experience. J. Palliat. Care 13 (1997), 15–21.
K. N. Moore, A. Estey, The early post-operative concerns of men after radical prostatectomy. J. Adv. Nurs. 29 (1999), 1121–9.
F. Wong, D. E. Stewart, J. Dancey, et al., Men with prostate cancer: influence of psychological factors on informational needs and decision making. J. Psychosom. Res. 49 (2000), 13–9.
P. J. Goodwin, M. Leszcz, G. Quirt, et al., Lessons learned from enrollment in the BEST study: a multicenter, randomized trial of group psychosocial support in metastatic breast cancer. J. Clin. Epidemiol. 53 (2000), 47–55.
D. A. Regier, W. E. Narrow, D. S. Rae, et al., The de facto US mental and addictive disorders service system: Epidemiologic Catchment Area prospective 1-year prevalence rates of disorders and services. Arch. Gen. Psychiatry 50 (1993), 85–94.
P. A. Sullivan, J. C. Coyne, S. C. Palmer, J. M. Metz, Antidepressant use in breast cancer patients: an Oncolink study. Presented at the 27th annual meeting of the American Society of Preventive Oncology, Philadelphia, PA, 3 March 2003.
W. J. Katon, J. Unutzer, G. Simon, Treatment of depression in primary care: where we are, where we can go. Med. Care 42 (2004), 1153–7.
J. W. Williams, Jr, C. D. Mulrow, E. Chiquette, et al., A systematic review of newer pharmacotherapies for depression in adults: evidence report summary. Ann. Intern. Med. 132 (2000), 743–56.
W. Katon, K. M. Von, E. Lin, et al., Collaborative management to achieve treatment guidelines: impact on depression in primary care. J. Am. Med. Assoc. 273 (1995), 1026–31.
J. C. Coyne, S. C. Palmer, P. A. Sullivan, Is case-finding an inefficient way of addressing depression as a public health problem? Pharmacoepidemiol. Drug Saf. 11 (2002), 545–7.
D. S. Brody, Improving the management of depression in primary care: recent accomplishments and ongoing challenges. Dis. Manage Health Outcomes 11 (2003), 21–31.
T. E. Oxman, A. J. Dietrich, H. C. Schulberg, The depression care manager and mental health specialist as collaborators within primary care. Am. J. Geriatr. Psychiatry 11 (2003), 507–16.
H. C. Schulberg, C. Bryce, K. Chism, et al., Managing late-life depression in primary care practice: a case study of the health specialist's role. Int. J. Geriatr. Psychiatry 16 (2001), 577–84.
E. M. Hunkeler, J. F. Meresman, W. A. Hargreaves, et al., Efficacy of nurse telehealth care and peer support in augmenting treatment of depression in primary care. Arch. Fam. Med. 9 (2000), 700–708.
G. E. Simon, M. VonKorff, C. Rutter, E. Wagner, Randomised trial of monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care. Br. Med. J. 320 (2000), 550–54.
V. Strong, M. Sharpe, A. Cull, et al., Can oncology nurses treat depression? A pilot project. J. Adv. Nurs. 46 (2004), 542–8.
M. Dwight-Johnson, K. Ell, P. J. Lee, Can collaborative care address the needs of low-income Latinas with comorbid depression and cancer? Results from a randomized pilot study. Psychosomatics 46 (2005), 224–32.
J. Lemon, S. Edelman, Perceptions of the ‘mind-cancer’ relationship among the public, cancer patients, and oncologists. J. Psychosoc. Oncol. 21 (2004), 43–58.
B. D. Doan, R. E. Gray, C. S. Davis, Belief in psychological effects on cancer. Psychooncology 2 (1993), 139–50.
B. L. Andersen, W. B. Farrar, D. M. Golden-Kreutz, et al., Psychological, behavioral, and immune changes after a psychological intervention: a clinical trial. J. Clin. Oncol. 22 (2004), 3570–80.
H. Faller, M. Schmidt, Prognostic value of depressive coping and depression in survival of lung cancer patients. Psychooncology 13 (2004), 359–63.
F. Efficace, L. Biganzoli, M. Piccart, et al., Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer. Eur. J. Cancer 40 (2004), 1021–30.
P. J. Goodwin, M. Leszcz, M. Ennis, et al., The effect of group psychosocial support on survival in metastatic breast cancer. N. Engl. J. Med. 345 (2001), 1719–26.
F. Efficace, P. Therasse, M. J. Piccart, et al., Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population an international multicenter study. J. Clin. Oncol. 22 (2004), 3381–8.
B. Garssen, Psychological factors and cancer development: evidence after 30 years of research. Clin. Psychol. Rev. 24 (2004), 315–38.
S. Greer, T. Morris, K. W. Pettingale, Psychological response to breast cancer: effect on outcome. Lancet 2 (1979), 785–7.
M. Watson, J. S. Haviland, S. Greer, J. Davidson, J. M. Bliss, Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet 354 (1999), 1331–6.
M. Watson, J. Homewood, J. Haviland, J. M. Bliss, Influence of psychological response on breast cancer survival: 10-year follow-up of a population-based cohort. Eur. J. Cancer 41 (2005), 1665–6.
D. Spiegel, J. R. Bloom, H. C. Kraemer, E. Gottheil, Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 2 (1989), 888–91.
D. Spiegel, Effects of psychotherapy on cancer survival. Nat. Rev. Cancer 2 (2002), 383–9.
F. I. Fawzy, N. W. Fawzy, C. S. Hyun, et al., Malignant melanoma: effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch. Gen. Psychiatry 50 (1993), 681–9.
J. L. Richardson, D. R. Shelton, M. Krailo, A. M. Levine, The effect of compliance with treatment on survival among patients with hematologic malignancies. J. Clin. Oncol. 8 (1990), 356–64.
T. Kuchler, D. Henne-Bruns, S. Rappat, et al., Impact of psychotherapeutic support on gastrointestinal cancer patients undergoing surgery: survival results of a trial. Hepatogastroenterology 46 (1999), 322–35.
R. McCorkle, N. E. Strumpf, I. F. Nuamah, et al., A specialized home care intervention improves survival among older post-surgical cancer patients. J. Am. Geriatr. Soc. 48 (2000), 1707–13.
M. W. Linn, B. S. Linn, R. Harris, Effects of counseling for late stage cancer patients. Cancer 49 (1982), 1048–55.
A. Ilnyckyj, J. Farber, M. Cheang, B. Weinerman, A randomized controlled trial of psychotherapeutic intervention in cancer patients. Ann. R. Coll. Physicians Surg. Can. 27 (1994), 93–6.
A. J. Cunningham, C. V. Edmonds, G. P. Jenkins, et al., A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer. Psychooncology 7 (1998), 508–17.
S. Edelman, J. Lemon, D. R. Bell, A. D. Kidman, Effects of group CBT on the survival time of patients with metastatic breast cancer. Psychooncology 8 (1999), 474–81.
S. C. Palmer, J. C. Coyne, Examining the evidence that psychotherapy improves the survival of cancer patients. Biol. Psychiatry 56 (2004), 61–2.
N. Frasure-Smith, F. Lesperance, Reflections on depression as a cardiac risk factor. Psychosom. Med. 67: Suppl 1 (2005), 19–25.
F. Lesperance, N. Frasure-Smith, The seduction of death. Psychosom. Med. 61 (1999), 18–20.

Reference Title: REFERENCES

Reference Type: reference-list

World Health Organization, Obesity and Overweight (Geneva: World Health Organization, 2003).
K. M. Flegal M. D. Carroll, C. L. Ogden, C. L. Johnson, Prevalence and trends in obesity among US adults, 1999–2000. J. Am. Med. Assoc. 288 (2002), 1723–7.
G. A. Bray, Medical consequences of obesity. J. Clin. Endocrinol. Metab. 89 (2004), 2583–9.
L. Khaodhiar, K. C. McCowen, G. L. Blackburn, Obesity and its comorbid conditions. Clin. Cornerstone 2 (1999), 17–31.
F. X. Pi-Sunyer, Medical hazards of obesity. Ann. Intern. Med. 119 (1993), 655–60.
T. L. Visscher, J. C. Seidell, The public health impact of obesity. Annu. Rev. Public Health 22 (2001), 355–75.
H. I. Kaplan, H. S. Kaplan, The psychosomatic concept of obesity. J. Nerv. Ment. Dis. 125 (1957), 181–201.
P. B. Goldblatt, M. E. Moore, A. J. Stunkard, Social factors in obesity. J. Am. Med. Assoc. 192 (1965), 1039–44.
P. Bjorntorp, Endocrine abnormalities of obesity. Metabolism 44 (1995), 21–3.
G. Oliver, J. Wardle, E. L. Gibson, Stress and food choice: a laboratory study. Psychosom. Med. 62 (2000), 853–65.
R. B. Harris, Leptin: much more than a satiety signal. Annu. Rev. Nutr. 20 (2000), 45–75.
A. Steptoe, S. R. Kunz-Ebrecht, L. Brydon, J. Wardle, Central adiposity and cortisol responses to waking in middle-aged men and women. Int. J. Obes. Relat. Metab. Disord. 28 (2004), 1168–73.
M. F. Dallman, N. Pecoraro, S. F. Akana, et al., Chronic stress and obesity: a new view of ‘comfort food’. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 11 696–701.
R. M. Puhl, K. D. Brownell, Psychosocial origins of obesity stigma: toward changing a powerful and pervasive bias. Obes. Rev. 4 (2003), 213–27.
R. Puhl, K. D. Brownell, Bias, discrimination, and obesity. Obes. Res. 9 (2001), 788–805.
M. A. Friedman, K. D. Brownell, Psychological correlates of obesity: moving to the next research generation. Psychol. Bull. 117 (1995), 3–20.
M. S. Faith, P. E. Matz, M. A. Jorge, Obesity-depression associations in the population. J. Psychosom. Res. 53 (2002), 935–42.
A. J. Stunkard, M. S. Faith, K. C. Allison, Depression and obesity. Biol. Psychiatry 54 (2003), 330–37.
T. A. Wadden, D. B. Sarwer, L. G. Womble, et al., Psychosocial aspects of obesity and obesity surgery. Surg. Clin. North Am. 81 (2001), 1001–24.
J. Istvan, K. Zavela, G. Weidner, Body weight and psychological distress in NHANES I. Int. J. Obes. Relat. Metab. Disord. 16 (1992), 999–1003.
T. A. Wadden, G. D. Foster, A. J. Stunkard, J. R. Linowitz, Dissatisfaction with weight and figure in obese girls: discontent but not depression. Int. J. Obes. 13 (1989), 89–97.
A. L. Stewart, R. H. Brook, Effects of being overweight. Am. J. Public Health 73 (1983), 171–8.
M. J. Seegers, C. Mertens, Psychological and bioclinical CHD risk factors: quantitative differences between obese, normal and thin subjects. J. Psychosom. Res. 18 (1974), 403–11.
M. Sullivan, J. Karlsson J. Sjostrom, et al., Swedish obese subjects (SOS): an intervention study of obesity – baseline evaluation of health and psychosocial functioning in the first 1743 subjects examined. Int. J. Obes. Relat. Metab. Disord. 17 (1993), 503–12.
R. R. Wing, K. A. Matthews, L. H. Kuller, E. N. Meilahn, P. Plantinga, Waist to hip ratio in middle-aged women: associations with behavioral and psychosocial factors and with changes in cardiovascular risk factors. Arterioscler. Thromb. 11 (1991), 1250–57.
K. M. Carpenter, D. S. Hasin, D. B. Allison, M. S. Faith, Relationships between obesity and DSM-IV major depressive disorder, suicide ideation, and suicide attempts: results from a general population study. Am. J. Public Health 90 (2000), 251–7.
E. Johnston, S. Johnson, P. McLeod, M. Johnston, The relation of body mass index to depressive symptoms. Can. J. Public Health 95 (2004), 179–83.
C. U. Onyike, R. M. Crum, H. B. Lee, C. G. Lyketsos, W. W. Eaton, Is obesity associated with major depression? Results from the Third National Health and Nutrition Examination Survey. Am. J. Epidemiol. 158 (2003), 1139–47.
C. Dong, L. E. Sanchez, R. A. Price, Relationship of obesity to depression: a family-based study. Int. J. Obes. Relat. Metab. Disord. 28 (2004), 790–95.
A. F. Jorm, A. E. Korten, H. Christensen, et al., Association of obesity with anxiety, depression and emotional well-being: a community survey. Aust. N. Z. J. Public Health 27 (2003), 434–40.
A. C. Ahlberg, T. Ljung, R. Rosmond, et al., Depression and anxiety symptoms in relation to anthropometry and metabolism in men. Psychiatry Res. 112 (2002), 101–10.
R. E. Roberts, S. Deleger, W. J. Strawbridge, G. A. Kaplan, Prospective association between obesity and depression: evidence from the Alameda County Study. Int. J. Obes. Relat. Metab. Disord. 27 (2003), 514–21.
M. S. Kaplan, N. Huguet, J. T. Newsom, B. H. McFarland, J. Lindsay, Prevalence and correlates of overweight and obesity among older adults: findings from the Canadian National Population Health Survey. J. Gerontol. A Biol. Sci. Med. Sci. 58 (2003), 1018–30.
L. Z. Bin, H. S. Yin, C. W. Man, et al., Obesity and depressive symptoms in Chinese elderly. Int. J. Geriatr. Psychiatry 19 (2004), 68–74.
H. Noppa, T. Hallstrom, Weight gain in adulthood in relation to socioeconomic factors, mental illness and personality traits: a prospective study of middle-aged women. J. Psychosom. Res. 25 (1981), 83–9.
L. DiPietro, R. F. Anda, D. F. Williamson, A. J. Stunkard, Depressive symptoms and weight change in a national cohort of adults. Int. J. Obes. Relat. Metab. Disord. 16 (1992), 745–53.
G. I. Papakostas, T. Petersen, D. V. Iosifescu, et al., Obesity among outpatients with major depressive disorder. Int. J. Neuropsychopharmacol. 8 (2005), 59–63.
A. M. Bardone, T. E. Moffitt, A. Caspi, et al., Adult physical health outcomes of adolescent girls with conduct disorder, depression, and anxiety. J. Am. Acad. Child Adolesc. Psychiatry 37 (1998), 594–601.
D. S. Pine, P. Cohen, J. Brook, J. D. Coplan, Psychiatric symptoms in adolescence as predictors of obesity in early adulthood: a longitudinal study. Am. J. Public Health 87 (1997), 1303–10.
D. S. Pine, R. B. Goldstein, S. Wolk, M. M. Weissman, The association between childhood depression and adulthood body mass index. Pediatrics 107 (2001), 1049–56.
L. P. Richardson, R. Davis, R. Poulton, et al., A longitudinal evaluation of adolescent depression and adult obesity. Arch. Pediatr. Adolesc. Med. 157 (2003), 739–45.
J. C. Barefoot, B. L. Heitmann, M. J. Helms, et al., Symptoms of depression and changes in body weight from adolescence to mid-life. Int. J. Obes. Relat. Metab. Disord. 22 (1998), 688–94.
G. Hasler, D. S. Pine, A. Gamma, et al., The associations between psychopathology and being overweight: a 20-year prospective study. Psychol. Med. 34 (2004), 1047–57.
R. E. Roberts, W. J. Strawbridge, S. Deleger, G. A. Kaplan, Are the fat more jolly? Ann. Behav. Med. 24 (2002), 169–80.
R. E. Roberts, G. A. Kaplan, S. J. Shema, W. J. Strawbridge, Are the obese at greater risk for depression? Am. J. Epidemiol. 152 (2000), 163–70.
I. Berlin, F. Lavergne, Relationship between body-mass index and depressive symptoms in patients with major depression. Eur. Psychiatry 18 (2003), 85–8.
T. L. Schwartz, N. Nihalani, S. Jindal, S. Virk, N. Jones, Psychiatric medication-induced obesity: a review. Obes. Rev. 5 (2004), 115–21.
K. Elfhag, S. Rossner, A. M. Carlsson, Degree of body weight in obesity and Rorschach personality aspects of mental distress. Eat. Weight Disord. 9 (2004), 35–43.
J. Glinski, S. Wetzler, E. Goodman, The psychology of gastric bypass surgery. Obes. Surg. 11 (2001), 581–8.
B. Laferrere, S. Zhu, J. R. Clarkson, et al., Race, menopause, health-related quality of life, and psychological well-being in obese women. Obes. Res. 10 (2002), 1270–75.
G. Marchesini, M. Bellini, S. Natale, et al., Psychiatric distress and health-related quality of life in obesity. Diabetes Nutr. Metab. 16 (2003), 145–54.
D. W. Black, R. B. Goldstein, E. E. Mason, Prevalence of mental disorder in 88 morbidly obese bariatric clinic patients. Am. J. Psychiatry 149 (1992), 227–34.
B. Britz, W. Siegfried, A. Ziegler, et al., Rates of psychiatric disorders in a clinical study group of adolescents with extreme obesity and in obese adolescents ascertained via a population based study. Int. J. Obes. Relat. Metab. Disord. 24 (2000), 1707–14.
M. L. Fitzgibbon, M. R. Stolley, D. S. Kirschenbaum, Obese people who seek treatment have different characteristics than those who do not seek treatment. Health Psychol. 12 (1993), 342–5.
K. R. Fontaine, S. J. Bartlett, I. Barofsky, Health-related quality of life among obese persons seeking and not currently seeking treatment. Int. J. Eat. Disord. 27 (2000), 101–5.
R. L. Kolotkin, R. D. Crosby, R. Pendleton, et al., Health-related quality of life in patients seeking gastric bypass surgery vs non-treatment-seeking controls. Obes. Surg. 13 (2003), 371–7.
R. L. Kolotkin, R. D. Crosby, G. R. Williams, Health-related quality of life varies among obese subgroups. Obes. Res. 10 (2002), 748–56.
M. L. Higgs, T. Wade, M. Cescato, et al., Differences between treatment seekers in an obese population: medical intervention vs. dietary restriction. J. Behav. Med. 20 (1997), 391–405.
R. J. Hafner, J. M. Watts, J. Rogers, Psychological status of morbidly obese women before gastric restriction surgery. J. Psychosom. Res. 31 (1987), 607–12.
E. V. Leckie, R. F. Withers, Obesity and depression. J. Psychosom. Res. 11 (1967), 107–15.
G. J. Musante, P. R. Costanzo, K. E. Friedman, The comorbidity of depression and eating dysregulation processes in a diet-seeking obese population: a matter of gender specificity. Int. J. Eat. Disord. 23 (1998), 65–75.
A. Ryden, J. Karlsson, L. O. Persson, et al., Obesity-related coping and distress and relationship to treatment preference. Br. J. Clin. Psychol. 40 (2001), 177–88.
M. P. Dymek, D. le Grange, K. Neven, J. Alverdy, Quality of life and psychosocial adjustment in patients after Roux-en-Y gastric bypass: a brief report. Obes. Surg. 11 (2001), 32–9.
J. Karlsson, L. Sjostrom, M. Sullivan, Swedish obese subjects (SOS): an intervention study of obesity – two-year follow-up of health-related quality of life (HRQL) and eating behavior after gastric surgery for severe obesity. Int. J. Obes. Relat. Metab. Disord. 22 (1998), 113–26.
S. R. Maddi, S. R. Fox, D. M. Khoshaba, et al., Reduction in psychopathology following bariatric surgery for morbid obesity. Obes. Surg. 11 (2001), 680–85.
G. S. Waters, W. J. Pories, M. S. Swanson, et al., Long-term studies of mental health after the Greenville gastric bypass operation for morbid obesity. Am. J. Surg. 161 (1991), 154–7.
A. Ryden, J. Karlsson, M. Sullivan, J. S. Torgerson, C. Taft, Coping and distress: what happens after intervention? A 2-year follow-up from the Swedish Obese Subjects (SOS) study. Psychosom. Med. 65 (2003), 435–42.
J. B. Dixon, M. E. Dixon, P. E. O'Brien, Depression in association with severe obesity: changes with weight loss. Arch. Intern. Med. 163 (2003), 2058–65.
T. A. Wadden, A. J. Stunkard, J. Liebschutz, Three-year follow-up of the treatment of obesity by very low calorie diet, behavior therapy, and their combination. J. Consult. Clin. Psychol. 56 (1988), 925–8.
O. Ryden, S. A. Olsson, A. Danielsson, P. Nilsson-Ehle, Weight loss after gastroplasty: psychological sequelae in relation to clinical and metabolic observations. J. Am. Coll. Nutr. 8 (1989), 15–23.
W. T. Tsushima, M. P. Bridenstine, J. F. Balfour, MMPI-2 scores in the outcome prediction of gastric bypass surgery. Obes. Surg. 14 (2004), 528–32.
M. M. Clark, B. M. Balsiger, C. D. Sletten, et al., Psychosocial factors and 2-year outcome following bariatric surgery for weight loss. Obes. Surg. 13 (2003), 739–45.
E. M. Inelmen, E. D. Toffanello, G. Enzi, et al., Predictors of drop-out in overweight and obese outpatients. Int. J. Obes. Relat. Metab. Disord. 29 (2005), 122–8.
P. J. Cooper, I. Goodyer, Prevalence and significance of weight and shape concerns in girls aged 11–16 years. Br. J. Psychiatry 171 (1997), 542–4.
D. Neumark-Sztainer, J. Croll, M. Story, et al., Ethnic/racial differences in weight-related concerns and behaviors among adolescent girls and boys: findings from Project EAT. J. Psychosom. Res. 53 (2002), 963–74.
P. Packard, K. S. Krogstrand, Half of rural girls aged 8 to 17 years report weight concerns and dietary changes, with both more prevalent with increased age. J. Am. Diet. Assoc. 102 (2002), 672–7.
J. Wardle, L. Cooke, The impact of obesity on psychological well-being in children. Best Pract. Res. Clin. Endocrinol. Metab. 19 (2005), 421–40.
J. Wardle, K. A. Robb, F. Johnson, et al., Socioeconomic variation in attitudes to eating and weight in female adolescents. Health Psychol. 23 (2004), 275–2.
C. E. Ross, Overweight and depression. J. Health Soc. Behav. 35 (1994), 63–79.
J. Wardle, S. Williamson, F. Johnson, C. Edwards, The psychological consequences of obesity in adolescence: cultural moderators of the obesity-depression association. Int. J. Obes. (Lond.) 30 (2006), 634–42.
R. Goodman, The Strengths and Difficulties Questionnaire: a research note. J. Child Psychol. Psychiatry 38 (1997), 581–6.
A. Myers, J. C. Rosen, Obesity stigmatization and coping: relation to mental health symptoms, body image, and self-esteem. Int. J. Obes. Relat. Metab. Disord. 23 (1999), 221–30.
M. de Zwaan, Binge eating disorder and obesity. Int. J. Obes. Relat. Metab. Disord. 25: Suppl 1 (2001), 51–5.
T. Reichborn-Kjennerud, C. M. Bulik, P. F. Sullivan, K. Tambs, J. R. Harris, Psychiatric and medical symptoms in binge eating in the absence of compensatory behaviors. Obes. Res. 12 (2004), 1445–54.
M. Malone, S. Alger-Mayer, Binge status and quality of life after gastric bypass surgery: a one-year study. Obes. Res. 12 (2004), 473–81.
J. A. Linde, R. W. Jeffery, R. L. Levy, et al., Binge eating disorder, weight control self-efficacy, and depression in overweight men and women. Int. J. Obes. Relat. Metab. Disord. 28 (2004), 418–25.
M. de Zwaan, J. E. Mitchell, L. M. Howell, et al., Characteristics of morbidly obese patients before gastric bypass surgery. Compr. Psychiatry 44 (2003), 428–34.
C. M. Grilo, D. E. Wilfley, K. D. Brownell, J. Rodin, Teasing, body image, and self-esteem in a clinical sample of obese women. Addict. Behav. 19 (1994), 443–50.
T. D. Jackson, C. M. Grilo, R. M. Masheb, Teasing history, onset of obesity, current eating disorder psychopathology, body dissatisfaction, and psychological functioning in binge eating disorder. Obes. Res. 8 (2000), 451–8.
K. E. Friedman, S. K. Reichmann, P. R. Costanzo, G. J. Musante, Body image partially mediates the relationship between obesity and psychological distress. Obes. Res. 10 (2002), 33–41.
D. B. Sarwer, T. A. Wadden, G. D. Foster, Assessment of body image dissatisfaction in obese women: specificity, severity, and clinical significance. J. Consult. Clin. Psychol. 66 (1998), 651–4.
F. Johnson, J. Wardle, Dietary restraint, body dissatisfaction, and psychological distress: a prospective analysis. J. Abnorm. Psychol. 114 (2005), 119–25.
J. P. Foreyt, R. L. Brunner, G. K. Goodrick, et al., Psychological correlates of weight fluctuation. Int. J. Eat. Disord. 17 (1995), 263–75.
S. J. Bartlett, T. A. Wadden, R. A. Vogt, Psychosocial consequences of weight cycling. J. Consult. Clin. Psychol. 64 (1996), 587–92.
T. A. Wadden, S. Bartlett, K. A. Letizia, et al., Relationship of dieting history to resting metabolic rate, body composition, eating behavior, and subsequent weight loss. Am. J. Clin. Nutr. 56 (1992), 203–8S.
G. D. Foster, T. A. Wadden, P. C. Kendall, A. J. Stunkard, R. A. Vogt, Psychological effects of weight loss and regain: a prospective evaluation. J. Consult. Clin. Psychol. 64 (1996), 752–7.
G. D. Foster, D. B. Sarwer, T. A. Wadden, Psychological effects of weight cycling in obese persons: a review and research agenda. Obes. Res. 5 (1997), 474–88.

Reference Title: REFERENCES

Reference Type: reference-list

S. M. Consoli, Depression and associated organic pathologies, a still under-estimated comorbidity: results of the DIALOGUE study. Presse Med. 32 (2003), 10–21.
M. A. Abidi, A. A. Gadit, Liaison psychiatry and referral rates among hospitalized patients. J. Coll. Physicians Surg. Pak. 13 (2003), 274–6.
D. W. Kissane, B. Grabsch, A. Love, et al., Psychiatric disorder in women with early stage and advanced breast cancer: a comparative analysis. Aust. N. Z. J. Psychiatry 38 (2004), 320–26.
D. D. Dunlop, J. S. Lyons, L. M. Manheim, J. Song, R. W. Chang, Arthritis and heart disease as risk factors for major depression: the role of functional limitation. Med. Care 42 (2004), 502–11.
P. P. Katz, E. H. Yelin, Prevalence and correlates of depressive symptoms among persons with rheumatoid arthritis. J. Rheumatol. 20 (1993), 790–96.
T. A. Murberg, E. Bru, T. Aarsland, S. Svebak, Functional status and depression among men and women with congestive heart failure. Int. J. Psychiatr. Med. 28 (1998), 273–91.
J. A. Spertus, M. McDonell, C. L. Woodman, S. D. Fihn, Association between depression and worse disease-specific functional status in outpatients with coronary artery disease. Am. Heart J. 140 (2000), 105–10.
A. M. Addington, J. J. Gallo, D. E. Ford, W. W. Eaton, Epidemiology of unexplained fatigue and major depression in the community: the Baltimore ECA follow-up, 1981–1994. Psychol. Med. 31 (2001), 1037–44.
R. Dantzer, Cytokine-induced sickness behaviour: where do we stand? Brain Behav. Immun. 15 (2001), 7–24.
R. Dantzer, Innate immunity at the forefront of psychoneuroimmunology. Brain Behav. Immun. 18 (2004), 1–6.
B. Beutler, Innate immunity: an overview. Mol. Immunol. 40 (2004), 845–59.
S. Kent, R. M. Bluthe, R. Dantzer, et al., Different receptor mechanisms mediate the pyrogenic and behavioural effects of interleukin 1. Proc. Natl. Acad. Sci. U. S. A. 89 (1992), 9117–20.
P. Parnet, K. W. Kelley, R. M. Bluthe, R. Dantzer, Expression and regulation of interleukin-1 receptors in the brain: role in cytokines-induced sickness behaviour. J. Neuroimmunol. 125 (2002), 5–14.
A. M. van Dam, M. Brouns, S. Louisse, F. Berkenbosch, Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: a pathway for the induction of non-specific symptoms of sickness? Brain Res. 588 (1992), 291–6.
S. Laye, P. Parnet, E. Goujon, R. Dantzer, Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Brain Res. Mol. Brain Res. 27 (1994), 157–62.
S. Laye, G. Gheusi, S. Cremona, et al., Endogenous brain IL-1 mediates LPS-induced anorexia and hypothalamic cytokine expression. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279 (2000), R93–8.
R. Dantzer, J. P. Konsman, R. M. Bluthe, K. W. Kelley, Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent? Auton. Neurosci. 85 (2000), 60–65.
G. N. Luheshi, R. M. Bluthe, D. Rushforth, et al., Vagotomy attenuates the behavioural but not the pyrogenic effects of interleukin-1 in rats. Auton. Neurosci. 85 (2000), 127–32.
J. P. Konsman, P. Parnet, R. Dantzer, Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci. 25 (2002), 154–9.
B. L. Hart, Biological basis of the behaviour of sick animals. Neurosci. Biobehav. Rev. 12 (1988), 123–37.
R. Dantzer, K. W. Kelley, Stress and immunity: an integrated view of relationships between the brain and the immune system. Life Sci. 44 (1989), 1995–2008.
M. J. Kluger, Temperature regulation, fever, and disease. Int. Rev. Physiol. 20 (1979), 209–51.
M. J. Kluger, Is fever beneficial? Yale J. Biol. Med. 59 (1986), 89–95.
L. R. Watkins, S. F. Maier, The pain of being sick: implications of immune-to-brain communication for understanding pain. Annu. Rev. Psychol. 51 (2000), 29–57.
N. E. Miller, Some psychophysiological studies of motivation and of the behavioural effects of illness. Bull. Br. Psychol. Soc. 17 (1964), 1–20.
A. Aubert, G. Goodall, R. Dantzer, Compared effects of cold ambient temperature and cytokines on macronutrient intake in rats. Physiol. Behav. 57 (1995), 869–73.
A. Aubert, C. Vega, R. Dantzer, G. Goodall, Pyrogens specifically disrupt the acquisition of a task involving cognitive processing in the rat. Brain Behav. Immun. 9 (1995), 129–48.
A. Aubert, G. Goodall, R. Dantzer, G. Gheusi, Differential effects of lipopolysaccharide on pup retrieving and nest building in lactating mice. Brain Behav. Immun. 11 (1997), 107–18.
H. Anisman, Z. Merali, Cytokines, stress and depressive illness: brain–immune interactions. Ann. Med. 35 (2003), 2–11.
L. Capuron, A. Ravaud, A. H. Miller, R. Dantzer, Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy. Brain Behav. Immun. 18 (2004), 205–13.
L. Capuron, J. F. Gumnick, D. L. Musselman, et al., Neurobehavioural effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 26 (2002), 643–52.
I. Jones, N. Craddock, Candidate gene studies of bipolar disorder. Ann. Med. 33 (2001), 248–56.
C. Heim, C. B. Nemeroff, The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol. Psychiatry 49 (2001), 1023–39.
L. Capuron, A. Ravaud, Prediction of the depressive effects of interferon alfa therapy by the patient's initial affective state. N. Engl. J. Med. 340 (1999), 1370.
H. Miyaoka, T. Otsubo, K. Kamijima, et al., Depression from interferon therapy in patients with hepatitis C. Am. J. Psychiatry 156 (1999), 1120.
L. Capuron, G. Neurauter, D. L. Musselman, et al., Interferon-alpha-induced changes in tryptophan metabolism: relationship to depression and paroxetine treatment. Biol. Psychiatry 54 (2003), 906–14.
C. Constant, L. Castera, R. Dantzer, et al., Mood alterations during interferon-alpha therapy in chronic hepatitis C: evidence for an overlap between manic/hypomanic and depressive symptoms. J. Clin. Psychiatry 66 (2005), 1050–57.
L. Capuron, A. Ravaud, P. J. Neveu, et al., Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol. Psychiatry 7 (2002), 468–73.
M. Maes, S. Bonaccorso, V. Marino, et al., Treatment with interferon-alpha (IFN alpha) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFN alpha-induced depressive and anxiety symptoms and immune activation. Mol. Psychiatry 6 (2001), 475–80.
J. Lestage, D. Verrier, K. Palin, R. Dantzer, The enzyme indoleamine 2,3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen. Brain Behav. Immun. 16 (2002), 596–601.
F. D. Juengling, D. Ebert, O. Gut, et al., Prefrontal cortical hypometabolism during low-dose interferon alpha treatment. Psychopharmacology (Berl.) 152 (2000), 383–9.
L. Capuron, G. Pagnoni, D. H. Lawson, et al., Altered fronto-pallidal activity during high-dose interferon-alpha treatment as determined by positron emission tomography. Abstr. Soc. Neurosci. (2002), 498.5.
R. Hashimoto, T. Nagatsu, T. Ohta, M. Mizutani, I. Omura, Changes in the concentrations of tetrahydrobiopterin, the cofactor of tyrosine hydroxylase, in blood under physical stress and in depression. Ann. N. Y. Acad. Sci. 1018 (2004), 378–86.
M. Gilchrist, C. Hesslinger, A. D. Befus, Tetrahydrobiopterin, a critical factor in the production and role of nitric oxide in mast cells. J. Biol. Chem. 278 (2003), 50 607–14.
T. Kitagami, K. Yamada, H. Miura, et al., Mechanism of systemically injected interferon-alpha impeding monoamine biosynthesis in rats: role of nitric oxide as a signal crossing the blood–brain barrier. Brain Res. 978 (2003), 104–14.
A. Appels, F. W. Bar, J. Bar, C. Bruggeman, M. de Baets, Inflammation, depressive symptomtology, and coronary artery disease. Psychosom. Med. 62 (2000), 601–605.
F. Lesperance, N. Frasure-Smith, P. Theroux, M. Irwin, The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes. Am. J. Psychiatry 161 (2004), 271–7.
C. S. Cleeland, G. J. Bennett, R. Dantzer, et al., Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer 97 (2003), 2919–25.
C. Holmes, M. El-Okl, A. L. Williams, et al., Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 74 (2003), 788–9.
P. Eikelenboom, W. J. Hoogendijk, C. Jonker, W. van Tilburg, Immunological mechanisms and the spectrum of psychiatric syndromes in Alzheimer's disease. J. Psychiatr. Res. 36 (2002), 269–80.

Reference Title: REFERENCES

Reference Type: reference-list

E. P. Guazzo, P. J. Kirkpatrick, I. M. Goodyer, S. Shiers, J. Herbert, Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age. J. Clin. Endocrinol. Metab. 81 (1996), 3951–60.
E. E. Baulieu, Neurosteroids: a novel function of the brain. Psychoneuroendocrinology 23 (1998), 963–87.
D. Liu, J. S. Dillon, Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Galpha(i2,3). J. Biol. Chem. 277 (2002), 21 379–88.
K. K. Karishma, J. Herbert, Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression. Eur. J. Neurosci. 16 (2002), 445–53.
V. G. Kimonides, M. G. Spillantini, M. V. Sofroniew, J. W. Fawcett, J. Herbert, Dehydroepiandrosterone antagonizes the neurotoxic effects of corticosterone and translocation of stress-activated protein kinase 3 in hippocampal primary cultures. Neuroscience 89 (1999), 429–36.
V. G. Kimonides, N. H. Khatibi, C. N. Svendsen, M. V. Sofroniew, J. Herbert, Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc. Natl. Acad. Sci. U. S. A. 95 (1998), 1852–7.
D. T. Chalmers, S. P. Kwak, A. Mansour, H. Akil, S. J. Watson, Corticosteroids regulate brain hippocampal 5-HT1A receptor mRNA expression. J. Neurosci. 13 (1993), 914–23.
S. Wissink, O. Meijers, D. Pearce, B. van der Berg, P. van der Saag, Regulation of the rat serotonin-1A receptor gene by corticosteroids. J. Biol. Chem. 275 (2000), 1321–6.
R. Rosmond, Y. C. Chagnon, M. Chagnon, et al., A polymorphism of the 5′-flanking region of the glucocorticoid receptor gene locus is associated with basal cortisol secretion in men. Metabolism 49 (2000), 1197–9.
R. Rosmond, M. Chagnon, C. Bouchard, P. Bjorntorp, A polymorphism in the regulatory region of the corticotropin-releasing hormone gene in relation to cortisol secretion, obesity, and gene–gene interaction. Metabolism 50 (2001), 1059–62.
C. B. Nemeroff, New directions in the development of antidepressants: the interface of neurobiology and psychiatry. Hum. Psychopharmacol. 17: Suppl 1 (2002), 13–16.
J. W. Smoller, J. F. Rosenbaum, J. Biederman, et al., Association of a genetic marker at the corticotropin-releasing hormone locus with behavioral inhibition. Biol. Psychiatry 54 (2003), 1376–81.
J. W. Smoller, J. F. Rosenbaum, J. Biederman, et al., Genetic association analysis of behavioral inhibition using candidate loci from mouse models. Am. J. Med. Genet. 105 (2001), 226–35.
B. G. Challis, J. Luan, J. Keogh, et al., Genetic variation in the corticotrophin-releasing factor receptors: identification of single-nucleotide polymorphisms and association studies with obesity in UK Caucasians. Int. J. Obes. Relat. Metab. Disord. 28 (2004), 442–6.
M. R. Gunnar, B. Donzella, Social regulation of the cortisol levels in early human development. Psychoneuroendocrinology 27 (2002), 199–220.
M. Bartels, E. J. de Geus, C. Kirschbaum, F. Sluyter, D. I. Boomsma, Heritability of daytime cortisol levels in children. Behav. Genet. 33 (2003), 421–33.
P. Linkowski, A. Van Onderbergen, M. Kerkhofs, et al., Twin study of the 24-h cortisol profile: evidence for genetic control of the human circadian clock. Am. J. Physiol. 264 (1993), E173–81.
A. W. Meikle, J. D. Stringham, M. G. Woodward, D. T. Bishop, Heritability of variation of plasma cortisol levels. Metabolism 37 (1988), 514–17.
I. M. Goodyer, J. Herbert, P. M. E. Altham, et al., Adrenal secretion during major depression in 8 to 16 year olds: I. Altered diurnal rhythms in salivary cortisol and dehydroepiandrosterone (DHEA) at presentation. Psychol. Med. 19 (1996), 245–56.
C. Kirschbaum, D. Hellhammer, Salivary cortisol in psychoendocrine research: recent developments and applications. Psychoneuroendocrinology 19 (1994), 313–33.
I. M. Goodyer, J. Herbert, A. Tamplin, P. M. Altham, First-episode major depression in adolescents: affective, cognitive and endocrine characteristics of risk status and predictors of onset. Br. J. Psychiatry 176 (2000), 142–9.
M. R. Gunnar, Quality of early care and buffering of neuroendocrine stress reactions: potential effects on the developing human brain. Prev. Med. 27 (1998), 208–11.
J. C. Pruessner, O. T. Wolf, D. H. Hellhammer, et al., Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity. Life Sci. 61 (1997), 2539–49.
J. C. Pruessner, D. H. Hellhammer, C. Kirschbaum, Burnout, perceived stress, and cortisol responses to awakening. Psychosom. Med. 61 (1999), 197–204.
P. M. Plotsky, M. J. Owens, C. B. Nemeroff, Psychoneuroendocrinology of depression: hypothalamic-pituitary-adrenal axis. Psychiatr. Clin. North Am. 21 (1998), 293–307.
M. Deuschle, U. Schweiger, U. Gotthardt, et al., The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test. Biol. Psychiatry 43 (1998), 762–6.
S. Watson, P. Gallagher, D. Del-Estal, et al., Hypothalamic-pituitary-adrenal axis function in patients with chronic depression. Psychol. Med. 32 (2002), 1021–8.
S. B. Park, D. J. Williamson, P. J. Cowen, 5-HT neuroendocrine function in major depression: prolactin and cortisol responses to d-fenfluramine. Psychol. Med. 26 (1996), 1191–6.
I. M. Goodyer, J. Herbert, A. Tamplin, P. M. Altham, Recent life events, cortisol, dehydroepiandrosterone and the onset of major depression in high-risk adolescents. Br. J. Psychiatry 177 (2000), 499–504.
T. O. Harris, S. Borsanyi, S. Messari, et al., Morning cortisol as a risk factor for subsequent major depressive disorder in adult women. Br. J. Psychiatry 177 (2000), 505–10.
P. L. Strickland, J. F. Deakin, C. Percival, et al., Bio-social origins of depression in the community: interactions between a. dversity. social, cortisol and serotonin neurotransmission. Br. J. Psychiatry 180 (2002), 168–73.
I. M. Goodyer, J. Herbert, A. Tamplin, Psychoendocrine antecedents of persistent first-episode major depression in adolescents: a community-based longitudinal enquiry. Psychol. Med. 33 (2003), 601–10.
J. W. Newcomer, G. Selke, A. K. Melson, et al., Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Arch. Gen. Psychiatry 56 (1999), 527–33.
S. J. Lupien, C. W. Wilkinson, S. Briere, et al., The modulatory effects of corticosteroids on cognition: studies in young human populations. Psychoneuroendocrinology 27 (2002), 401–16.
S. J. Lupien, M. Lepage, Stress, memory, and the hippocampus: can't live with it, can't live without it. Behav. Brain Res. 127 (2001), 137–58.
S. J. Lupien, S. King, M. J. Meaney, B. S. McEwen, Can poverty get under your skin? Basal cortisol levels and cognitive function in children from low and high socioeconomic status. Devel. Psychopathol. 13 (2001), 653–76.
S. J. Lupien, C. W. Wilkinson, S. Briere, et al., Acute modulation of aged human memory by pharmacological manipulation of glucocorticoids. J. Clin. Endocrinol. Metab. 87 (2002), 3798–807.
S. J. Lupien, S. King, M. J. Meaney, B. S. McEwen, Child's stress hormone levels correlate with mother's socioeconomic status and depressive state. Biol. Psychiatry 48 (2000), 976–80.
W. C. Drevets, Neuroimaging abnormalities in the amygdala in mood disorders. Ann. N. Y. Acad. Sci. 985 (2003), 420–44.
D. A. Seminowicz, H. S. Mayberg, A. R. McIntosh, et al., Limbic-frontal circuitry in major depression: a path modeling metanalysis. Neuroimage 22 (2004), 409–18.
M. Liotti, H. S. Mayberg, S. K. Brannan, et al., Differential limbic–cortical correlates of sadness and anxiety in healthy subjects: implication for affective disorders. Biol. Psychiatry 48 (2000), 30–42.
J. H. Meyer, S. Kapur, B. Eisfeld, et al., The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study. Am. J. Psychiatry 158 (2001), 78–85.
S. Wust, E. F. Van Rossum, I. S. Federenko, et al., Common polymorphisms in the glucocorticoid receptor gene are associated with adrenocortical responses to psychosocial stress. J. Clin. Endocrinol. Metab. 89 (2004), 565–73.
A. Stevens, D. W. Ray, E. Zeggini, et al., Glucocorticoid sensitivity is determined by a specific glucocorticoid receptor haplotype. J. Clin. Endocrinol. Metab. 89 (2004), 892–7.
E. F. Van Rossum, P. G. Voorhoeve, S. J. te Velde, et al., The ER22/23EK polymorphism in the glucocorticoid receptor gene is associated with a beneficial body composition and muscle strength in young adults. J. Clin. Endocrinol. Metab. 89 (2004), 4004–4009.
E. F. van Rossum, J. W. Koper, A. W. van den Beld, et al., Identification of the BclI polymorphism in the glucocorticoid receptor gene: association with sensitivity to glucocorticoids in vivo and body mass index. Clin. Endocrinol. (Oxf.) 59 (2003), 585–92.
P. D. Kroboth, F. S. Salek, A. L. Pittenger, T. J. Fabian, R. F. Frye, DHEA and DHEA-S: a review. J. Clin. Pharmacol. 39 (1999), 327–48.
C. R. Parker, Dehydroepiandrosterone and dehydroepiandrosterone sulfate production in the human adrenal during development and aging. Steroids 64 (1999), 640–47.
F. Labrie, A. Belanger, L. Cusan, J. L. Gomez, B. Candas, Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J. Clin. Endocrinol. Metab. 82 (1997), 2396–402.
P. D. Kroboth, J. A. Amico, R. A. Stone, et al., Influence of DHEA administration on 24-hour cortisol concentrations. J. Clin. Psychopharmacol. 23 (2003), 96–9.
I. M. Goodyer, R. J. Park, J. Herbert, Psychosocial and endocrine features of chronic first-episode major depression in 8–16 year olds. Biol. Psychiatry 50 (2001), 351–7.
A. Beishuizen, L. G. Thijs, I. Vermes, Decreased levels of dehydroepiandrosterone sulphate in severe critical illness: a sign of exhausted adrenal reserve? Crit. Care 6 (2002), 434–8.
C. Marx, S. Petros, S. R. Bornstein, et al., Adrenocortical hormones in survivors and nonsurvivors of severe sepsis: diverse time course of dehydroepiandrosterone, dehydroepiandrosterone-sulfate, and cortisol. Crit. Care Med. 31 (2003), 1382–8.
F. A. Huppert, J. K. Van Niekerk, Dehydroepiandrosterone (DHEA) supplementation for cognitive function. Cochrane Database Syst. Rev. 2 (2001), CD000304.
P. J. Hunt, E. M. Gurnell, F. A. Huppert, et al., Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J. Clin. Endocrinol. Metab. 85 (2000), 4650–56.
J. K. van Niekerk, F. A. Huppert, J. Herbert, Salivary cortisol and DHEA: association with measures of cognition and well-being in normal older men, and effects of three months of DHEA supplementation. Psychoneuroendocrinology 26 (2001), 591–612.
O. M. Wolkowitz, V. I. Reus, A. Keebler, et al., Double-blind treatment of major depression with dehydroepiandrosterone. Am. J. Psychiatry 156 (1999), 646–9.
R. D. Strous, R. Maayan, R. Lapidus, et al., Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia. Arch. Gen. Psychiatry 60 (2003), 133–41.
I. C. Weaver, N. Cervoni, F. A. Champagne, et al., Epigenetic programming by maternal behavior. Nat. Neurosci. 7 (2004), 847–54.
S. L. Halligan, J. Herbert, I. M. Goodyer, L. Murray, Exposure to postnatal depression predicts elevated cortisol in adolescent offspring. Biol. Psychiatry 55 (2004), 376–81.
M. Champoux, A. Bennett, C. Shannon, et al., Serotonin transporter gene polymorphism, differential early rearing, and behavior in rhesus monkey neonates. Mol. Psychiatry 7 (2002), 1058–63.
A. Caspi, K. Sugden, T. E. Moffitt, et al., Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301 (2003), 386–9.
M. R. Gunnar, S. J. Morison, K. Chisholm, M. Schuder, Salivary cortisol levels in children adopted from Romanian orphanages. Dev. Psychopathol. 13 (2001), 611–28.
R. Yehuda, S. L. Halligan, J. A. Golier, R. Grossman, L. M. Bierer, Effects of trauma exposure on the cortisol response to dexamethasone administration in PTSD and major depressive disorder. Psychoneuroendocrinology 29 (2004), 389–404.
R. Loeber, S. M. Green, B. B. Lahey, P. J. Frick, K. McBurnett, Findings on disruptive behavior disorders from the first decade of the Developmental Trends Study. Clin. Child. Fam. Psychol. Rev. 3 (2000), 37–60.
K. Pajer, W. Gardner, R. T. Rubin, J. Perel, S. Neal, Decreased cortisol levels in adolescent girls with conduct disorder. Arch. Gen. Psychiatry 58 (2001), 297–302.
A. A. Stone, J. E. Schwartz, J. Smyth, et al., Individual differences in the diurnal cycle of salivary free cortisol: a replication of flattened cycles for some individuals. Psychoneuroendocrinology 26 (2001), 295–306.
S. H. van Goozen, W. Matthys, P. T. Cohen-Kettenis, et al., Salivary cortisol and cardiovascular activity during stress in oppositional-defiant disorder boys and normal controls. Biol. Psychiatry 43 (1998), 531–9.
S. H. van Goozen, W. Matthys, P. T. Cohen-Kettenis, J. K. Buitelaar, H. van Engeland, Hypothalamic-pituitary-adrenal axis and autonomic nervous system activity in disruptive children and matched controls. J. Am. Acad. Child. Adolesc. Psychiatry 39 (2000), 1438–45.
A. Raine, P. H. Venables, S. A. Mednick, Low resting heart rate at age 3 years predisposes to aggression at age 11 years: evidence from the Mauritius Child Health Project. J. Am. Acad. Child. Adolesc. Psychiatry 36 (1997), 1457–64.
A. Raine, C. Reynolds, P. H. Venables, S. A. Mednick, D. P. Farrington, Fearlessness, stimulation-seeking, and large body size at age 3 years as early predispositions to childhood aggression at age 11 years. Arch. Gen. Psychiatry 55 (1998), 745–51.
R. J. Blair, E. Colledge, L. Murray, D. G. Mitchell, A selective impairment in the processing of sad and fearful expressions in children with psychopathic tendencies. J. Abnorm. Child Psychol. 29 (2001), 491–8.
A. Raine, T. Lencz, S. Bihrle, L. LaCasse, P. Colletti, Reduced prefrontal gray matter volume and reduced autonomic activity in antisocial personality disorder. Arch. Gen. Psychiatry 57 (2000), 119–27.
M. Dolan, W. J. Deakin, N. Roberts, I. Anderson, Serotonergic and cognitive impairment in impulsive aggressive personality disordered offenders: are there implications for treatment? Psychol. Med. 32 (2002), 105–17.
R. DeRijk, M. Schaaf, E. de Kloet, Glucocorticoid receptor variants: clinical implications. J. Steroid. Biochem. Mol. Biol. 81 (2002), 103–22.
C. L. Raison, A. H. Miller, When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am. J. Psychiatry 160 (2003), 1554–65.

Reference Title: REFERENCES

Reference Type: reference-list

American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, 4th edn (Washington, DC: American Psychiatric Association, 2000).
M. H. Rapaport, L. L. Judd, P. J. Schettler, et al., A descriptive analysis of minor depression. Am. J. Psychiatry 159 (2002), 637–43.
A. K. Berger, B. J. Small, Y. Forsell, L. Backman, Preclinical symptoms of major depression in very old age: a prospective longitudinal study. Am. J. Psychiatry 155 (1998), 1039–43.
J. M. Lyness, E. D. Caine, Y. Conwell, D. King, Depressive symptoms, medical illness, and functional status in depressed psychiatric inpatients. Am. J. Psychiatry 150 (1993), 910–15.
R. D. Hays, K. B. Wells, C. D. Sherbourne, W. Rogers, K. Spritzer, Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Arch. Gen. Psychiatry 52 (1995), 11–19.
L. R. Wulsin, G. E. Vailant, V. E. Wells, A systematic review of the mortality of depression. Psychosom. Med. 61 (1999), 6–17.
M. L. Bruce, P. J. Leaf, G. P. Rozal, L. Florio, R. A. Hoff, Psychiatric status and 9-year mortality data in the New Haven Epidemiologic Catchment Area Study. Am. J. Psychiatry 151 (1994), 716–21.
C. Herrmann, S. Brand-Driehorst, B. Kaminsky, et al., Diagnostic groups and depressed mood as predictors of 22-month mortality in medical inpatients. Psychosom. Med. 60 (1998), 570–77.
B. W. Rovner, Depression and increased risk of mortality in the nursing home patient. Am. J. Med. 94 (1993), 19–22S.
N. Frasure-Smith, F. Lespérance, M. Talajic, Depression following myocardial infarction: impact on 6-month survival. J. Am. Med. Assoc. 270 (1993), 1819–25.
N. Frasure-Smith, F. Lespérance, M. Talajic, The impact of negative emotions on prognosis following myocardial infarction: is it more than depression? Health Psychol. 14 (1995), 388–98.
M. A. Dew, C. C. Hoch, D. J. Buysse, et al., Healthy older adults' sleep predicts all-cause mortality at 4 to 19 years of follow-up. Psychosom. Med. 65 (2003), 63–73.
D. F. Kripke, L. Garfinkel, D. L. Wingard, M. R. Klauber, M. R. Marler, Mortality associated with sleep duration and insomnia. Arch. Gen. Psychiatry 59 (2002), 131–6.
D. Gottlieb, D. Schulman, B. Nam, R. Agostino, W. Kannel, Sleep duration predicts mortality: the Framingham study. Presented at the 16th Annual Meeting of the Associated Professional Sleep Societies, 8–13 June 2002, Seattle, WA.
A. B. Newman, C. F. Spiekerman, P. Enright, et al., Daytime sleepiness predicts mortality and cardiovascular disease in older adults: the Cardiovascular Health Study Research Group. J. Am. Geriatr. Soc. 48 (2000), 115–23.
M. J. Owens, C. B. Nemeroff, Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev. 91 (1991), 425–73.
E. M. Friedman, M. A. Irwin, A role for CRH and the sympathetic nervous system in stress-induced immunosuppression. Ann. N. Y. Acad. Sci. 771 (1995), 396–418.
E. M. Friedman, M. R. Irwin, Modulation of immune cell function by the autonomic nervous system. Pharmacol. Ther. 74 (1997), 27–38.
M. Irwin, W. Vale, C. Rivier, Central corticotropin-releasing factor mediates the suppressive effect of stress on natural killer cytotoxicity. Endocrinology 126 (1990), 2837–44.
M. Irwin, Brain corticotropin releasing hormone- and interleukin-1 β-induced suppression of specific antibody production. Endocrinology 133 (1993), 1352–60.
M. Irwin, M. Brown, T. Patterson, et al., Y. Neuropeptide and natural killer cell activity: findings in depression and Alzheimer caregiver stress. FASEB J. 5 (1991), 3100–107.
V. M. Sanders, R. H. Straub, Norepinephrine, the beta-adrenergic receptor, and immunity. Brain Behav. Immun. 16 (2002), 290–332.
J. A. Moynihan, S. Y. Stevens, Mechanisms of stress-induced modulation of immunity in animals. In Psychoneuroimmunology, ed. R. Ader, D. L. Felten, N. Cohen (San Diego, CA: Academic Press, 2001), pp. 227–50.
F. S. Dhabhar, A. H. Miller, B. S. McEwen, R. L. Spencer, Stress-induced changes in blood leukocyte distribution: role of adrenal steroid hormones. J. Immunol. 157 (1996), 1638–44.
M. Irwin, T. Patterson, T. L. Smith, et al., Reduction of immune function in life stress and depression. Biol. Psychiatry 27 (1990), 22–30.
M. Irwin, H. Weiner, Depressive symptoms and immune function during bereavement. In Biopsychosocial Aspects of Bereavement, ed. S. Zisook (Washington, DC: APA Press, 1987), pp. 156–74.
M. Maes, M. Van der Planken, W. J. Stevens, et al., Leukocytosis, monocytosis, and neutrophilia: hallmarks of severe depression. J. Psychiatr. Res. 26 (1992), 125–34.
Z. Kronfol, R. Turner, H. Nasrallah, G. Winokur, Leukocyte regulation in depression and schizophrenia. Psychiatry Res. 13 (1984), 13–18.
M. Irwin, T. L. Smith, J. C. Gillin, Low natural killer cytotoxicity in major depression. Life Sci. 41 (1987), 2127–33.
P. Surtees, N. Wainwright, N. Day, et al., Association of depression with peripheral leukocyte counts in EPIC-Norfolk-role of sex and cigarette smoking. J. Psychsom. Res. 54 (2003), 303–6.
S. J. Schleifer, J. A. Bartlett, S. E. Keller, et al., Immunity in adolescents with major depression. J. Am. Acad. Child Adolesc. Psychiatry 41 (2002), 1054–60.
T. B. Herbert, S. Cohen, Depression and immunity: a meta-analytic review. Psychol. Bull. 113 (1993), 472–86.
D. L. Evans, J. D. Folds, J. M. Petitto, et al., Circulating natural killer cell phenotypes in men and women with major depression. Arch. Gen. Psychiatry 49 (1992), 388–95.
S. J. Schleifer, S. E. Keller, R. N. Bond, J. Cohen, M. Stein, Major depressive disorder and immunity: role of age, sex, severity, and hospitalization. Arch. Gen. Psychiatry 46 (1989), 81–7.
E. P. Zorrilla, L. Luborsky, J. R. McKay, et al., The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav. Immun. 15 (2001), 199–226.
Z. Kronfol, J. D. House, Depression, hypothalamic-pituitary adrenocortical activity and lymphocyte function. Psychopharmacol. Bull. 21 (1985), 476–8.
Z. Kronfol, J. Silva, J. Greden, et al., Impaired lymphocyte function in depressive illness. Life Sci. 33 (1983), 241–7.
J. Albrecht, J. Helderman, M. Schlesser, J. Rush, A controlled study of cellular immune function in affective disorders before and during somatic therapy. Psychiatry Res. 15 (1985), 185–93.
E. Syvalahti, J. Eskola, O. Ruuskanen, T. Laine, Nonsuppression of cortisol and immune function in depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 9 (1985), 413–22.
S. J. Schleifer, S. E. Keller, S. G. Siris, K. L. Davis, M. Stein, Depression and immunity: lymphocyte function in ambulatory depressed patients, hospitalized schizophrenic patients, and patients hospitalized for herniorrhaphy. Arch. Gen. Psychiatry 42 (1985), 129–33.
Z. Kronfol, J. D. House, J. Silva, J. Greden, B. J. Carroll, Depression, urinary free cortisol excretion, and lymphocyte function. Br. J. Psychiatry 148 (1986), 70–73.
J. R. Calabrese, R. G. Skwerer, B. Barna, et al., Depression, immunocompetence, and prostaglandins of the E-series. Psychol. Res. 17 (1986), 41–7.
M. T. Lowy, A. T. Reder, G. J. Gormley, H. Y. Meltzer, Comparison of in vivo and in vitro glucocorticoid sensitivity in depression: relationship to the dexamethasone suppression test. Biol. Psychiatry 24 (1988), 619–30.
M. Maes, E. Bosmans, E. Suy, B. Minner, J. Raus, Impaired lymphocyte stimulation by mitogens in severely depressed patients: a complex interface with HPA axis hyperfunction, noradrenergic activity and the ageing process. Br. J. Psychiatry 155 (1989), 793–8.
L. L. Altshuler, S. Plaeger-Marshall, S. Richeimer, M. Daniels, L. R. Baxter, Jr, Lymphocyte function in major depression. Acta Psychiatr. Scand. 80 (1989), 132–6.
D. F. Darko, J. C. Gillin, S. C. Risch, et al., Mitogen-stimulated lymphocyte proliferation and pituitary hormones in major depression. Biol. Psychiatry 26 (1989), 145–55.
Z. Kronfol, M. Nair, J. Goodson, et al., Natural killer cell activity in depressive illness: a preliminary report. Biol. Psychiatry 26 (1989), 753–6.
P. Cosyns, M. Maes, M. Vandewoude, et al., Impaired mitogen-induced lymphocyte responses and the hypothalamic-pituitary-adrenal axis in depressive disorders. J. Affect. Disord. 16 (1989), 41–8.
C. Bartoloni, L. Guidi, L. Antico, et al., Psychological status of institutionalized aged: influences on immune parameters and endocrinological correlates. Int. J. Neurosci. 51 (1990), 279–81.
C. McAdams, B. E. Leonard, Neutrophil and monocyte phagocytosis in depressed patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 17 (1993), 971–84.
B. Birmaher, B. S. Rabin, M. R. Garcia, et al., Cellular immunity in depressed, conduct disorder, and normal adolescents: role of adverse life events. J. Am. Acad. Child Adolesc. Psychol. 33 (1994), 671–8.
S. J. Schleifer, S. E. Keller, J. A. Bartlett, Panic disorder and immunity: few effects on circulating lymphocytes, mitogen response, and NK cell activity. Brain Behav. Immun. 16 (2002), 698–705.
M. Stein, A. H. Miller, R. L. Trestman, Depression, the immune system, and health and illness. Arch. Gen. Psychiatry 48 (1991), 171–7.
M. Irwin, C. Miller, Decreased natural killer cell responses and altered interleukin-6 and interleukin-10 production in alcoholism: an interaction between alcohol dependence and African-American ethnicity. Alcohol Clin. Exp. Res. 24 (2000), 560–69.
M. Irwin, Effects of sleep and sleep loss on immunity and cytokines. Brain Behav. Immun. 16 (2002), 503–12.
P. C. Mohl, L. Huang, C. Bowden, et al., Natural killer cell activity in major depression. Am. J. Psychiatry 144 (1987), 1619.
Z. Kronfol, D. G. Remick, Cytokines and the brain: implications for clinical psychiatry. Am. J. Psychiatry 157 (2000), 683–94.
M. E. Bauer, A. Papadopoulos, L. Poon, et al., Altered glucocorticoid immunoregulation in treatment resistant depression. Psychoneuroendocrinology 28 (2003), 49–65.
A. Seidel, V. Arolt, M. Hunstiger, et al., Cytokine production and serum proteins in depression. Scand. J. Immunol. 41 (1995), 534–8.
P Trzonkowski, J. Mysliwska, B. Godlewska, et al., Immune consequences of the spontaneous pro-inflammatory status in depressed elderly patients. Brain Behav. Immun. 18 (2004), 135–48.
M. A. Maes, review on the acute phase response in major depression. Rev. Neurosci. 4 (1993), 407–16.
M. Maes, S. Scharpe, L. Van Grootel, et al., Higher alpha 1-antritrypsin, haptoglobin, ceruloplasmin and lower retinol binding protein plasma levels during depression: further evidence for the existence of an inflammatory respose during that illness. J. Affect. Disord. 24 (1992), 183–92.